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Oocytes acquire developmental competence during the final stages of folliculogenesis and 
during oocyte maturation to enable successful preimplantation embryo development. It is 
increasingly evident that the peri-conceptual environment surrounding the oocyte has a 
significant impact on the developmental competence and long-term health of offspring. Thus 
alterations to oocytes are emerging as significant contributors to the reduced conception and 
pregnancy rates that are commonly observed in conditions such as maternal diabetes or 
obesity. This thesis investigated a number of mechanisms by which alterations to oocytes, 
particularly lipids and oxidative stress, impinge upon the developmental program, namely 
the mitochondria and differentiation potential of embryonic cells.  
  
Firstly, the role of membrane functional domains in oocyte developmental competence was 
examined. Oocytes are cholesterol-laden cells and I sought to determine whether oocyte 
cholesterol stores are important for establishing membrane structure and functional lipid 
rafts during embryogenesis (via cholesterol depletion). I established that cholesterol 
depletion resulted in a significant reduction of cholesterol in the oocytes and disrupted 
oocyte raft distribution as verified by staining. I also showed that cholesterol depletion 
resulted in a failure to cleave in some embryos and delayed cleavage in others. Even when 
they developed to morphologically normal blastocysts, comprehensive analysis 
demonstrated that cholesterol depletion of oocytes led to embryos with reduced cell number, 
lower neutral lipid content and a disruption in raft distribution. These experiments 
underscored the importance of oocyte cholesterol stores for preimplantation development 
and membrane lipid raft formation and function during embryogenesis. 
 
To extend these findings, lipid raft and mitochondrial phenotypes were examined in oocytes 
and embryos of mice with high-fat diet (HFD)-induced obesity.  I showed that oocytes and 
embryos from HFD mice exhibited disorganised lipid raft distribution and that mitochondrial 
activity was significantly reduced in the oocytes. Interestingly, BGP-15 treatment, an orally 
active compound that is currently in human clinical trials for type II diabetes, was able to 
restore oocyte mitochondrial activity, lipid raft distribution in the oocytes and to a lesser 
extent in the HFD embryos. In particular, there was a massive induction of mitochondrial 
DNA (mtDNA) copy number in oocytes following BGP-15 treatment to HFD mice. 
II 
 
To understand the mechanism by which BGP-15 improves oocyte developmental 
competence, I focused on the mitochondria, essential organelles that are critical for embryo 
development and transgenerationally inherited. The kinetics of mtDNA replication and 
ability of BGP-15 to counteract stress was examined in multiple species and in vitro models 
of lipid-induced or oxidative stress. There was an accumulation of mtDNA levels during 
oocyte maturation from germinal vesicle (GV) to metaphase II (MII) oocytes in the mice 
and a significant mtDNA replication during embryo development in the mice, bovine and 
macaque. Supplementation of in vitro maturation (IVM) culture medium with high lipids 
suppressed mtDNA levels in the oocytes and embryos and this was partially prevented by 
BGP-15; an observation consistent in both mice and bovine embryos. Thus, supplementation 
of maturation medium with BGP-15 provides a means to increase mtDNA in both oocytes 
and embryos, thereby improving oocyte viability and developmental competence, 
particularly in the context of elevated lipids. 
 
Building on these results, BGP-15 was tested as a supplement to in vitro fertilisation (IVF) 
medium for its ability to counteract oxidative stress in cumulus-oocyte complexes (COCs) 
exposed to hydrogen peroxide (H2O2). Exposure of COCs to H2O2 significantly impaired 
cleavage rate following IVF. Embryo cell numbers, reactive oxygen species, mtDNA levels 
were altered but restored to control levels by BGP-15 treatment. Thus, oxidative stress in 
COCs recapitulates many of the defects seen with obesity and these are similarly normalised 
by BGP-15. 
 
Taken together, this study demonstrates that changes or alterations, as a result of 
environmental insult, before conception alter the phenotype of oocytes and that this is 
retained through to the course of later preimplantation development. I also demonstrated that 
BGP-15 is able to alleviate the effects of cellular stress via effects on mitochondria. These 
findings provide important benchmarks for future pre-clinical and clinical evaluations of 
preconception pharmaceuticals. This research is significant because increasing numbers of 
women seeking pregnancy have an altered follicular environment due to obesity, diabetes or 
poor diet; and my research has generated critically needed knowledge towards understanding 
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The establishment and maintenance of embryo and fetal development, pregnancy,  and even 
adult diseases are determined by the oocyte quality (Krisher 2004). Oocyte quality, i.e. its 
developmental competence (the ability of the oocyte to support fertilisation and subsequent 
embryo development) are acquired during folliculogenesis as the oocyte grows, and during 
the period of oocyte maturation (Krisher 2004). Oocytes are highly responsive to 
environmental signals (Leroy et al. 2011). Thus alterations to the oocytes are emerging as 
significant contributors to the reduced conception and pregnancy rates that are commonly 
observed in conditions such as maternal diabetes or obesity (Turner and Robker 2015).  
 
Maternal nutrition/metabolism and metabolic rate of the oocyte and its surrounding cumulus 
cells are very important for early embryo development (Gu et al. 2015). Perturbations in any 
of these can skew embryo metabolism and development. For example, oocytes recovered 
from mice fed with high levels of omega-3 fatty acids exhibited altered mitochondrial 
distribution and calcium levels and increased production of reactive oxygen species 
(Wakefield et al. 2008). Furthermore, the embryos resulting from fertilisation of these 
oocytes had poorer morphology and decreased developmental ability to the blastocyst stage 
(Wakefield et al. 2008).  
 
Previous studies on the effects of maternal nutrition have mainly focused on the later stages 
of pregnancy or the early neonatal period because demand for maternal nutrients for growth 
is highest during these periods (Morrison and Regnault 2016). However, the preimplantation 
embryo passes through distinct metabolic phases, undergoing changes in protein synthesis, 
energy requirements and amino acid uptake. Therefore the mother’s diet prior to pregnancy 
and during early pregnancy, the period of preimplantation embryo development, creates a 
nutritional environment that is critical in determining embryo health.  For instance, embryo 
quality in obese women was significantly reduced when compared to non-obese women with 
a body mass index (BMI) between 20 and 30 (Carrell et al. 2001). Furthermore, oocyte 
quality is also altered with reduced oocyte number (Fedorcsak et al. 2000). This scenario is 
more likely to result in pregnancy loss in obese women, suggesting alterations in oocyte 
quality with obesity. In mice, high-fat diet (HFD) females exhibited impaired oocyte 
developmental competence, characterised by altered mitochondrial metabolism, more 
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apoptotic ovarian follicles, smaller and fewer mature oocytes, and decreased rates of oocyte 
nuclear maturation and fertilisation when compared to the controls (Jungheim et al. 2010; 
Wu et al. 2010; Wu et al. 2012). Alterations such as these have been shown to result in 
smaller offspring with compromised health (Luzzo et al. 2012). Thus, obese women exhibit 
altered oocyte quality, which is likely to influence embryo development and mitochondrial 
metabolism as early as during the periconception period.  
 
It remains to be determined however, the precise molecular mechanisms by which obesity 
alters oocytes; and these are likely to be multi-factorial. Recent reports have revealed the 
involvement of membrane raft in the determination of fertilisation rate and index in mice 
(Buschiazzo et al. 2013). Lipid rafts are scaffolds for many molecular entities, including 
communicating extracellular stimuli to the intracellular organelles (Head et al. 2014). 
Mitochondria also  play an important role in oocyte biology (Chappel 2013), raising the 
intriguing possibility that their function may represent one of the key molecular defects 
responsible for sub-fertility. Identifying how these defects can be reversed in poor quality 
oocytes also requires further research. This review will describe conditions associated with 
maternal overnutrition, particularly obesity, the clinical and biological consequences on 
early embryogenesis, the involvement of membrane rafts in fertilisation and their association 
with intracellular organelles, the role of mitochondria and oxidative stress on reproduction.  
 
1.2 Mammalian ovarian folliculogenesis and preimplantation 
development: from oocyte to embryo 
1.2.1 Folliculogenesis and ovulation 
The follicle is the basic unit of the female ovary which contains the oocyte and the 
surrounding somatic cells; and folliculogenesis is the growth maturation of the ovarian 
follicle from a primordial stage through ovulation (Figure 1). Females are born with a finite 
number of primordial follicles which varies between species, with approximately 4270 in 
the mouse (Gosden and Telfer 1987) and about 400,000 follicles in women at puberty (Krogh 
2011). The primordial follicle is an immature oocyte encircled by a simple squamous layer 
of follicular cells, and these are scattered in the outer portions of the ovarian cortex, just 
beneath the tunica albuginea (Chang et al. 2009). At this stage, each oocyte has pale 
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cytoplasm and a large, round nucleus with a prominent nucleolus (Yadav 2004). The first 
step of folliculogenesis is the development of primordial follicles into primary follicles. 
Development of follicles to this stage appears to be relatively independent of pituitary 
control but it probably influences by intraovarian non-steroidal processes that remain to be 
understood (Hsueh et al. 2015). In a primary follicle, the follicular cells enlarge and undergo 
repeated cell divisions. This division creates several layers of follicular cells around the 
oocyte. As the wall of the follicle thickens further and the diameter of the developing oocyte 
increases, a thick zona pellucida (ZP) layer is formed around the oocyte. Although many 
primordial follicles develop into primary follicles, usually only a few will take the next step. 
The transformation begins as ZP formation and the thickened follicular cells begin secreting 
small amounts of fluid. Fluid also accumulates due to transudation from the plasma and 
surrounding tissue. The accumulation of follicular fluid gradually expands to separate the 
inner and outer layers of the follicle. At this stage, the complex is known as a secondary 
follicle. The oocyte continues to grow. The follicle as a whole enlarges rapidly due to this 
accumulation of fluid. The formation of a fluid-filled cavity surrounding the oocyte 
characterises the stage of follicle development, as an antral follicle. Granulosa and theca 
cells continue to undergo mitosis concomitant with an increase in antrum volume. As follicle 
enlarge, the granulosa cells and theca cells progressively stop dividing to express 
differentiated functions. Granulosa cells become dependent on FSH and theca cells express 
receptors for luteinising hormone (LH) for further growth and follicle maturation. Theca 
cells express LH receptors and pituitary LH induces the production of androgens by the theca 
cells, which are aromatised by granulosa cells to produce estrogens, primarily estradiol. 
Consequently, estrogen levels begin to rise. As more estrogen is secreted, more LH receptors 
are made by the theca cells. At this stage the follicle spans the entire width of the ovarian 
cortex and stretches the ovarian capsule, creating a prominent bulge in the surface of the 
ovary. The oocyte, surrounded by the specialised cumulus cells, projects into the expanded 
central chamber. The LH surge triggers ovulation of mature cumulus-oocyte complex (COC). 
Bidirectional communication between oocyte and its surrounding granulosa cells is vital, 
both for oocyte development and for granulosa cells differentiation (Thomas and 
Vanderhyden 2006). Oocytes depend on differentiated cumulus cells, which provide them 
with nutrients and regulatory signals needed to promote oocyte nuclear and cytoplasmic 
maturation and consequently the acquisition of developmental competence.   




The LH surge also triggers the terminal differentiation of the granulosa and theca cells to 
form the corpus luteum. Initially, the high levels of estrogen from the follicles cause the 
release of LH from the pituitary gland. This LH is temporarily associated with the 
transcriptional regulation of numerous genes and synthesis and/or activation of specific 
proteases such as Adamts1 (ADAM Metallopeptidase with Thrombospondin Type 1 Motif 
1) that stimulates the rupturing of the follicle. Rupturing occurs at the apex of the 
preovulatory follicle, and involves degradation of the follicle wall and expulsion of the 
expanded COC from the ovary, which is then picked up by the oviduct (or Fallopian tube) 
where fertilisation may occur (Russell and Robker 2007). The granulosa and theca cells of 
the follicle undergo luteinisation and transform into a corpus luteum that makes the 
progesterone (Figure 1). The progesterone functions to prepare the uterus for pregnancy, by 









Figure 1 Schematic of folliculogenesis, oocyte maturation and ovulation. 
Primordial follicles consist of an immature oocyte surrounded by a layer of flattened somatic 
granulosa cells. The transition to a primary follicle is marked by the transformation of the 
granulosa cells into a cuboidal shape. Pre-antral follicles develop layers of a second somatic 
cell type, theca cells, and antral follicles contain a fluid-filled antrum, which increases in 
size under the influence of follicle-stimulating hormone (FSH) or its analogue pregnant 
mare's serum gonadotropin (PMSG). The oocyte directs the differentiation of a sub-
population of granulosa cells into cumulus cells, forming the cumulus-oocyte complex 
(COC). Pre-ovulatory follicles which do not undergo atresia respond to the luteinising 
hormone (LH) or hCG surge to induce final maturation of the oocyte, ovulation and corpus 
luteum formation. Moreover, bi-directional communication between cumulus cells and the 
oocyte regulates numerous aspects of oocyte maturation, including control of meiotic 
induction, regulation of membrane potential, and suppression of transcriptional activity in 
the oocyte. Concurrently, the oocyte also regulates aspects of the development and activity 
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1.2.2 Oocyte maturation 
Oocytes remain arrested in an immature state in the follicle at the prophase I stage of meiosis. 
The acquisition of developmental competence by an oocyte, encompasses a number of 
critical events (Takeuchi et al. 2005). The final development of oocyte competence usually 
occurs during the process of meiosis, and is referred to as oocyte maturation. Oocyte 
maturation includes nuclear maturation and cytoplasmic maturation accompanied by 
expansion of surrounding cumulus cells, and both are essential for fertilisation and embryo 
development (Eppig 1991; Albertini et al. 2001; Terasaki et al. 2001; Krisher 2004) . 
Nuclear maturation refers to the meiotic process of chromosomal reduction to a haploid 
content, so as to produce a diploid organism upon fusion with sperm (Cooper 2000). 
Cytoplasmic maturation involves the cytoplasmic changes in organelles such as the 
endoplasmic reticulum (ER) and mitochondria required to prepare the cell for fertilisation, 
activation, and embryo development. Aberrations in these processes result in arrested 
development and embryo demise.  
 
The process of oocyte nuclear or meiotic maturation traditionally has been described by 
changes in chromosome morphology during meiosis. Before maturation starts, the oocyte 
contains a large germinal vesicle (GV) with a large nucleolus. The chromosomes in the GV 
are mostly decondensed, dispersed, and transcriptionally active (Coticchio et al. 2015). Once 
growth is achieved and the oocyte develops the ability to resume meiosis and progress to the 
mature stage in the later stages of folliculogenesis, the chromatin is subject to an extensive 
process of condensation. In several species, chromatin condensation is accompanied by 
intense transcription down-regulation followed by the germinal vesicle breakdown (GVBD), 
and nucleoli disperse (Takeuchi et al. 2005). As maturation progresses, the paired 
homologous chromosomes align in the middle of the forming meiotic spindle during 
metaphase I (MI), followed by the first polar body formation. Then the chromosomes 
remaining in the oocyte are again arranged on a meiotic spindle at MII and following 
ovulation are capable of fertilisation. 
 
Lipid metabolism in oocytes is critical for oocyte growth, fertilisation, and the development 
of early embryos (Dunning et al. 2014). Failure of proper lipid delivery leads to abnormal 
oocytes, a low egg production rate, and low viability of embryos (Grant and Hirsh 1999; 
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Brock et al. 2007). Notably, the lipid content of oocytes varies considerably between species. 
Triglycerides are the most abundant lipid in oocytes, constituting over 50% of all lipid 
material (Homa et al. 1986; Ferguson and Leese 1999; Kim et al. 2001) and provide a large 
potential energy reserve. They are typically stored as neutral lipid droplets in the cell 
cytoplasm. The lipid droplets are small and diffuse in oocytes of pre-ovulatory COCs, 
accumulate during oocyte growth and undergo temporal and spatial changes during 
maturation. They become larger and more centrally located in response to ovulatory hCG in 
vivo, or FSH + epidermal growth factor (EGF) in vitro (Yang et al. 2010). In species such 
as porcine, ovine and bovine, these endogenous lipids are so high that the oocytes appear 
dark when viewed under the light microscope (Leroy et al. 2005; Prates et al. 2013). 
However, mouse oocytes and embryos are pale, indicating its low content of endogenous 
lipid. There has been very little study examining the specific lipid content of the human 
oocyte; however, their lipid profiles in general are thought to be relatively similar to those 
in other species (Dunning et al. 2014). 
 
The process of oocyte maturation is also accompanied by fundamental changes in cellular 
organelles in the cytoplasm. Oocytes possess a variety of organelles typical of most cells 
(such as Golgi apparatus, mitochondria, ER) as well as oocyte-specific organelles such as 
cortical granules, annulate lamellae, acidic granules, and pigment granules. (Luciano et al. 
2012), Cytoplasmic maturation involves modifications in oocyte mitochondrial distribution, 
clustering and activity in response to changing energy demands of the cell machinery (Dalton 
and Carroll 2013), and ER reorganisation and maturation finalised to intracellular Ca2+ 
signaling (Mann et al. 2010). Van Blerkom and Runner (1984) reported the first 
redistribution of mitochondria in mouse oocytes. They described a mitochondrial 
translocation to the perinuclear  region during formation of the first meiotic spindle, followed 
by a redistribution of mitochondria at the time of polar body extrusion (Van Blerkom and 
Runner 1984). These changes were only observed in maturing oocytes and therefore 
proposed to be a necessary feature of oocyte maturation. Furthermore, in MII oocytes, the 
mitochondria are also dispersed throughout the cytoplasm (Dalton and Carroll 2013; Wakai 
et al. 2014). The translocations of mitochondria during this period appears to be controlled 
by oocyte microtubule networks and is likely to involve cytoplasmic rather the spindle 
associated microtubules (Van Blerkom 1991; Sun et al. 2001; Brevini et al. 2005; Liu et al. 
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2010). The redistributions of mitochondria have also been observed in the human oocyte and 
bovine oocyte where they were correlated with increased development to blastocyst and 
higher adenosine triphosphate (ATP) levels (Stojkovic et al. 2001). 
 
On the other hand, in vitro maturation (IVM) of oocytes is a reproductive technology by 
which immature oocytes are retrieved from unstimulated or minimally stimulated ovaries 
and subsequently matured in vitro in appropriate medium until they reach MII (Figure 2). 
However, there is a discrepancy in the success rate of embryos derived from in vitro matured 
oocytes compared to in vivo oocytes, with the pregnancy rate post-IVM less than half of the 
pregnancy of post-IVF (in vitro fertilisation) in women with Polycystic Ovary Syndrome 
(PCOS) (Gremeau et al. 2012). In mice and bovine, when compared to in vivo matured 
oocytes, embryos derived from IVM oocytes have decreased cleavage and blastocyst 
development rates, and poorer blastocyst quality (Rizos et al. 2002; Sanfins et al. 2015). 
Factors affecting oocyte developmental competence in vitro include culture media additives 
such as serum, hormones and growth factors, as well as the companion somatic cells which 
surround the oocyte. To date, many ingredients have been added to IVM medium to nurture 
the immature oocytes in the Petri dish (Demyda and Genero 2011). However, further 
development is needed to achieve an acceptable pregnancy success rate for IVM-derived 
oocytes because pregnancy rates with IVM are lower than those achieved with conventional 
IVF. Importantly, IVM can also be used to experimentally test the effects of physiological 
factors added exogenously to the culture on oocyte maturation and competence, as well as 
to test the beneficial effects of new supplements on early embryo development. 
  


























Figure 2 Schematic of oocyte maturation in vivo and in vitro (mouse). 
In vivo maturation involves folliculogenesis until the LH surge or administration of hCG. 
Meiosis is then resumed concurrent with cumulus expansion. The COC is then ovulated, 
extrudes its first polar body to reach MII and is capable of being fertilised. In in vitro 
maturation (IVM), following FSH or PMSG administration, immature oocytes in the large 
antral follicles are extracted and matured in laboratory conditions. These oocytes are not 
exposed to LH but rather FSH and epidermal growth factor (EGF) which trigger cumulus 










Immature, unexpanded COC  
Mature, expanded COC 
FSH + EGF + FCS 
37°C, 20% O2, 6% CO2 
(mouse) 
IN VIVO MATURATION IN VITRO MATURATION (IVM) 
Chapter 1       Literature review 
11 
 
1.2.3 Fertilisation and embryo development 
Once the mature oocyte is released into the fallopian tube at ovulation, it can be fertilised by 
a sperm cell, forming a single nucleus in the cytoplasm of the fertilised oocyte which 
contains both the female and male chromosomes. This unit is called a zygote. Mitochondrial 
redistribution also occurs during early development in embryos from several species. 
Following fertilisation, they became progressively aggregated and localised in the 
perinuclear region (Bavister and Squirrell 2000; Van Blerkom et al. 2000; Wilding et al. 
2001). Abnormal distribution of mitochondria at the pronucleus stage results in some 
blastomeres with reduced mitochondrial content and diminished ATP generating capacity 
(Van Blerkom et al. 2000). Thus, mitochondrial redistributions appear to be a feature of 
competent oocytes and successful early development. However, the exact way in which 
mitochondrial translocations contribute to developmental competence has not yet been 
established. 
 
 Following fertilisation, the zygote further divides into a 2-cell embryo and is transported 
through the oviduct by cilia beating and oviductal muscle contractions. The 2-cell embryo 
further divides into a 4-cell embryo then becomes eight, and so forth. Successive cell 
divisions result in a morula which is an embryonic stage consisting of a solid, compact mass 
of 16 or more cells. From this stage onwards, morphological appearance becomes distinct, 
with the outer cell layer differentiating into trophectoderm (TE) and the cells within the 
embryo forming a compact inner cell mass (ICM). A blastocoel, a fluid-filled cavity, 
develops and grows and the embryo is now called a blastocyst. In human and mouse, the 
embryo reaches the uterus around the blastocyst stage where it expands and breaks out of 
the zona pellucida, a process known as “hatching”. The TE cells then adhere to uterine 
epithelial cells and continue to develop, a process called implantation. The ICM contributes 
to the formation of fetal tissue, whilst the TE burrows into the wall of uterus and develops 
into the placental tissues. The distribution of TE and ICM lineage specific proteins in 
preimplantation embryos have been extensively studied and Caudal-type homeobox 
transcription factor-2 (Cdx2) and Octamer binding transcription factor 3/4 (Oct4) are the 
best-known markers for distinguishing TE and ICM respectively. The distribution of other 
lineage-specific protein in preimplantation embryos found in prior reports is shown in the 
Appendix, Table 3. Successful implantation involves intimate molecular and cellular 
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interactions between the competent blastocyst and the uterus, however, there are substantial 
differences among species in the process of implantation, particularly with regard to 
“invasiveness”, or how much the embryo erodes into maternal tissues. 
 
1.3 Impact of obesity on embryo development and female fertility  
1.3.1 Obesity and metabolic syndrome 
A significant global health problem is that an increasing number of reproductive age women 
are overweight, obese or diabetic. In 2015, 63.4% of Australians over 18 of age were 
overweight or obese (Australian Bureau Statistics 2016). Obesity is most commonly defined 
as a BMI; weight (kg)/ height (m2) of 30 or more whereas a BMI of 25 to 29.9 is defined as 
overweight (AIHW 2012). Obesity, particularly abdominal obesity, is intimately associated 
with the development of metabolic syndromes (Eckel et al. 2005). 
 
Two major systemic perturbations are associated with being overweight or obese: elevations 
in plasma insulin, that leads to increased circulating glucose, and elevations in free fatty 
acids (Eckel et al. 2005). As obesity progresses, tissues become resistant to the effects of 
insulin and this leads to type II diabetes mellitus, which is becoming a leading cause of health 
problems around the world. Obese individuals tend to have high plasma follicular fatty acids 
(FFAs) concentrations, especially saturated fatty acids (Boden and Shulman 2002). 
Elevation of plasma FFAs leads to insulin resistance and hepatic inflammation, thus 
contributing to type II diabetes, hypertension and dyslipidemia.  
 
1.3.2 Clinical consequences of obesity on female reproduction 
It is well-established that maternal obesity is associated with reduced conception rates and 
with complications in the maintenance of pregnancy and delivery of a healthy baby (Purcell 
and Moley 2011). Obesity is associated with PCOS, which affects about 50% of obese 
women (Norman et al. 2004; Azziz et al. 2009). PCOS can be characterised by elevated 
androgens and insulin resistance leading to irregular menstrual cycles, anovulation, 
subfertility and pregnancy loss (Jain et al. 2007; Metwally et al. 2008a; Brewer and Balen 
2010). Obese women are also more at risk of having spontaneous abortions, preeclampsia, 
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miscarriage, pre-term birth or a high birth weight baby when compared with normal-weight 
women (O'Brien et al. 2003; Dokras et al. 2006; Metwally et al. 2008b; McDonald et al. 
2010). Specifically, obesity in women has been shown to increase time to conception 
compared with women of healthy weight (Gesink Law et al. 2007; Nohr et al. 2009). When 
their pregnancies are successful, obese women are more likely to give birth to large-for-
gestational infants, who are then themselves at increased risk of childhood (2-9 years) and 
adolescent (14 years) obesity (Maftei et al. 2015). Babies born from obese mothers are also 
at an increased risk of developing metabolic syndromes (including insulin resistance, 
hypertension, and diabetes) later in life, suggesting the effects of maternal obesity are 
transgenerational and life-long (Rooney and Ozanne 2011). 
 
1.3.3 Impacts of obesity on oocytes 
One of the ways that obesity exerts detrimental effects on female fertility, particularly 
conception and pregnancy rates, is by causing numerous perturbations in oocyte structure 
and function prior to fertilisation.  
 
Many studies using mouse models of obesity and in vitro studies which culture oocytes in 
lipid-rich media have shown delays in meiotic maturation accompanied by spindle defects 
and chromosome misalignment during oocyte maturation in response to these conditions 
(Jungheim et al. 2010; Luzzo et al. 2012; Yang et al. 2012; Sohrabi et al. 2015). Studies 
from human assisted reproductive technology (ART) clinics have shown an impairment in 
oocyte maturation associated with increasing BMI (Wittemer et al. 2000; Carrell et al. 2001; 
Dokras et al. 2006), however, others found no difference in oocyte maturation between 
different BMI scores (Metwally et al. 2007). 
 
In women, increasing BMI is associated with increased insulin, glucose, lactate, triglycerides, 
non-esterified fatty acids (NEFA) and C-reactive protein, an inflammatory marker in 
follicular fluid (Robker et al. 2009; Jungheim et al. 2011b; Valckx et al. 2012; Yang et al. 
2012; Valckx et al. 2014). The most abundant free fatty acids detected in the follicular fluid 
of women were oleic, palmitic, linoleic, and stearic acids (Jungheim et al. 2011b; Valckx et 
al. 2014). Elevated follicular free fatty acids in women are associated with poor COC 
morphology (Jungheim et al. 2011b). Abnormal lipid accumulation and distribution within 
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oocytes have been demonstrated in mice on an obesogenic diet for as little as four weeks 
(Wu et al. 2010; Reynolds et al. 2015). This result was also observed in a genetic obese 
mouse model (Wu et al. 2015). These consistent observations of excess lipid in the follicular 
fluid as well as in the oocytes suggest that lipotoxicity mechanisms maybe activated in the 
ovarian follicular environment in response to obesity. Lipotoxicity is a cellular response to 
a high lipid environment that leads to endoplasmic reticulum (ER) stress, mitochondrial 
damage and reactive oxygen species (ROS) release and can ultimately lead to apoptosis.  
 
Evidence of lipotoxicity mechanisms within the ovarian preovulatory follicles of obese 
female mice is that a high-fat diet (HFD) induces apoptosis in both granulosa cells and COCs 
(Wu et al. 2010; Jungheim et al. 2011b). This would likely contribute to poor gamete quality 
due to the tight bi-directional communication between these cells and the oocyte. Moreover, 
data from clinical studies of IVF patients has shown that cumulus cells apoptosis correlate 
with poor pregnancy rates (Wittmaack et al. 1994; Arnot et al. 1995; Bergh et al. 1998). 
Consistent with the data from mice with HFD-induced obesity, genetic mutation-induced 
obese mice also exhibit oocytes with high levels of apoptosis and autophagy when compared 
to oocytes from control non-obese mice (Wu et al. 2015; Hou et al. 2016). 
 
A number of studies have reported altered mitochondrial function in mouse oocytes in 
response to a HFD or genetic obesity. The mitochondria in oocytes from HFD mice have 
altered structure and distribution, increased mitochondrial membrane potential (MMP) and 
increased mitochondrial DNA (mtDNA) copy number, the latter usually associated with 
increased oocyte competence (Igosheva et al. 2010). In contrast, Wu et al. (2010) found that 
MMP of oocytes from HFD mice was lower than that of oocyte mitochondria from mice fed 
a control diet. Differences between the two studies include the use of different diets, strains 
of mice and different dyes used. In genetic mutation induced obese mouse models, 
impairments in mitochondria have also been reported. Oocytes from obese mice had 
abnormal mitochondrial distributions and structures (Hou et al. 2016) and reduced MMP 
(Wu et al. 2015). 
  
The redox states of the  Nicotinamide Adenine Dinucleotide Hydride (NADH) and 
Nicotinamide Adenine Dinucleotide Phosphate Hydrogen (NADPH) play critical roles in 
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defining the activity of energy production pathways, in driving oxidative stress and in 
maintaining antioxidant defences (Blacker and Duchen 2016). Redox state of oocytes from 
obese mice was also previously measured by assessing NADPH levels. Oocytes from HFD 
fed mice contained more oxidised NADPH than those from the control diet mice, suggesting 
that they were in a state of oxidative stress (Igosheva et al. 2010). Additionally, the 
intracellular ROS levels in the oocytes of both diet-induced and genetic mutation induced 
obese mice were also significantly higher than those of the lean mice (Igosheva et al. 2010).   
 
COCs from mice fed a HFD as well as Blobby mice, were shown to have increased 
expression of ER stress marker genes, activating transcription factor 4 (Atf4) and  
glucose-regulated protein 78 (Grp78) (Wu et al. 2010; Wu et al. 2015), similar to those 
matured in lipid-rich follicular fluid (Yang et al. 2012). Similar events occur in human 
ovarian cells, with increased ATF4 expression observed in granulosa cells of obese women 
(Wu et al. 2010). Moreover, oocyte size is also affected by obesity, with oocytes from diet-
induced obese mice smaller than control oocytes (Jungheim and Moley 2010). The link 
between maternal obesity and small oocytes is also observed in humans, with smaller 
oocytes collected from obese women undergoing IVF or intracytoplasmic sperm injection 
(ICSI) than from non-obese women (Marquard et al. 2011). Previous studies in humans have 
shown that small oocyte size correlates with poor pregnancy outcomes (Wittmaack et al. 
1994; Arnot et al. 1995; Bergh et al. 1998). 
 
1.3.4 Consequences of obesity on embryos 
Obesity also has detrimental effects on preimplantation embryogenesis which are likely due 
to ER stress and mitochondrial alterations in the COC. Obese women have been reported to 
have significantly poorer quality embryos than lean women (Carrell et al. 2001), and another 
group observed a similar effect, but only in women aged below 35 years old (Metwally et al. 
2007). However, others have been unable to demonstrate a significant correlation between 
embryo quality and BMI (Fedorcsak et al. 2001; Spandorfer et al. 2004; Dechaud et al. 2006; 
Esinler et al. 2008; Shalom-Paz et al. 2011). In an obese mouse model, significantly fewer 
embryos reached the blastocyst stage of development when compared to control mice and 
cell type distribution of the embryos was also disrupted (Minge et al. 2008). The blastocysts 
from these resultant embryos displayed a lower ICM to TE ratio. This altered differentiation 
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was reversed by the insulin sensitiser rosiglitazone. Similarly, Wakefield et al. also showed 
decreased developmental ability to the blastocyst stage in mouse embryos after exposure of 
oocytes to an environment of high n-3 polyunsaturated fatty acid (PUFA) (Wakefield et al. 
2008). Moreover, following the exposure of in vivo flushed morulae to a high concentration 
of palmitic acid for 30 hours, the resulting mouse blastocyst had reduced ICM cells and the 
fetuses were growth restricted (Jungheim et al. 2011a). This implies that exposure to a high 
concentration of palmitic acid leads to aberrant metabolism and long-term metabolic 
perturbation.  
 
Early embryogenesis alone is susceptible to damage, with embryos from HFD mice impaired 
as early as the 2-cell stage (Luzzo et al. 2012; Sohrabi et al. 2015). In addition, embryos 
from HFD mice also exhibited delayed on-time progression to all developmental milestones 
(4-8-cell stage, morula/early blastocyst stage, and the expanded/hatching blastocyst stage) 
(Minge et al. 2008; Luzzo et al. 2012) and a higher frequency of embryo degradation (Luzzo 
et al. 2012). Our group has previously showed that the in vivo fertilisation rate was lower in 
HFD mice than in the controls (Wu et al. 2010). By using a severely obese Blobby model, 
we showed that Day 2 cleavage rate was lower when compared to those of embryos from 
lean mice and there was a further reduction in blastocyst formation rate following IVF in the 
Blobby mice. Blastocysts generated from these obese mice have reduced mtDNA copy 
number. 
 
In women, being overweight or obesity also induces phenotypic and metabolic abnormalities 
in the embryos. Blastocysts from obese women have reduced glucose consumption, modified 
amino acid metabolism and increased levels of endogenous triglyceride (Leary et al. 2015). 
In cattle, oocytes that were exposed to elevated NEFA concentrations yielded blastocysts 
with lower cell number, increased apoptotic cell ratio, reduced oxygen, pyruvate and glucose 
consumption and higher amino acid metabolism (Van Hoeck et al. 2011). In mice, maternal 
obesity increased the lipid content and apoptosis rate in the embryos. Alternatively, embryos 
from diet-induced obese female mice also exhibited altered mitochondrial properties and 
produced significantly higher ROS levels when compared to those from the lean mice 
(Igosheva et al. 2010).  
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Together, these are compelling evidence showing that maternal overnutrition has detrimental 
effects as early as the oocyte stage, which further predisposes them to embryo developmental 
abnormalities and even metabolic diseases in the offspring. In addition, there are also studies 
showing changes in dietary composition, in particular n-3 PUFA can have detrimental effects 
without a change in kcal intake or over-nutrition, and independent of females being obese 
(Wakefield et al. 2008). 
 
1.3.5 Strategies to improve oocyte quality and fertility in obese females 
Despite the significant problems caused by being overweight or obese on oocytes and 
embryos, strategies to sustain or improve oocyte quality have remained elusive. Diet or 
exercise interventions are the most common suggestions for obese patients to improve their 
egg quality. A recent study showed that an exercise intervention on HFD mice can improve 
lipid metabolism and reverse lipid accumulation in GV oocytes (Boudoures et al. 2016). But 
delays in meiosis and disorganised metaphase II (MII) spindles remained unresolved. Thus, 
exercise intervention is able to improve but not reverse the damage imposed on oocytes as a 
result of a high-fat diet and obesity. 
 
Besides exercise, pharmaceutical treatment could be another option. We have previously 
shown that in vivo administration of rosiglitazone (four day treatment) in the periovulatory 
period was able to reverse the negative effects of obesity and a high-fat diet on oocyte 
developmental competence in the mouse (Minge et al. 2008). Rosiglitazone concomitantly 
lowered blood glucose, insulin and triglyceride levels indicating that oocytes are affected by 
insulin sensitivity, and that treatment of obese/insulin-resistant females with an insulin 
sensitiser before conception can significantly improve embryonic developmental 
competence (Robker 2008). However, it is unclear if this effect results from the regulation 
of systemic insulin or from actions directly on the oocyte and/or ovarian cells. Importantly 
this insulin sensitiser uniquely lowered circulating triglycerides while others that failed to 
improve oocyte quality (AICAR, salicylate) did not (Minge et al. 2008)); which again 
indicates that lipotoxicity is likely a problem for oocytes.  
 
An alternative therapy to reduce lipotoxicity/ER stress in the oocytes involves directly 
targeting molecules that regulate the unfolded protein response (UPR). A previous mouse 
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study from our laboratory showed that salubrinal, an ER stress inhibitor, was able to restore 
both oocyte mitochondrial activity and oocyte developmental competence in COCs that were 
exposed to high lipid (Wu et al. 2012). These findings were further demonstrated in bovine 
COCs in vitro (Sutton-McDowall et al. 2016) demonstrating that ER stress is a key 
mechanism mediating fatty acid-induced defects in oocyte developmental potential. 
Furthermore, treatment of obese female mice with salubrinal before ovulation completely 
restored oocyte quality, embryo development, blastocyst mtDNA and the mtDNA content 
of fetal tissue to levels equivalent to those derived from lean mice (Wu et al. 2015). 
Salubrinal is a laboratory reagent that is well understood but not tested for its safety in 
humans. Alternatively, another pharmaceutical compound, BGP-15, which is known to 
alleviate ER stress via different pathways is currently being tested for human use in clinical 
trials. So, one goal of the current project was to assess the therapeutic potential of this 
compound in improving oocyte quality. 
 
Our group recently focused on a new pharmaceutical compound to reverse the effects of 
obesity on oocytes and to restore embryo development. BGP-15 is a hydroximic acid 
derivative which is a chaperone inducer and protects against obesity-induced insulin 
resistance (Chung et al. 2008). BGP-15 was developed by N-Gene Research Laboratory 
(USA and Hungary) and is a compound that has undergone human clinical trials for type II 
diabetes (Literati-Nagy et al. 2009; Literati-Nagy et al. 2010). BGP-15 has been shown to 
have beneficial effects in different cell types and Table 1 summarises the effects of BGP-15 
in different cell types of several species. It has been shown to act as an inhibitor of 
poly(ADP-ribose) polymerase (PARP) to aid DNA repair (Szabados et al. 2000) and affects 
ER chaperone GRP78 (Sapra et al. 2014), as well as activates Heat Shock Protein 72 (HSP72) 
(Gehrig et al. 2012). In particular, we have recently discovered that treatment of obese 
female mice with BGP-15 before ovulation increased the amount of mitochondrial 
replication factors and mtDNA content in the oocytes, as well as restored oocyte quality, 
embryo development and normalised mtDNA content of fetal tissues to levels that were 
comparable to the controls, revealing its mechanism of action might be via the mitochondria 
(Wu et al. 2015). BGP-15 was also found to influence the level and size distribution pattern 
of cholesterol-rich membrane rafts in melanoma cells; and likely triggers raft-associated 
stress sensing and signaling pathways (Gombos et al. 2011). In a HFD mouse model of type 
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II diabetes, BGP-15 increases mitochondrial number and oxidative metabolism in skeletal 
muscle and improves insulin sensitivity (Henstridge et al. 2014). Consistent with these 
results in muscle, treatment of obese female Blobby mice with BGP-15 restored 
mitochondrial activity in oocytes, and induced mtDNA levels (Wu et al. 2015). However, in 









Table 1 Effects of BGP-15 on different cell types and its proposed mechanism of action. 
Species Tissues Findings Mechanism of action 
Mice Oocyte  (Wu et al. 2015) Reverse mitochondrial dysfunction caused by obesity Likely via mitochondrial replication 
Heart (Sapra et al. 2014) Improve cardiac function and reduce arrhythmic 
episodes in murine models with heart failure and atrial 
fibrillation 
Not via induction of heat shock protein 70 
(Hsp70). Likely to be associated with 
phosphorylated insulin-like growth factor 
1 receptor (pIGF1R) 
Muscle (Gehrig et al. 2012) Improve muscle architecture, strength and contractile 
function in Duchenne muscular dystrophy 
Inducer of the chaperone heat shock 
protein 72 (Hsp72) 
Liver and Muscle (Chung 
et al. 2008) 
Protect against obesity-induced insulin resistance Likely to be via up-regulation of Hsp72 
Hepatoma Xenografts 
(Kardon et al. 2006) 
Suppress hepatoma development by affecting 
angiogenesis 
Via hypoxia signaling 
Rats Langendorff heart 
perfusion (Szabados et al. 
2000) 
Decrease reactive oxygen species levels and cell injury 
during ischemia-reperfusion in the heart 
Via poly(ADP-ribose) polymerase (PARP) 
activity 
Langendorff heart 
perfusion (Sarszegi et al. 
2012) 
Prevent Imatinib-induced cardiotoxicity Likely via mitochondria protective role 
Skeletal muscle 
(Henstridge et al. 2014) 
Increase mitochondrial number, oxidative capacity and 
insulin sensitivity in type II diabetes 
Likely to be via up-regulation of Hsp72 
Diaphragm muscle (Salah 
et al. 2016) 
Alleviate ventilation-induced diaphragm dysfunction Likely to be via Hsp72 induction and 
PARP-1 inhibition 
Rabbits, Rats Systemic (Literati-Nagy et 
al. 2014) 
Increase insulin sensitivity in cholesterol-fed rabbits, 
protect against streptozotocin-induced changes in 
vasorelaxation 




Human Systemic (Literati-Nagy et 
al. 2009) 
Increase insulin sensitivity, total body glucose 
utilisation, muscle tissue glucose utilisation and fat-
free body mass glucose utilisation 
Likely via Hsp induction 
Systemic (Literati-Nagy et 
al. 2010) 
Reduce olanzapine-induced metabolic side effects, 
such as weight gain, insulin resistance and blood 
glucose abnormalities 
Not exclusively mediated by Hsp. Possibly  





Mouse melanoma cells, 
human embryonic kidney 
cell line (Gombos et al. 
2011) 
Prevent transient structural disintegration of rafts 
induced by fever-type heat stress. Able to remodel 
cholesterol-enriched lipid platforms 
Likely to be via GTPase protein Rac1 and 
heat shock factor (HSF) signaling  
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1.4 Mechanisms by which obesity might affect embryos 
The fundamental mechanisms by which the preimplantation embryo is changed by obesity 
or other metabolic syndromes are not fully understood. However, based on the available 
literature published to date it is likely that the defects are due to changes in the oocyte. This 
was previously confirmed in a study where the increased pregnancy failure rate in obese 
women returned to a normal rate if donor oocytes were used rather than autologous oocytes 
(Luke et al. 2011). A large number of studies, primarily in mice, have elucidated some of 
the cellular mechanisms by which obesity impacts oocyte developmental competence. These 
include excess lipid in oocytes, induction of ER stress and mitochondrial dysfunction and it 
is likely that several aspects of embryogenesis are thus subsequently disrupted. In particular 
I hypothesise that these aspects are: membrane integrity, mitochondrial replication and 
function, and oxidative stress responses. Thus the aims of this thesis are to explore each of 
these biochemical parameters in embryogenesis, the impact of obesity and the ability of 



















Poor oocyte quality 
Mitochondrial 
dysfunction 
1) Does membrane integrity in oocytes 
influence mitochondrial activity and how is it 
impacted by obesity and BGP-15? 
2) What are the kinetics of mtDNA replication 
during oocyte maturation and embryogenesis 
and how are these impacted by obesity and 
BGP-15? 
3) How does oxidative stress during oocyte 
maturation impact embryogenesis and can the 
effects be reversed by BGP-15? 
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1.5 Summary and Outline of Aims 
The preconception environment is known to influence the developmental competence of the 
oocyte. In particular, it is well known that obesity/HFD conditions during this time are 
detrimental to subsequent embryo and fetal health; but the mechanisms for this effect are 
poorly understood. The importance of membrane structure and mitochondria as the effectors 
is becoming increasingly evident in a wide variety of fields. Additionally, there is also very 
little known about the contribution of cholesterol to oocytes or whether  it acts to influence 
membrane rafts, particularly under HFD conditions, and how BGP-15 may act to counteract 
the stress. Understanding these will generate critically needed knowledge towards how 
obesity affects fertility, and identify possible therapeutic targets. 
 
Specific hypotheses and aims 
Hypothesis 1: Membrane integrity in oocytes influences mitochondrial activity and 
these are disrupted by obesity but normalised by BGP-15 
Chapter 2 will investigate whether oocyte membrane integrity influences oocyte 
mitochondrial activity and embryogenesis by examining the effect of oocyte membrane 
disruption (via cholesterol depletion) on embryogenesis and mitochondrial activity and 
whether BGP-15 can stabilise oocyte membranes. 
 
Chapter 3 will determine whether membrane integrity in embryos is disrupted by maternal 
obesity and whether this is reversible by BGP-15 treatment.  
 
Hypothesis 2: Mitochondrial replication during oocyte maturation and embryogenesis 
is disrupted by exposure to excess lipid but induced by treatment with BGP-15 
Chapter 4 will examine the kinetics of mtDNA replication during oocyte maturation and 
embryogenesis in mouse, cow, macaque and humans, the effects of high lipid during oocyte 
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Hypothesis 3: Oxidative stress during oocyte maturation impairs embryogenesis 
similar to obesity but these effects are reversible with BGP-15 treatment. 
Chapter 5 will utilise a brief treatment with H2O2 to induce oxidative stress in oocytes and 
then determine whether the changes in ROS, mtDNA and embryo quality are reversible by 
supplementing the IVF media with BGP-15.
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EMBRYO CLEAVAGE KINETICS 
AND LIPID RAFTS BUT NOT VIA 
ALTERED MITOCHONDRIAL 
ACTIVITY 





Follicular fluid of obese women contains elevated levels of triglyceride and findings from 
our laboratory showed that exposure of cumulus-oocyte complexes (COCs) to high level of 
fatty acids increased lipid content and altered mitochondrial activity in the oocytes. After 
fatty acids are taken up by somatic cells, they are esterified into triacylglycerols (TAG) and 
cholesterol-esters and stored as neutral lipids in lipid droplets. Lipid droplets are not simple 
lipid storage depots, but rather complex organelles that have multiple cellular functions. One 
of its proposed functions is to distribute neutral lipid as well as phospholipids to various 
membrane-bound organelles, including the oocytes. It has been suggested that neutral lipid 
in the oocytes fulfill an important function in supplying energy and in the biosynthesis of 
membranes during early embryonic development (Kruip et al. 1983; Ferguson and Leese 
1999; McEvoy et al. 2000; Kim et al. 2001; Sturmey et al. 2006). To date, membrane 
dynamics in the oocyte are not well understood. Recent findings showed that membrane rafts 
play an important role in oocyte maturation, fertilisation and oocyte quality (Buschiazzo et 
al. 2013). Furthermore, based on the evidence that there was a build-up of lipid droplets in 
the oocytes of obese mice (Wu et al. 2015) and elevated follicular fluid fatty acids have been 
associated with poor oocyte morphology, I hypothesise that membrane integrity in the oocyte 
influences mitochondrial activity and these are disrupted by obesity but normalised by BGP-
15.  Therefore, the first aim of this thesis will investigate whether oocyte membrane integrity 
influences oocyte mitochondrial activity by examining the effect of membrane disruption 
(via cholesterol depletion) on embryogenesis and mitochondrial activity and whether BGP-
15 can stabilise oocyte membranes. I also speculate that overabundant fatty acids in an 
obesogenic environment can severely compromise membrane integrity and subsequently 
lead to mitochondrial dysfunction. Therefore, an additional aim of this thesis is to determine 
whether membrane integrity on embryos is disrupted by maternal obesity and whether this 
is reversible by BGP-15 treatment. 
 
  




Mammalian embryos undergo dramatic membrane reorganisation as they develop from a 
single-celled zygote to a differentiated multicellular blastocyst capable of implantation in 
the maternal uterus. In addition to a structural role, cell membrane integrity also serves as an 
important platform for cell adhesion and attachment, ion conductivity and signaling 
processes (Miner et al. 2004; Tutuncu et al. 2004; Yurchenco 2011). Lipid rafts are highly 
specialised, liquid-ordered subdomains of the cell membrane. The current understanding of 
lipid rafts under basal conditions sees them as extremely small and/or dynamic assemblies 
of cholesterol, sphingolipids and proteins that are directly involved in a variety of cell 
membrane functions including membrane signaling and trafficking (Simons and Toomre 
2000). 
 
In mammalian oocytes, lipid raft microdomains of the plasma membrane contain the 
ganglioside monosialotetrahexosylganglioside (GM1) and tetraspanin CD9, and previous 
studies have shown that these domains are involved in gamete fusion and adhesion (Kaji et 
al. 2000; Miyado et al. 2000; Alfieri et al. 2003). In oocytes, cell membrane integrity serves 
as an important platform for cell adhesion and attachment, ion conductivity and signaling 
processes (Evans 2012; McGinnis et al. 2013). The dynamic changes in membrane 
bioactivity can be mediated by the nanometer-sized lipid rafts. In respect to the lipid raft 
component, ganglioside GM1 is multi-functional in the exoplasmic leaflet, with essential 
roles in cell adhesion, cell recognition, ligand binding and signal transduction (Janes et al. 
1999; Lopez and Schnaar 2009). The cholera toxin subunit B (CTB) which binds to the 
extracellular domain of GM1 is an established marker of lipid rafts. Other techniques used 
to identify rafts are shown in the Appendix, Table 4. 
 
Lipid rafts were reported to play a critical role in spindle assembly during cell cleavage in 
embryogenesis, as well as cleavage furrow ingression (Albertson et al. 2005). For instance, 
GM1 was shown to contribute to cytokinesis during the cleavage of mouse preimplantation 
embryos and sea urchin eggs (Ng et al. 2005; Comiskey and Warner 2007). 
 
Cholesterol is a key component of cell membranes and is essential for lipid raft formation 
and function. Thus, cholesterol depletion is often used to elucidate functional roles of 
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membrane integrity and lipid raft microdomain signaling. To date, relatively little is known 
about the essential roles of lipid rafts in oocytes and their functions during preimplantation 
embryo development.  
 
In mouse oocytes, cholesterol synthesis is at least in part mediated by the surrounding 
cumulus cells and then transferred to the oocytes. In other words, cumulus cells are the 
source of cholesterol for mouse oocytes (Su et al. 2008). Interestingly, mice deficient in high 
density lipoprotein (HDL) receptor scavenger receptor, type B class I (SRBI) display 
abnormally large HDL particles, enriched in unesterified cholesterol and are infertile due to 
severely impaired oocyte developmental competence. The oocytes from these SRBI 
knockout (KO) mice showed abnormally high levels of cholesterol (Yesilaltay et al. 2014). 
However, fertility in these mice can be rescued by a HDL cholesterol lowering drug probucol 
(Miettinen et al. 2001). The SRBI KO oocytes were also prematurely activated-exiting 
metaphase II (MII) and completing meiotic progression under in vitro maturation (IVM) 
conditions. Similar events were also observed when these premature eggs were treated with 
a molecular complex containing cholesterol, again possibly because of an excess of 
cholesterol in the eggs (Yesilaltay et al. 2014).  
 
In contrast, treatment of one-cell mouse zygotes with a cholesterol-depleting drug, methyl-
-cyclodextrin (MCD) prevented embryonic development beyond 2 to 4 cells stages in 
culture (Comiskey and Warner 2007) further implicating the importance of cholesterol 
during preimplantation development. However, these embryos were not extensively 
characterised and the basis for arrested development was not determined. Thus although 
these studies cumulatively show that cholesterol is essential for normal oocyte 
developmental competence, the cellular mechanisms on which it impinges are not clear. 
 
Intracellularly, cholesterol is found unevenly distributed among cellular membranes with the 
endoplasmic reticulum (ER) containing about 0.5-1% of total cellular cholesterol (Miller and 
Bose 2011). In contrast, mitochondria are relatively cholesterol-poor organelles, with the 
majority of cholesterol located in the outer mitochondrial membrane. A combination of in 
vivo and in vitro analyses reveal that cholesterol accumulation promotes organelle 
dysfunction via different levels, one of which is via reducing the fluidity of the mitochondrial 
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membrane, thereby clearly pinpointing causality of cholesterol levels in organelle 
malfunction. Additionally, it is well-established that ER is in physical contact with the 
mitochondria, interacting through a subregion of ER referred to as the mitochondria-
associated ER membrane (MAM), a unique lipid composition enriched in cholesterol and 
phospholipids, with  characteristics of lipid rafts (de Meis et al. 2010; Area-Gomez et al. 
2012; Hedskog et al. 2013).  It was recently suggested that lipid rafts may form contacts 
between organelles and transfer membrane-derived signals. For instance, they play a role in 
ER sorting by stabilising the association of glycosylphosphatidylinositol (GPI)-proteins with 
the ER membrane (Helms and Zurzolo 2004). It is possible that the MAM domains would 
act as a contact site for facilitating cholesterol transport to the mitochondria (Flis and Daum 
2013). So, changes in cellular cholesterol levels might also disturb these contact sites and 
may ultimately cause a dysfunction in signaling between the ER and mitochondria. In 
oocytes, mitochondria are consistently found in clusters in close proximity to ER membranes. 
Given the proximity of the ER and mitochondria, it was reasoned that changes in local 
cholesterol levels would specifically affect these organelles, predominantly the mitochondria 
and in turn trigger cell death and impaired embryogenesis. In human oocytes, it was 
previously shown that mitochondria participate in GM1 lipid raft microdomain organisation 
(Van Blerkom and Caltrider 2013).  
 
To date, no study has explored the relationship between rafts and mitochondria in oocytes; 
thus we also sought to examine mitochondrial membrane potential (MMP) (a marker for 
oocyte or embryo health) in response to oocyte cholesterol depletion and membrane 
disruption. In addition we have recently identified a compound, BGP-15 which increases 
oocyte mitochondrial membrane potential when given to mice (Wu et al. 2015). It has also 
been found to increase skeletal muscle mitochondrial number (Henstridge et al. 2014). 
Interestingly, in other cells BGP-15 acts a membrane fluidiser (Sapra et al. 2014) and can 
counteract the effects of cellular cholesterol depletion (Gombos et al. 2011). Thus, the aim 
of this study was to investigate the functional importance and significance of lipid rafts in 
mouse embryogenesis using MCD, which extracts cholesterol from the cell membrane. The 
effect of MCD-mediated cholesterol depletion on oocyte mitochondrial activity and 
subsequent embryo health was evaluated. The effect of BGP-15 on stabilising membrane 
rafts was also examined.  
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2.2 Materials and Methods 




All experimental procedures were approved by the University of Adelaide Animal Ethics 
Committee and were performed in accordance with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes. C57BL/6 mice were obtained from the 
University of Adelaide Laboratory Animal Services and housed in the Animal Facility under 
a 14:10 hour light:dark cycle with ad libitum access to food and water.  
 
Female mice (6 weeks of age) were hormonally induced to ovulate by intraperitoneal (i.p.) 
injection of 5 IU (international units) per 12 g body weight of pregnant mare's serum 
gonadotrophin (PMSG; National Hormone and Peptide Program, Torrance, CA, USA) 
followed 48 h later by 5 IU per 12 g body weight human chorionic gonadotrophin (hCG; 
Merck, Sharp and Dohme), each in 0.1 mL 0.9 % saline. Mice were humanely killed by 
cervical dislocation 13 h to 16 h post-hCG and COCs obtained from oviducts and collected 
in HEPES-buffered -minimum essential medium (MEM) handling media (Life 
Technologies, Invitrogen, Carlsbad, CA, USA) supplemented with 1% fetal calf serum (FCS) 
(Life Technologies, Invitrogen, Carlsbad, CA, USA) and pre-warmed to 37C prior to use. 
Male mice (8 weeks of age) of proven fertility were humanely killed by cervical dislocation 
and vas deferens/epididymis dissected for isolation of sperm for IVF. 
 
2.2.2 Cholesterol Depletion of Oocytes 
Methyl-β-cyclodextrin (MβCD) was used to deplete cholesterol from ovulated oocytes. A 
stock solution (1 M) in HEPES-buffered-MEM culture media (Life Technologies, 
Invitrogen, Carlsbad, CA, USA) was stored at 4C. The stock solution was vortexed at room 
temperature before preparing working solution (15 mM) in HEPES-buffered-MEM 
handling media. Before use, solutions were pre-warmed at 37C in an atmosphere of 5% 
CO2 and 95% air until the reagent was completely dissolved. A control aliquot of HEPES-
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buffered-MEM handling media was also pre-warmed in the same conditions. Ovulated 
COCs were placed in drops with or without 15 mM MCD in HEPES-buffered-MEM 
handling media and incubated for 30 min at 37C in an atmosphere of 5% CO2, 20% O2 and 
95% air.   
 
The dose (15 mM) and timing (30 min) of MβCD treatment were chosen based on 
preliminary dose-finding experiments (Supplemental Figure 1) which tested the effects of 
doses from 5 mM MβCD to 40 mM MβCD for either 30 min or 1 h incubation on oocyte 
viability.  
 
2.2.3 In vitro Fertilisation (IVF) and Embryo Culture  
Fertilisation, wash and embryo culture media were Research Vitro Fertilisation, Research 
Vitro Wash and Research Vitro Cleave, respectively, from Cook Medical (William A. Cook 
Australia Pty. Ltd., Queensland, Australia). Ovulated COCs isolated from oviducts were 
cultured in the presence or absence of 15 mM MCD for 30 min at 37C and then used for 
in vitro fertilisation (IVF). Epididymides and vasa deferentia from male mice were collected 
into 1 mL of warm (37C) fertilisation medium. Sperm were extracted into the medium and 
allowed to capacitate at 37C in an atmosphere of 5% CO2, 20% O2 and 95% air for 1 h. 
Capacitated sperm (10 µL) was added to each fertilisation drop (90 L).   
 
Following cholesterol depletion in MβCD (or control) media as above, COCs were washed 
twice in wash medium, and co-incubated with the sperm for 4 h at 37C in an atmosphere of 
5% CO2, 20% O2 and 95% air. Presumptive zygotes were then washed in embryo culture 
medium and placed into culture drops (15-20 zygotes per 20 μL drop) at 37°C in an 
atmosphere of 5% CO2, 20% O2 and 95% air.  On Day 2, fertilisation was assessed and 2-
cell embryos were transferred into a fresh 20 L drop of embryo culture medium (10 
embryos per drop). Embryo morphology was classified as appropriately developed (‘on-
time’) using the following criteria; on Day 2, embryos at the 2-cell stage; and on Day 5, 
blastocysts or hatching blastocysts. Development rate was assessed on Day 2 as the 
percentage of embryos meeting the on-time development criteria from starting number of 
oocytes; while development on Day 5 as the percentage of embryos meeting the on-time 
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development criteria from 2-cell embryos. Twenty-three experimental replicates were 
performed, with 30 COCs used per treatment group within replicates. 
 
2.2.4 Time-Lapse Embryo Culture 
In separate experiments, time-lapse imaging was employed to more closely analyse 
developmental kinetics and cell size of oocytes. Oocytes were fertilised as previously 
described and then presumptive zygotes placed in 16-well dishes (Primovision, Vitrolife, 
Sweden), in culture media and conditions as described above, and monitored by Primo 
Vision time-lapse embryo monitoring system (Primovision, Thermo Scientific HERAcell 
VIOS 160i CO2 incubator) with images of individual embryos generated every 15 min 
throughout culture. The timing of morphokinetic events, including first, second and third 
cleavage division and cavitation were recorded and intervals between each event determined 
and analysed using the Primo Vision Analyser Software (version 4.4.1.01.010). The 
diameters of the oocytes and embryos (measured to the outer circumference of the zona 
pellucida) were also automatically recorded throughout development. Therefore, the 
measurement included both the oocyte/embryo and its zona pellucida, and incorporated 
differences in perivitelline space and zona thickness. Three experimental replicates were 
performed, with 16 COCs per treatment group and replicate. 
 
2.2.5 Cholesterol Staining of Oocytes and Embryos 
Filipin complex from Streptomyces filipinesis was used to stain free cholesterol in ovulated 
oocytes and embryos (Day 5 blastocysts). Following cholesterol depletion or IVF, oocytes 
or embryos were immediately fixed in 4% paraformaldehyde in 1x phosphate buffered saline 
(PBS) with 1 mg/mL polyvinylpyrrolidone (PBS/PVP) for 1 h. Zona-enclosed oocytes or 
embryos were then washed three times in PBS, and incubated with 50 µg/mL filipin in PBS 
for 1 h in the dark at room temperature. This dose of filipin stain was used based on 
optimisation experiments which showed dose-dependent staining of free cholesterol in 
oocytes using filipin doses ranging from 20 µg/mL to 200 µg/mL (Supplementary Fig 2). 
After staining, the oocytes were washed in PBS/PVP for 5 min and mounted onto a 
microscope slide adhered with a secure-seal spacer (Life Technologies, Molecular Probes, 
Eugene, OR) in 5 µL PBS/PVP. Embryos were transferred with minimum medium onto 
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slides with a microdrop of glycerol (5 µL) without spacer. Images were captured using a 
Leica SP5 spectral scanning confocal microscope using blue filter (excitation = 405 nm, 
emission = 420-520 nm). Images were captured at 60x magnification and laser, sensitivity, 
and imaging parameters were kept constant between replicates and across experiments. 
Intensity of fluorescence was determined using Image J version 1.47r software by placing a 
circle across the oocyte image and measuring pixel intensity. The mean, area and integrated 
density (the sum of the pixel values in the circle) were reported and the corrected total cell 
fluorescence was calculated using the formula stated below. The data were then represented 
graphically as intensity of fluorescence over pixel widths. Three experimental replicates 
were performed, with 10 oocytes per treatment group. 
Total fluorescence = Integrated Density- (Area of selected cell  Mean fluorescence of 
background readings) 
 
2.2.6 Lipid Raft Staining of Oocytes and Embryos 
Fluorescent-labeled cholera toxin subunit B (CTB-AF488, Life Technologies, Molecular 
Probes, Eugene, OR) staining was optimised using concentrations based on a previous study 
(Buschiazzo et al. 2013) with  20 g/mL CTB-AF488 in 1x PBS resulting in clear 
visualisation of lipid rafts (data not shown). Briefly, COCs were hyaluronidase-treated by 
the addition of 10 µL of pre-warmed 1000 IU/mL hyaluronidase to the handling media, 
oocytes collected and fixed in 4% paraformaldehyde in PBS/PVP. Zona-enclosed oocytes 
were then washed in PBS/PVP followed by incubation in 100 L drops with 20 g/mL of 
CTB-AF488 for 30 min at 37C in the dark. After staining, the oocytes were washed in 
PBS/PVP for 5 min and mounted under a coverslip in 5 L PBS/PVP. Three experimental 
replicates were performed, with 6 oocytes per treatment group. 
 
For embryos, they were permeabilised in 0.5% Triton X-100 in Cook Vitro Wash for 20 min 
at room temperature. To block non-specific uptake of staining reagents, embryos were 
incubated in 10% Normal Goat Serum (NGS) in PBS/PVP for 40 min. Embryos were then 
washed in PBS/PVP followed by incubation in 100 L drops with 20 g/mL of CTB-AF488 
for 30 min at 37C in the dark. To label cell nuclei, 1 g/mL of Hoechst 33342 (Life 
Technologies, Molecular Probes, Eugene, OR) was added to the culture drop during the last 
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10 min of the incubation. After staining, embryos were washed in PBS/PVP for 5 min and 
transferred with minimum medium onto slides with a microdrop of glycerol (5 L). Images 
were captured using a Leica SP5 spectral scanning confocal microscope using green filter 
(excitation = 473nm, emission = 490-590 nm). Images were captured at 90x magnification 
and laser, sensitivity, and imaging parameters were kept constant between replicates and 
across experiments. Four experimental replicates were performed, with 6 embryos per 
treatment group. 
 
2.2.7 Mitochondrial Membrane Potential Assay 
Denuded oocytes or embryos were incubated with 1.5 mM JC-1 (5,5’, 6,6’-tetrachloro-1,1’, 
3,3’, tetraethylbenzimida-zolylcarbocyanine iodide (Invitrogen, CA, USA) in handling 
media (oocytes)/ Cook Vitro Wash (embryos) for 15 min at 37C in the dark. Oocytes were 
washed once in PBS/PVP and then imaged immediately using the confocal microscope using 
a narrow green filter (490-540 nm) and a narrow red filter (570-620 nm). Images were 
captured at 60x magnification and laser, sensitivity, and imaging parameters were kept 
constant between replicates and across experiments. Intensity of fluorescence was 
determined as described above for filipin staining. Four experimental replicates were 
performed for oocytes and five replicates for embryos, with 10 oocytes/blastocysts per 
treatment group. 
 
2.2.8 Inner Cell Mass (ICM) and Trophectoderm (TE) Assessments 
Allocation of cells to TE and ICM lineages was assessed in Day 5 blastocyst-stage embryos 
using a modification of the method of Handyside and Hunter (1984) (Handyside and Hunter 
1984). Briefly, blastocysts were incubated with 0.5% pronase at 37C to remove the zona 
pellucida, followed by 10 min incubation at 4C in 10 mM TNBS (2,4,6-trinibrobenzene 
sulfonic acid) in the dark. Blastocysts were then washed with MOPS (3-(N-
morpholino)propanesulfonic acid) and incubated with 0.1 mg/mL anti-DNP (Dinitrophenyl) 
for 10 min at 37C. Following, blastocysts were washed again and incubated for 5-10 min 
in 10 g/mL of propidium iodide (PI) in 10% guinea pig serum. Blastocysts were then 
transferred to 6 g/mL bisbenzimide in ethanol overnight and washed in 100% ethanol the 
following day. Blastocysts were then mounted on microscopic slides in glycerol underneath 
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a cover slip and visualised using an epifluorescence microscope (Nikon, TE 2000-E) at 200× 
equipped with an ultraviolet filter (excitation, 340–380 nm; emission, 440–480 nm). ICM 
nuclei labeled with bisbenzimide appear blue whereas TE nuclei labeled with a combination 
of bisbenzimide and PI appear pink or red. Total and TE cell numbers were counted 
individually and ICM cell numbers were calculated by subtracting TE from the total cell 
number.  
 
2.2.9 Neutral Lipid Staining in Embryos 
Embryos were fixed in 4% paraformaldehyde in PBS/PVP, washed in PBS/PVP and stained 
with 1 g/mL of the neutral lipid stain BODIPY 493/503 (Life Technologies, Invitrogen, 
CA, USA) in PBS/PVP for 1 h in the dark at room temperature. Embryos were washed in 
PBS/PVP for 5 min and mounted under a coverslip in 5 µL of DAKO fluorescent mounting 
media (Dako North America Inc, CA, USA). Images were captured using a Leica SP5 
spectral scanning confocal microscope using green filter microscope using green filter 
(excitation = 473nm, emission = 490-590 nm). Images were captured at 90x magnification 
and laser, sensitivity, and imaging parameters were kept constant between replicates and 
across experiments. Intensity of fluorescence was determined as described above for filipin 
staining. Two experimental replicates were performed, with five blastocysts per treatment 
group. 
 
2.2.10 In vitro BGP-15 Treatment 
To test the effect of BGP-15 on lipid raft distribution in oocytes, preliminary experiments 
were conducted under different conditions. Treatment groups were i) control (-MEM 
handling media supplemented with 1% FCS), ii) cholesterol depletion (15 mM MβCD), iii) 
15 min 10 µM BGP-15 followed by 30 min cholesterol depletion, iv) 30 min cholesterol 
depletion followed by 30 min 10 µM BGP-15, and v) 30 min of cholesterol depletion + 10 
µM BGP-15. Following treatment, oocytes were washed in PBS/PVP and then fixed in 4% 
paraformaldehyde for at least 1 h. Lipid raft staining was performed as previously described. 
After staining, the oocytes were washed in PBS/PVP for 5 min and mounted under a 
coverslip in 5 µL of DAKO fluorescent mounting media. Images were captured using the 
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Olympus Fluoview FV10i confocal microscope (Olympus; Tokyo, Japan). Two 
experimental replicates were performed, with 6 oocytes per treatment group. 
 
2.2.11 Statistical Analyses 
All measures are reported as mean ± SEM. Statistical significance was determined as 
indicated, by using Student's t-test or one-way ANOVA with Tukey’s post hoc tests, as 
appropriate, using GraphPad Prism v008 (GraphPad Software, La Jolla, CA, USA) for 
Windows. Time-lapse data were analysed by using repeated measures with linear mixed-
effects model in SPSS (IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM 
Corp.). Normality of data was confirmed by analysing the spread of residuals. A P-value of 
less than 0.05 was considered statistically significant. 
  




2.3.1. Cholesterol depletion alters oocyte lipid raft distribution but not 
membrane potential 
The ability of MβCD to deplete mouse oocyte cholesterol levels was verified by incubating 
oocytes in increasing doses of MCD (0, 5, 10 and 15 g/mL) for 30 min followed by filipin 
staining of free cholesterol. Fluorescent filipin stain in oocytes was visibly reduced with 
increasing MCD concentration (Figure 1A). Image analysis confirmed that MCD 
significantly and dose-dependently, reduced cholesterol content in the treated oocytes (P ≤ 
0.05; Figure 1B). The reduction in cholesterol content by MCD at doses up to 15 mM for 
30 min did not impact oocyte morphology, while MβCD doses of more than 20 mM for 30 
min, or more than 15 mM for 1 h were toxic to oocytes (Suppl. Fig. 1). These results, similar 
to others (Buschiazzo et al. 2013), indicate that treatment of oocytes with 15 mM MCD for 
30 min significantly decreases oocyte cholesterol content but does not affect viability.  
 
The effect of cholesterol depletion on oocyte raft distribution was also examined. Untreated 
oocytes showed uniform distribution of lipid rafts throughout the cell membrane as well as 
punctate staining within the cytoplasm (Figure 2A). This staining pattern was specific as 
negative control oocytes processed identically but without CTB stain gave minimal 
background. Oocytes treated with MβCD exhibited disrupted lipid raft distribution, 
specifically a marked reduction in the plasma membrane staining (Figure 2A) although 
punctate cytoplasmic staining persisted.  
 
To determine whether oocyte cholesterol depletion and lipid raft disruptions are associated 
with changes to mitochondrial function, MMP was examined using JC-1 potentiometric dye. 
Both control and MCD-treated oocytes exhibited red punctate fluorescence localised to the 
pericortical region and green fluorescence concentrated in the deeper cytoplasm (Figure 2B). 
Reductions in MMP, determined by the ratio of red to green fluorescence, are considered a 
hallmark of mitochondrial damage (Vayssier-Taussat et al. 2002; Savitha and 
Panneerselvam 2006). Analysis of the ratio of red/green fluorescence intensity showed that 
oocytes depleted of cholesterol with MCD exhibited no differences compared with 
untreated oocytes (Figure 2C). 
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Cumulatively these results confirm that cholesterol is essential for lipid raft formation in 
mouse oocytes and demonstrate that disruptions to lipid rafts in the oocyte plasma membrane 
is not associated with significant alterations in oocyte mitochondrial activity.  
  















Figure 1 Effect of methyl-β-cyclodextrin (MβCD) on mouse oocyte cholesterol content. 
(A) Representative photos of oocytes stained with filipin after incubation in the indicated 
dose of MβCD for 30 min. (B) Fluorescence intensity (arbitrary units) of filipin-stained 
oocytes. Data presented as mean ± SEM; n = 21-32 oocytes per treatment group from at least 
3 independent experiments. Groups with different superscripts differ significantly by one-








Figure 2 Effect of cholesterol depletion on mouse oocyte lipid raft distribution and 
mitochondrial membrane potential. 
(A) Representative photos of oocyte lipid rafts detected by Cholera Toxin Subunit B (CTB-
AF488 staining in untreated oocytes or those treated with MCD.  Negative control 
consisted of omission of the CTB stain in untreated oocytes. (B) Representative photos of 
untreated or MCD-treated oocytes stained with JC-1 dye for detection of mitochondrial 
membrane potential. (C) JC-1 fluorescence intensity quantification presented as mean  
SEM, n = 25 (untreated) and n = 26 (MCD) oocytes from 4 independent experiments. P > 
0.05, unpaired t-test. Scale bar = 50 µm. 
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2.3.2 Oocyte cholesterol depletion alters developmental kinetics and 
embryo development 
Control oocytes or those depleted of cholesterol using MCD were subjected to IVF, 
followed by morphometric assessment and time-lapse imaging to closely monitor 
developmental kinetics and cell size. Following IVF, a significant proportion of cholesterol-
depleted oocytes failed to undergo cleavage, however, those which cleaved continued to 
develop to blastocyst stage with no further reduction in the blastocyst development rate 
(Figure 3A). On average, embryos cleaved at 14 h post-insemination and reached the 3-cell 
stage and 4-cell stage at 43 h and 45 h, respectively (Figure 3B). Blastocyst formation ranged 
from 92 h to 96 h post-insemination (Figure 3B). Interestingly, the timing of the 
morphokinetic events revealed that the time to cleavage was longer in the cholesterol-
depleted oocytes when compared to control (Figure 3B and Figure 3C). Although the 
cholesterol-depleted oocytes took longer to cleave, they were quicker to progress from 2-
cell to 3-cell stage when compared to the control. Thus they were ‘caught up’ by the 3-cell 
to 4-cell cleavage division (Figure 3C). However, as the embryo progressed from 4-cell to 
morula, the time duration was again increased in the cholesterol-depleted group when 
compared to the control. Similarly, the timing from morula to blastocysts was slightly longer 
in the cholesterol-depleted group, but this was not statistically different compared to the 
control (Figure 3C). Furthermore, the time interval from post-insemination to blastocyst was 
also not different between the groups (Figure 3C). Overall, these results indicate that 
cholesterol depletion affects the time intervals between early developmental milestones as 
early as the 2-cell stage. Moreover, examination of oocyte size showed that MCD-induced 
cholesterol depletion significantly reduced oocyte size (Figure 3D). Subsequently, 
blastomere size in the 2-cell embryos generated from the cholesterol-depleted oocytes was 
also significantly reduced (Figure 3E); and this reduction in embryo size was maintained 
through to the blastocyst stage (Suppl. Fig. 3).  
  














Figure 3 Effect of cholesterol depletion on developmental kinetics and cell size 
following time-lapse imaging. 
(A) Cleavage rate assessed on Day 2 and blastocyst rate on Day 5. Data are presented as 
mean  SEM; n = 23 experimental replicates. (B) Timing of developmental milestones 
(hours post-insemination) in control embryos and those treated with 15 mM MβCD. (C) 
Time intervals between each developmental stage. (D) Oocyte diameter post-insemination. 
(E) Blastomere size of 2-cell embryos. (B-E) Data are presented as mean  SEM; n = 38-46 
embryos from 3 independent experiments; * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, unpaired 
t-test and repeated measure by linear mixed-effects model; PI- post-insemination, 2C- 2-cell, 
3C- 3-cell, 4C- 4-cell, ML- morula, BL- blastocyst. 
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2.3.3 Oocyte cholesterol depletion affects embryo phenotypes 
To determine whether oocyte cholesterol stores influence embryo health, preimplantation 
embryos generated by IVF of control or MβCD-treated oocytes were assayed for a number 
of markers of quality and differentiation, including cell number allocation, neutral lipid 
content, free cholesterol and lipid raft distribution. Differential staining for ICM and TE 
showed a significant reduction in total cell number in embryos derived from cholesterol-
depleted oocytes compared to controls (Control = 47.91 ± 0.89 vs. MβCD = 43.56 ± 1.35;  
P ≤ 0.01; Table 1). TE cell numbers in the embryos from the cholesterol-depleted oocytes 
were also significantly lower than those in the control embryos (Control = 32.98 ± 1.24 vs. 
MβCD = 27.83 ± 1.33; P ≤ 0.05). No differences in the ICM cell numbers and ICM:TE cell 
ratio, a marker of embryo health (Van Soom et al. 2002), were observed between the groups 
(Table 1). 
 
Embryo lipid droplet abundance and localisation were measured using BODIPY 493/503 
stain which stains neutral lipids, i.e. triglycerides and cholesterol. Lipid droplets were 
distributed throughout control embryos (Figure 4A). Embryos from MβCD-treated oocytes 
showed visibly lower levels of lipid than control embryos with droplets localised mainly in 
the TE (Figure 4A). Quantification of total fluorescence confirmed that lipid content was 
significantly reduced in embryos derived from cholesterol-depleted oocytes (P ≤ 0.05; 
Figure 4B). This result suggests that the reduction in cholesterol in oocytes is maintained 
through embryogenesis. 
 
MMP and reactive oxygen species (ROS) levels were also assessed as markers of embryo 
quality. Visualised using JC-1 staining, MMP levels and distribution in embryos was similar 
to previous reports (Van Blerkom et al. 2002; Acton et al. 2004; Van Blerkom 2004) and no 
difference was found in MMP in the intermediate or outer region of the embryos (Figure 5). 
Similarly, intracellular ROS levels, assayed using the fluorescent probe CM-H2DCFDA, 
were not different between embryos generated from cholesterol-depleted oocytes compared 
to controls (Suppl. Fig. 4).  
 
To determine the impact of cholesterol depletion on embryo membrane structure, 
specifically lipid bilayer and raft integrity, blastocysts were stained with either filipin or 
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CTB-AF488. Embryos derived from oocytes depleted of cholesterol exhibited a clear 
disruption to membrane structure. Specifically the TE cell junctions were apparent in the 
control embryos but were not visible in embryos derived from cholesterol depleted oocytes 
(Figure 6A, Suppl. Fig. 5). 
 
Similarly, intensive staining of lipid rafts was observed in the TE and ICM cells of embryos 
from untreated oocytes, but to a lesser extent in the embryos generated from MβCD-treated 
oocytes (Figure 6B, Suppl. Fig 6), reflective of changes to the lipid bilayer structure and 
disorganisation of lipid rafts. Quantification of total fluorescence confirmed that cholesterol-
depletion in oocytes led to significantly reduced lipid raft staining in embryos (P ≤ 0.05; 
Figure 6C). These results provide functional data showing that the cholesterol content of 
oocytes influences lipid content and membrane structures through to the blastocyst stage. 
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Table 1 Effect of oocyte cholesterol depletion on subsequent mouse blastocyst cell 
number. 
 
 Untreated 15 mM MCD P-value 
Total cell number 47.91  0.8882 43.56  1.352 0.0064 
TE cell number 32.98  1.239 27.83  1.328 0.0130 
ICM cell number 14.94  1.116 14.86  0.5706 NS 
Ratio of ICM to TE 0.5276  0.05412 0.5946  0.04247 NS 
TE: trophectoderm; ICM: inner cell mass; n = 47 untreated oocytes and n = 36 MCD-
treated oocytes. NS = not significant. P-values are from unpaired t-test.  
  





















Figure 4 Effect of cholesterol depletion in oocytes on mouse embryo neutral lipid 
content.  
COCs were untreated or cholesterol-depleted using MCD then fertilised and cultured in 
vitro to the blastocyst stage. Blastocysts were stained with BODIPY 493/503. (A) 
Representative photos of BODIPY-stained blastocysts. (B) Quantification of fluorescence 
intensity. Data are presented as mean  SEM, n = 8 blastocysts per group from two 
independent experiments. * P ≤ 0.05, unpaired t-test. Scale bar = 100 µm. 
  




Figure 5 Effect of cholesterol depletion in oocytes on mouse embryo mitochondrial 
membrane potential. 
COCs were untreated or cholesterol-depleted using MCD then fertilised and cultured in 
vitro to the blastocyst. Blastocysts were stained with JC-1. (A) Representative photos of 
embryos stained with JC-1. (B) The ratio of red to green fluorescence quantified as an 
indicator of mitochondrial activity. Data are presented as mean  SEM, n = 12 (control) and 
n = 15 (MβCD) embryos from 5 independent experiments. P > 0.05, unpaired t-test. Scale 
bar = 100 µm. 
  




Figure 6 Effect of cholesterol depletion in oocytes on mouse embryo membrane 
structures.  
(A) Representatives photos of blastocysts derived from oocytes depleted of cholesterol using 
MβCD (or controls) stained with filipin to detect cholesterol level. (B) Representative photos 
of CTB-stained blastocysts. Hoechst 33342 (blue) shows DNA staining; CTB-AF488 (green) 
shows lipid rafts staining. (C) Quantification of CTB-AF488 fluorescence intensity. Data are 
presented as mean  SEM, n = 13 (untreated) and n = 14 (MCD) blastocysts from four 
independent experiments. * P ≤ 0.05, unpaired t-test. Scale bar = 100 µm. 
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2.3.4 BGP-15 does not rescue the disruption of oocyte raft distribution in 
vitro  
To determine whether short exposure to BGP-15 has any effect on the cholesterol-depleted 
oocyte membrane structure, oocytes were exposed to 10 µM of BGP-15 before, after or 
simultaneously with 15 mM MβCD. Lipid raft distribution was clearly observed on the 
plasma membrane of control oocytes and as punctate staining intracellularly (Figure 7A). 
Consistent with earlier findings, short exposure to 15 mM MβCD disrupted lipid raft 
distribution in the oocytes particularly on the plasma membrane (Figure 7B). BGP-15 
treatment for 15 min prior to exposure to MβCD did not restore lipid rafts distribution, 
although some patches of plasma membrane had low amounts of staining (Figure 7C). 
Similarly, exposure of oocytes to BGP-15 after MβCD incubation also did not rescue the 
raft organisation (Figure 7D), indicating that BGP-15 treatment before or after cholesterol 
depletion did not promote the remodelling of raft organisation. When BGP-15 was added 
together with MβCD, identical results were observed; there was no improvement in raft 
distribution (Figure 7E).  




















Figure 7 Effect of BGP-15 treatment on mouse oocyte membrane raft distribution in 
vitro. 
(A) Representatives photos of control oocytes stained with CTB-AF488, (B) Oocytes that 
were exposed to 15 mM MβCD, (C) Oocytes that were incubated with 10 µM BGP-15 for 
15 min followed by 30 min of 15 mM MβCD, (D) Oocytes exposed to 30 min of MβCD 
followed by 30 min of BGP-15 and (E) Oocytes incubated with MβCD and BGP-15 for 30 
min. Scale bar = 60 µm. 




Our data confirms that lipid rafts are distributed throughout the oocyte plasma membrane 
and in embryonic TE and ICM. Experiments using a cholesterol-extracting reagent provided 
functional data showing that removal of cholesterol from the oocyte disrupted oocyte raft 
distributions and caused significant disruptions to embryogenesis. Interestingly, cholesterol 
depletion and lipid raft disruptions were not associated with alterations in mitochondrial 
membrane potential in either oocytes or embryos. Importantly however, we have shown that 
cholesterol is necessary to support normal embryo development to the blastocyst stage and 
the formation of normal embryonic membrane structure.  
 
Consistent with previous studies, we saw a uniform distribution of lipid rafts on the oocyte 
membrane (Comiskey and Warner 2007; Buschiazzo et al. 2013). Our finding that treatment 
of oocytes with 15 mM MβCD for 30 minutes significantly decreases oocyte cholesterol 
content but does not affect viability was also supported by a previous study (Buschiazzo et 
al. 2013). Following cholesterol depletion, lipid raft distribution surrounding the oocyte 
membrane was completely disrupted demonstrating that cholesterol has a 
structural/stabilising role in the membrane microdomain assembly. This phenomenon has 
also been observed in several other cell types (Diaz et al. 2005; Barman and Nayak 2007; 
Chubinskiy-Nadezhdin et al. 2013). This result also suggests that signaling machinery on 
the oocyte surface may be altered, as many proteins involved in signal transduction processes 
are embedded within the plasma membrane. Consistent with this, Buschiazzo et al. (2013) 
reported that membrane localised signaling molecule, c-Src was disturbed in oocytes 
following cholesterol removal (Buschiazzo et al. 2013). In contrast, even though plasma 
membrane staining was disrupted, there was clear intracellular staining persistent in the 
oocyte cytoplasm. This accumulation of fluorescent probe has a localisation pattern that 
resembles MAMs, contact sites between mitochondria and ER, as judged by their shape, size, 
and distribution. This intracellular staining is not disrupted by MβCD suggesting that MAMs 
are more resistant to cholesterol depletion and possibly that communication between 
mitochondria and ER is not affected. 
 
The disruption of rafts in the oocytes was maintained through embryo development; with 
MCD-treated, cholesterol-depleted embryos exhibiting a disruption of lipid rafts in the 
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embryos as revealed by fluorescent labeling of ganglioside GM1. In early developing 
mammalian embryos, lipid rafts have been reported to play a key role in cytokinesis 
(Comiskey and Warner 2007; Sato et al. 2011). During cell cleavage, they were shown to 
play a vital role in central spindle assembly and cleavage furrow ingression (Albertson et al. 
2005). Moreover, it was previously reported that MβCD-mediated disruption of lipid rafts 
in 8-cell embryos caused the release of a specific raft domain into the perivitelline space and 
decompaction, and suppressed cell division (Sato et al. 2011). In addition, cell-surface 
antigens that are markers of pluripotency, in particular, stage–specific embryonic antigen 4 
(SSEA4), were reported to have a similar pattern of localisation with that of CT staining 
(Comiskey and Warner 2007). Therefore, the disorganisation of lipid rafts in the embryos 
may correlate to reduced pluripotency which would affect cell lineage differentiation. Our 
results extend these observations by demonstrating that manipulation of cholesterol levels 
even prior to fertilisation impairs zygote cleavage in a large subset of embryos, reduces 
proliferation in those that progress and alters in TE cell numbers. 
 
Mitochondrial membrane potential (MMP) is a key indicator of cellular viability and is 
crucial to embryo viability. It reflects the pumping of hydrogen ions across the mitochondrial 
inner membrane during the process of electron transport and oxidative phosphorylation, the 
driving force behind adenosine triphosphate (ATP) production. A reduction in MMP is a 
hallmark of mitochondrial damage (Vayssier-Taussat et al. 2002; Savitha and 
Panneerselvam 2006), which triggers the production of reactive oxygen species (ROS) and 
ultimately leads to apoptosis. Furthermore, dysfunction or abnormalities of the mitochondria 
in oocytes can also induce apoptosis in embryos, compromising their developmental ability 
(Mitchell et al. 2009; Yu et al. 2010). Surprisingly, and counter to our hypothesis, cholesterol 
depletion, did not affect mitochondrial membrane potential. This conclusion is supported by 
the observation of unchanged ROS levels in embryos derived from cholesterol depleted 
oocytes (Suppl. Fig. 4) and may again be due to MβCD more greatly affecting plasma 
membrane raft structures rather than intracellular CTB-stained raft structures. Further,  
mitochondrial organisation is also considered an important parameter for evaluating oocyte 
quality. Thus, qualitative measures such as distribution of mitochondria, degree of 
mitochondrial clustering, and patterning of stains were also assessed in all the oocytes but 
no difference was observed between the treatment groups. Future studies could be directed 
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toward assessing the actual number, size or morphology of the mitochondria as mitochondria 
in oocytes are known to undergo substantial change from the oocyte to blastocyst stage 
embryo. 
  
Cholesterol depletion appears to affect various aspects of the fertilisation process (Comiskey 
and Warner 2007; Buschiazzo et al. 2013). By using the same cholesterol depletion method, 
Buschiazzo et al. (2013) showed that the fertilisation index was decreased as measured by 
the number of sperm heads within the oocyte cytoplasm (Buschiazzo et al. 2013). Another 
study by Comiskey and Warner (2007) also reported that the presence of MCD in the 
embryo culture media reduced the percentage of embryos from reaching the blastocyst stage 
(Comiskey and Warner 2007). In the current study, we exposed the COCs to MCD for a 
short period of time prior to IVF and time-lapse video recording and image analysis were 
performed to determine the time of some key events during embryo development.  In control 
embryos, cell division occurs every 18-20 hours. Embryos dividing either too slow or too 
fast may have metabolic and/or chromosomal defects (Leese 2002; Munne 2006; Magli et 
al. 2007; Lee et al. 2015). Besides the importance of timing of cleavage, the time between 
each division is also crucial (Scott et al. 2007; Lemmen et al. 2008; Wong et al. 2010; 
Meseguer et al. 2011). In our study, we observed a slower cleavage time in the cholesterol-
depleted oocytes than in the controls. Studies have found that early cleavage time was a 
strong predictor of embryo quality and that transfer of early cleaving embryos resulted in 
higher implantation and pregnancy rates (Lundin et al. 2001; Van Montfoort et al. 2004). In 
addition, blastocysts generated from early-cleaving embryos were of higher quality than 
those from later-cleaving embryos such that they had a larger ICM cell number and higher 
percentage of developing fetuses on E13.5 (Fenwick et al. 2002; Salumets et al. 2003; Lee 
et al. 2015).  
 
In this study, exposure of mouse COCs to MβCD had notable negative effects on embryo 
quality. Using BODIPY 493/503 which stains triglycerides and cholesterol, there was a clear 
reduction in these neutral lipid droplets in the embryos generated from the cholesterol-
depleted oocytes. This implicates that availability of cholesterol is essential for lipid droplet 
formation or maintenance in the embryos. Lipid droplets are now understood to be involved 
in a range of cellular processes and interact with various organelles and in embryos may 
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possibly regulate lipid exchange to various membrane organelles to support further 
development. Cholesterol depletion also resulted in changes in the blastocyst cell numbers. 
Total and TE cell numbers were significantly decreased in the embryos generated from the 
cholesterol-depleted oocytes. This alteration in cell numbers can have long-term effects for 
embryo growth. Changes in the blastocyst cell numbers have been shown to positively 
correlate with implantation and pregnancy rates (Lane and Gardner 1997). For instance, total 
blastocyst cell count has been associated with hatching ability in vitro (Van Blerkom 1993; 
Lea et al. 1996). The overall blastocyst cell numbers reported here might be considered 
relatively low; even though our results are consistent with a previous study (Banwell et al. 
2007). It is important to note that these embryos were cultured under atmospheric oxygen 
(i.e. 20% concentration) and studies in both mice and human embryos have reported a 
reduced cell number in embryos cultured under 20% oxygen when compared to those 
cultured under 5% or 7% oxygen (Gardner and Lane 1996; Dumoulin et al. 1999; Karagenc 
et al. 2004). Further, it is well known that proliferation of embryonic cells can be negatively 
influenced by suboptimal conditions and that TE cells, which are in closer contact with the 
environment (culture medium), are the first cells to differentiate in the embryo; providing 
likely explanations for the TE-specific reduction in cell numbers that was observed, Given 
that TE cells are precursor cells for the placenta and are more metabolically active (Hewitson 
and Leese 1993; Houghton 2006), the reduction in TE cells may have downstream effects 
on placental growth, which is clinically relevant since both low and high placental weight at 
birth in humans have been shown to correlate with the likelihood to develop coronary heart 
disease, hypertension, stroke and cancer in adulthood (Barker et al. 1990; Eriksson et al. 
2011).  
 
Interestingly, embryos derived from oocytes depleted of cholesterol exhibited a clear 
disruption to membrane structure. Specifically, the ‘tight junction-like’ permeability seals 
on the embryo surface were not visible. This permeability seal is thought to be important for 
vectorial transport of ions and water to generate the blastocoel cavity (Biggers et al. 1988). 
The presence of cholesterol-filipin complexes on the cell surface membrane suggests the 
likelihood of high cholesterol concentration in this region. Defects in the membrane 
structures of these outer, likely TE cells, further suggests that subsequent placenta 
development may be altered.  




BGP-15 has the potential to stabilise membranes and remodel lipid rafts in some cellular 
contexts (Gombos et al. 2011) and since we have observed that BGP-15 is highly effective 
in improving oocyte quality (Wu et al. 2015) we wanted to determine whether BGP-15 
action in oocytes is via membrane stabilisation. However, in the present study, in vitro BGP-
15 treatment did not promote the remodeling of lipid rafts in the oocyte that were exposed 
to MβCD. In these experimental conditions, lack of cholesterol accounts for the defects 
observed, and thus it is possible that BGP-15 may not affect cholesterol-mediated defects in 
the oocytes.  
 
In conclusion, we show that membrane raft integrity is necessary to accomplish efficient 
fertilisation in mouse oocytes. Functional data from embryo culture experiments supports 
the concept of a critical role for lipid rafts in development as removal of cholesterol from 
oocytes by MCD reduced the rates of cleavage, altered morphokinetic events during 
embryo development and subsequently perturbed developmental competence. Taken 
together, our results demonstrate that changes in oocyte cholesterol level cause an effect on 
the oocyte and embryo membrane structure organisation and impact fertilisation success. 
Furthermore, obesity, a condition associated with elevated levels of cholesterol in the 
follicular fluid, is known to cause poor fertility outcome (Valckx et al. 2012). Therefore, it 
is speculated that high cholesterol would also disrupt rafts and this may be one of the 
underlying issues with obesity-mediated effects on conception rates. This study provides us 
a better understanding of the role of cholesterol stores and membrane organisation during 
preimplantation development.  
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2.5 Supplementary Materials 
The optimal dose of MCD to deplete cholesterol without reducing oocyte viability was 
determined by examining the effect of increasing doses of MCD on oocyte survival. MCD 
doses of 0, 5, 15, 20, 30 and 40 mM were chosen based on previous reports in other cell 
types (Sun and Whittaker 2003; Breen et al. 2012; Buschiazzo et al. 2013). 
 
An initial experiment (n = 1 experimental replicate with 30 oocytes) was conducted in which 
oocytes were incubated in HEPES-buffered-MEM culture medium supplemented with 
MCD at concentrations ranging from 0 mM to 40 mM for 1 h. Oocyte morphology was 
assessed as a marker of viability with live oocytes defined as having homogeneous 
cytoplasm and the shape is maintained (round). The oocyte survival rate in 15 mM MCD 
was approximately 80% yet none survived at 20 mM (Suppl. Fig 1A). Subsequent 
experiments utilised a shorter incubation time (30 min; n = 2 experimental replicates with 
56 oocytes). In these, oocyte viability was again 100% in the presence of 5 mM MCD there 
was 100% survival rate (Suppl. Fig. 1B), decreasing to a survival rate of 0% with high 
MCD concentrations. Increasing doses caused clear morphological changes in the oocytes 
(Suppl. Fig. 1C). Both 15 mM and 20 mM MCD was able to elicit limited survival. Thus, 
the ability of oocytes to survive in the presence of MCD was established. A dose of 15 mM 
was non-toxic and thus subsequent experiments used 15 mM at 30 min to deplete cholesterol, 
unless otherwise stated. Long incubation with MβCD induced cell death; however, it is 
important to note that its effect is non-cytotoxic and occurred as a non-apoptotic mechanism 
in other cell types (Motoyama et al. 2009).  
 
2.5.1 Cholesterol depletion survival assessment  
An independent assessor assessed the oocytes survival by the following criteria. In living 
oocytes, the cytoplasm is homogeneous and the shape is maintained (round) whereas dead 
oocytes are morphologically darkened, granular and with retracted cytoplasm from the zona.  




Supplemental Figure 1: Increasing doses of methyl-β-cyclodextrin (MCD) cause 
morphological changes in live mouse oocytes. 
(A) Effect of cholesterol depletion mediated by MCD on oocyte viability after 1 h and (B) 
30 min. Data are presented as (A) one experiment from a total of 6 control oocytes, 4 oocytes 
treated at 5 mM, 5 oocytes depleted at 15 mM, 6 oocytes depleted at 20 mM, 5 oocytes 
depleted at 30mM and 5 oocytes depleted at 40 mM MCD. (B) n = two experimental 
replicates from a total of  7 control oocytes, 8 oocytes depleted at 5 mM, 11 oocytes depleted 
at 15mM, 12 oocytes depleted at 20 mM, 9 oocytes depleted at 30 mM and 9 oocytes 
depleted at 40 mM of MCD. Groups with different superscripts differ significantly by one-
way ANOVA with Tukey’s post hoc test (P < 0.05). (C) Representative photos of oocytes 
after 30 min of MCD treatment. 
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To optimise staining for free cholesterol in oocytes, a dose response of filipin was conducted 
using concentrations of the filipin stain ranging from 20 g/mL to 200 g/mL. The level of 
fluorescence was clearly dependent on the concentration of the filipin stain in the medium 
(Suppl. Fig. 2.1A). In the absence of the stain, minimal positive fluorescence was detected 
(Suppl. Fig. 2.1B). Increased filipin concentrations resulted in significantly higher level of 
fluorescence (P ≤ 0.05; Supp. Fig. 2.1B). At 200 g/mL, the oocytes appeared to have the 
highest positive fluorescence than other doses. Filipin concentration at 50 g/mL gave clear 
fluorescence without saturation and was selected as the concentration to be used for 
subsequent experiments. 
  




Supplemental Figure 2: Increasing doses of filipin stain resulted in higher fluorescence 
level. 
(A) Representative photos of filipin-stained mouse oocytes. (B) Densitometry analysis of 
oocytes stained with increasing filipin concentrations. Data are presented as mean  SEM 
fluorescence intensity where n = 22 control (0 g/mL) oocytes, 11 oocytes at 20 g/mL, 11 
oocytes at 40 g/mL, 28 oocytes at 50 g/mL, 12 oocytes at 100 g/mL and 19 oocytes at 
200 g/mL of filipin. Groups with different superscripts differ significantly by one-way 
ANOVA with Tukey’s post hoc test (P ≤ 0.05). Scale bar = 50 µm. 
  




Supplemental Figure 3: Mouse embryo diameter was decreased throughout 
development following cholesterol depletion. 
Embryo diameter was recorded using the Primo Vision time-lapse embryo monitoring 
system and analysed with the Primo Vision software version 4.4.1.01.010 (Vitrolife). 
Representative line of n = 19 embryos (control) and n = 15 embryos (MCD). 
  












Supplemental Figure 4: Cholesterol depletion in mouse oocytes did not increase 
intracellular reactive oxygen species (ROS) in embryos. 
COCs were untreated or cholesterol depleted using 15 mM MCD for 30 min and subjected 
to IVF and in vitro culture until the blastocyst stage (Day 5). Stock concentration (1 mM) of 
CM-H2DCFDA was prepared in 100% DMSO prior to staining. Day 5 blastocysts were 
incubated with 10 M CM-H2DCFDA for 30 min at 37C in the dark. Embryos were washed 
once with PBS/PVP and images were captured using the Olympus Fluoview FV10i confocal 
microscope using a 10x lens (Olympus, Japan). Data are presented as mean  SEM, n = 15 































Supplemental Figure 5: Cholesterol depletion altered mouse embryo membrane 
structure. 
(A) Additional images of filipin-stained embryos generated from mouse untreated cumulus-
oocyte complexes (COCs) and (B) 15 mM MβCD-treated COCs. Scale bar = 100 µm.  


























Supplemental Figure 6: Cholesterol depletion in oocytes alters lipid raft distribution in 
mouse embryos. 
(A) Additional images of CTB-stained embryos generated from untreated cumulus-oocyte 
complexes (COCs) and (B) 15 mM MβCD-treated COCs. Scale bar = 100 µm. 
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In the previous chapter, I demonstrated that cholesterol is essential for the formation of 
membrane domains during preimplantation development. In this chapter I now address the 
next aim of my research (Aim 2), by examining the consequences of a high-fat diet (HFD) 
and BGP-15 treatment on membrane functional domains in oocytes and embryos. I utilised 
a diet consisting of high fat and cholesterol in order to mimic the “Western Style” diet 
consumed by modern day humans. In this chapter, I considered the incidence of elevated 
triglycerides, cholesterol and free fatty acids, each typically perturbed  in human obesity, 
and also incorporated the criteria of metabolic syndrome in women, and the impact these 
would have on embryo membrane domains. In the previous chapter short treatment with 
BGP-15 in vitro did not affect membrane rafts in cholesterol-depleted oocytes; however in 
this chapter, I tested whether in vivo BGP-15 treatment would stabilise membrane structure 













Schematic illustrating the general hypothesis that perturbations in oocyte lipid rafts may 
develop in response to a HFD environment, and that in vivo BGP-15 treatment may mitigate 
the HFD-induced defects. 
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The number of reproductive-aged women who are overweight and obese is increasing, as is 
the incidence of reproductive pathologies linked to female obesity (Jungheim et al. 2013). 
Obesity is a contributing factor for the development of type II diabetes, characterised by 
elevated blood glucose and impaired insulin signaling (Norman 2010; Dag and Dilbaz 2015; 
Nicholas et al. 2016). Obesity is also an independent risk factor for a range of metabolic 
complications including reproductive disorders (Malnick and Knobler 2006; Rachon and 
Teede 2010; Teede et al. 2010). The exact mechanism(s) by which obesity affects ovarian 
function remain poorly understood. Obese women have an increased likelihood to display 
signs of Polycystic Ovary Syndrome (PCOS), ovulation defects, gestational diabetes and 
premature and still-births, (Balen et al. 2006; Leddy et al. 2008).  
 
The periconception period (including the final stages of oocyte development and 
fertilisation) is particularly sensitive to maternal metabolic environment. For instance, 
zygotes collected from oviducts of diabetic mice and subsequently transferred to non-diabetic 
pseudopregnant female recipients exhibit retarded fetal growth and increased fetal 
abnormalities (Wyman et al. 2008). Similarly, in our obese but not diabetic mice-the Blobby 
mice, blastocysts transferred to normal weight surrogates showed that oocytes from obese 
blobby mice gave rise to fetuses that were heavier than controls and had reduced liver and 
kidney mitochondrial DNA (mtDNA) content (Wu et al. 2015). It was also shown that 
female mice fed a high-fat diet (HFD) have a higher rate of anovulation, smaller and fewer 
mature oocytes with increased lipid accumulation and altered mitochondrial activity and 
poor developmental competence (Igosheva et al. 2010; Jungheim et al. 2010; Wu et al. 2010; 
Luzzo et al. 2012) compared with oocytes from control diet mice.  
 
Yet the basis for these defects, their ability to program embryo metabolism and the potential 
for reversal are poorly understood. Excitingly, we have identified a compound, BGP-15, 
which is known to combat cellular stress by inducing chaperones (Gehrig et al. 2012), that 
act to restore oocyte mitochondrial activity and developmental potential in oocytes exposed 
to a high lipid environment (Wu et al. 2012b; Wu et al. 2015), providing proof-of-concept 
that pharmaceutical drugs can efficaciously improve oocyte and embryo quality.  
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Data from our lab and others indicate that mitochondria are morphologically and 
functionally altered in oocytes exposed to high levels of lipid (Wu et al. 2012a) and oocytes 
of obese mice (Igosheva et al. 2010; Wu et al. 2010; Reynolds et al. 2015; Hou et al. 2016). 
Mitochondrial complement of the oocyte has been suggested to have an impact on 
developmental competence (El Shourbagy et al. 2006; Santos et al. 2006; Wai et al. 2010) 
and it is well-documented that post-implantation development requires threshold amounts of 
mitochondria in the oocyte/embryo because the mtDNA encodes for electron transport 
proteins essential for cellular energy production (Wai et al. 2010; Babayev and Seli 2015; 
Fragouli et al. 2015). We have recently published that following fertilisation, the ‘obese 
oocytes’ have poor developmental competence and give rise to blastocysts that have less 
mtDNA; which is restored by BGP-15 treatment (Wu et al. 2015). This compelling data 
suggest that embryos from obese mothers are fundamentally deficient in mitochondria and 
this may be the basis for their metabolic reprogramming.  
 
In the current study, mitochondria-specific fluorescent probes MitoTracker Green FM and 
MitoTracker Orange CM-H2TMRos were utilised to measure mitochondrial activity. 
MitoTracker Green FM binds to mitochondrial membranes irrespective of respiratory status 
(Fernandes et al. 2012) whereas MitoTracker Orange CM-H2TMRos, a non-fluorescent 
reduced form of tetramethylrosamine, is oxidised by molecular oxygen in actively respiring 
cells; thereby allowing mitochondrial oxidative activity to be estimated (Agnello et al. 
2008). 
 
Cellular membranes are complex structures capable of regulating numerous cell functions 
including cell signaling, pore formation, protein clustering, and vesiculation. Membrane 
lipid composition is associated with membrane-linked cellular processes that are major 
contributors to energy metabolism, and are influenced by high lipid diet (Hulbert et al. 2005). 
Evidence to support the concept that obesity and associated dyslipidemia modify the 
biomechanical properties of the cell membrane has been reported in a variety of cell types. 
For instance, hypercholesterolemia in humans has been shown to increase both membrane 
cholesterol content and mechanical shear damage in erythrocytes (Koter et al. 2004). In 
skeletal muscle, consumption of a HFD can increase the saturation of fatty acyl chains within 
the sarcolemma (Andersson et al. 2002). However, it is unknown if an excessive fatty acid 
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environment could exert any effect on the oocyte membrane and its correlation with 
intracellular organelles such as the mitochondria. Importantly, BGP-15 treatment has been 
reported to impact the level and size distribution pattern of cholesterol-rich membrane rafts 
and is likely involved in raft-associated stress sensing and signaling pathways (Gombos et 
al. 2011). However whether it is via a membrane-stabilising mechanism such that it restores 
oocyte mitochondria and developmental competence is not known and requires investigation. 
I hypothesised that the high lipid environment resulting from HFD would alter the membrane 
structures of oocytes and embryos, and be reflected as disruptions in lipid raft distribution. 
The aim of the experiments in this chapter was to investigate the perturbations that develop 
in response to a HFD environment, on these membrane functional domains, and whether in 
vivo BGP-15 treatment is able to reverse the HFD-induced defects. Ovulation and embryo 
development were measured in female mice fed HFD, and metaphase II (MII) rates, 
mitochondrial activity and lipid raft distribution on the oocytes were determined.   
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3.2 Materials and Methods 




All experimental procedures were approved by the University of Adelaide Animal Ethics 
Committee and were performed in accordance with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes. C57BL/6 mice were obtained from the 
University of Adelaide Laboratory Animal Services and housed in the Animal Facility under 
a 14:10 hour light:dark cycle at 24°C with ad libitum access to food and water.  
 
Upon arrival at 6 weeks of age, female mice were randomly allocated to either the control 
diet (CD) or the high-fat diet (HFD) group for 10 weeks. The control group was fed a diet 
containing 20% calories from fat, 16% calories from protein, and 64% calories from 
carbohydrates (SF06-105, Specialty Feeds, Glen Forrest, Australia). HFD was made in house 
using the same recipe as D12492 of Research Diets (New Brunswick, NJ); 60% energy from 
fat with 91% lard and 9% soybean oil, 20% energy from protein, and 20% energy from 
carbohydrates. HFD recipe is shown in Table 1 (Appendix) and nutrient composition of these 
diets is shown in Table 2 (Appendix). 
 
3.2.2 Oocyte and Embryo Collections 
After 10 weeks feeding, female mice were induced to ovulate by intraperitoneal (i.p.) 
injections of 5 IU (international units) per 12 g body weight of pregnant mare’s serum 
gonadotrophin (PMSG; National Hormone and Peptide Program, Torrance, CA, USA) and 
46 h later with human chorionic gonadotrophin (hCG; Merck, Sharp and Dohme, Kenilworth, 
NJ, USA). BGP-15 (kindly provided by N-Gene Research Laboratories, Budapest, Hungary) 
was injected i.p. at 40 mg/kg in approximately 0.1 mL saline daily for four consecutive days 
starting the day prior to treatment with PMSG. Mature, expanded cumulus-oocyte complexes 
(COCs) were obtained from oviducts 13-16 h following hCG injection. 
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Additional mice received ovarian hormonal stimulation and then mated overnight with males. 
Male mice were 8-10 weeks old at time of mating, were proven fertile, and had been 
maintained on normal rodent chow.  Mating was confirmed the following morning with the 
presence of a vaginal plug. Morulae or blastocysts were obtained by flushing the oviducts 
86-88 h post-hCG with pre-warmed HEPES-buffered α-MEM (Life Technologies, 
Invitrogen, CA, USA) supplemented with 1% (vol/vol) FCS (Invitrogen). 
  
All COCs and embryos were collected into HEPES-buffered α-minimum essential medium 
(MEM) handling media supplemented with 1% fetal calf serum (FCS) (Invitrogen) and pre-
warmed to 37°C prior to use. 
 
3.2.3 Lipid Raft Staining in Mouse Oocytes and Embryos  
Ovulated COCs for raft staining were hyaluronidase-treated by adding 10 µL of pre-warmed 
1000 IU/mL hyaluronidase to the handling media, at the time of collection and oocytes were 
fixed in 4% paraformaldehyde in 1% phosphate buffered saline/ polyvinylpyrrolidone 
(PBS/PVP). Zona-enclosed oocytes were then washed in PBS/PVP followed by incubation 
with 20 g/mL of fluorescently-labeled cholera toxin B subunit (CTB-AF488; Molecular 
Probes, Eugene, OR, USA), for 30 min at 37C in the dark. After staining, the oocytes were 
washed in PBS/PVP for 5 min and mounted under a coverslip in 5 L PBS/PVP.  
 
Embryos flushed from the uteri were fixed in 4% paraformaldehyde in PBS/PVP. After 
fixing, the embryos were washed in PBS/PVP for 5 min and permeabilised in 0.5% Triton-
X in Cook Vitro Wash (William A. Cook Australia Pty. Ltd., Queensland, Australia) for 20 
min at room temperature. Embryos were placed in 10% Normal Goat Serum (NGS; Vector 
Laboratories) in Cook Vitro Wash for 40 min to block non-specific uptake of staining 
reagents. To label the cell nuclei, 1 g/mL of Hoechst 33342 (Life Technologies, Molecular 
Probes, Eugene, OR, USA) was added to the culture drop during the last 10 min of the 
incubation. After staining, the embryos were washed in PBS/PVP for 5 min and transferred 
with minimum medium onto slides with a microdrop of glycerol (5 L). Images were 
captured using a Leica SP5 spectral scanning confocal microscope using green filter 
(excitation = 473nm, emission = 490-590 nm). Images were captured at 90x magnification 
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and laser, sensitivity, and imaging parameters were kept constant between replicates and 
across experiments. Three experimental replicates were performed, with 10 embryos per 
treatment group. Intensity of fluorescence was determined using Image J version 1.47r 
software by placing a circle across the embryo image and measuring pixel intensity. The 
mean, area and integrated density (the sum of the pixel values in the circle) were reported 
and the corrected total cell fluorescence was calculated using the formula: 
Total fluorescence = Integrated Density- (Area of selected cell  Mean fluorescence of 
background readings) 
 
3.2.4 Dual Fluorescent Staining of Mitochondria 
Stock solutions of MitoTracker Green FM (1 mM) (Life Technologies, Molecular Probes, 
Eugene, OR) and MitoTracker Orange CM-H2TMRos (1 mM) (Life Technologies, 
Molecular Probes, Eugene, OR) were prepared in 100% dimethyl sulfoxide (DMSO) and 
stored in the dark at -20°C. Ovulated oocytes from hyaluronidase-treated COCs were first 
incubated in 500 nM of MitoTracker Orange CM-H2TMRos for 30 min and MitoTracker 
Green FM (100 nM) was added during the last 15 min of the incubation. Oocytes were then 
washed once in PBS/PVP and mounted under a coverslip in 5 µL PBS/PVP. Images were 
captured using the Leica Sp5 spectral scanning confocal microscope using a narrow green 
filter (490-540 nm) and a narrow red filter (570-620 nm). Images were captured at 60x 
magnification and laser, sensitivity, and imaging parameters were kept constant between 
replicates and across experiments. Total fluorescence intensity was measured as above. Two 
experimental replicates were performed with 10 oocytes per treatment group. 
 
3.2.5 Mitochondrial DNA (mtDNA) Copy Number Quantification 
The mtDNA copy number in individual oocytes was quantified as previously described 
(Kameyama et al. 2010; Wu et al. 2015). Briefly, denuded oocytes were washed with 
PBS/PVP (1 mg/mL of PVP in PBS), collected individually into 1.5 mL siliconised low 
retention microcentrifuge tubes (Fisher Scientific) with 5 L of PBS/PVP and stored at -
80°C. Genomic DNA was isolated using the QIAamp DNA micro kit (Qiagen) according to 
manufacturer’s protocol with carrier RNA (1 g; Qiagen) added to each sample. Genomic 
DNA was eluted with 50 L of water and diluted 10 times for quantitative PCR.  




The quantification standard was a plasmid containing a 1186 bp fragment of the 12S 
ribosomal (r)RNA region of mtDNA (Wu et al. 2015). Plasmid copy number was calculated 
as: mass of plasmid (g) = plasmid size (bp)×(1.096×10–21 g/bp); mass of plasmid required to 
generate 1×107 copy number standard stock = 1×107×mass of single plasmid. A standard 
curve was generated by using seven ten-fold serial dilutions (10−1×107 copies), and standard 
curve correlation coefficients were consistently greater than 0.98. Real-time quantitative 
PCR using the primer pair 5′-CGTTAGGTCAAGGTG-TAGCC-3′ and 5′-
CCAGACACACTTTCCAGTATG-3′ was performed in triplicate using SYBR Green PCR 
master mix (Applied Biosystems) and a Rotor-Gene 6000. Primer sequences for the 
quantification of mtDNA were derived from (Kameyama et al. 2007). Standard curves were 
created for each run and sample copy number was generated from the equation of Ct value 
against copy number for the corresponding standard curve. 
 
The PCR program employed an initial step of 95°C for 10 min followed by 40 cycles, 
denaturation at 95°C for 10s, annealing at 60°C for 30s and extension at 72°C for 20s. Every 
reaction was followed by melting curve analysis to ensure the specificity of the amplification. 
All reactions were performed in triplicate with total reaction volumes of 20 µL. Premix for 
quantitative PCR was prepared from Power SYBR Green PCR Master Mix (Applied 
Biosystems, CA, USA). The premix consisted of 10 μL of Power SYBR Green, 6 μL of PCR 
grade water, 2 μL of 50 µM primer pair; with 2 μL of DNA template then added to 18 μL of 
premix for PCR reaction. 
 
3.2.6 Statistical Analysis 
All measures are reported as mean ± SEM. Statistical significance was determined as 
indicated, by using one-way ANOVA with Tukey’s post hoc tests, using GraphPad Prism 
v008 for Windows. A P-value of less than 0.05 was considered statistically significant. 
  




3.3.1 HFD affects ovulation and oocyte maturation 
After 10 weeks of feeding, there was no significant difference in the total body weight of 
mice fed a HFD compared to controls.  Treatment with BGP-15 (40 mg/kg/day) for 4 days 
also had no effect on body weight (Figure 1A).   
 
Following superovulation, the number of ovulated oocytes was significantly reduced in the 
HFD mice compared to the control mice. Treatment of mice with BGP-15 did not 
significantly influence the ovulation rate (P ≤ 0.01; Figure 1B). Inspection of the ovulated 
oocytes showed that the number of live oocytes ovulated by HFD mice was reduced 
compared to controls and that BGP-15 treatment resulted in a slight increase in number but 
there were no statistically significant differences between groups (Figure 1C). Oocyte 
nuclear maturation, assessed as the extrusion of the first polar body during progression to 
MII, was dramatically decreased in the HFD group (P ≤ 0.05; Figure 1D). Treatment with 
BGP-15 had no significant effect on oocyte maturation to MII in the HFD mice.  
  




Figure 1 Effects of high-fat diet (HFD) and BGP-15 on body weight, ovulation and 
mouse oocyte maturation.  
(A) Body weight of mice on the CD, HFD and HFD+BGP-15 treatments over 10 weeks. 
Data are expressed as mean  SEM, n = 25 mice for control diet, n = 36 mice for HFD and 
n = 33 mice for HFD+BGP-15. (B) Ovulation rate and (C) number of live oocytes ovulated 
by CD, HFD, and HFD+BGP-15 mice following the 10 weeks treatment period. (D) 
Assessment of oocyte maturation to metaphase II (MII). Data are expressed as mean  SEM, 
n= 11 (CD), n = 19 (HFD) and n = 21 (HFD+BGP-15) mice. * P ≤ 0.05, ** P ≤ 0.01, one-
way ANOVA with Tukey’s post hoc test. CD- control diet. 
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3.3.2 BGP-15 normalises lipid raft distributions in oocytes of mice fed HFD 
Oocytes collected from the mice were stained for assessment of lipid raft distribution. 
Similar to previous observations (Chapter 2), lipid rafts were distributed throughout the 
plasma membrane of oocytes derived from the control diet mice (Figure 2). However, the 
oocyte rafts were visibly different in the HFD oocytes (Figure 2), namely the distinct staining 
on the oocyte plasma membrane was not apparent. Interestingly, in vivo BGP-15 treatment 
of the female mice was able to restore the raft distributions in the oocytes (Figure 2). In 
addition, all oocytes irrespective of treatment showed a homogenous distribution of positive 
intracellular fluorescence staining which is likely to be intracellular lipid rafts. This 
intracellular staining was markedly increased in the HFD oocytes when compared to the CD, 
and following BGP-15 treatment was more similar to those of CD oocytes. The oocytes of 
mice fed HFD also displayed an accumulation of the fluorescent probe in the peri-cortical 
region in structures that resemble lipid droplets as judged by their size, shape, and 
distribution (Figure 2); however these were no longer apparent following treatment with 
BGP-15. 
  




Figure 2 Lipid rafts in oocytes of mice fed control diet, or high-fat diet (HFD) or HFD 
followed by treatment with BGP-15. 
Ovulated oocytes were stained with CTB-AF488 to visualise lipid rafts. Photos are of oocytes from 
three different animals. CD- control diet. 
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3.3.3 BGP-15 restores oocyte mitochondrial activity in mice fed HFD 
Oocytes collected from mice of each treatment group were examined for mitochondrial 
distribution and oxidative activity using MitoTracker Green FM (MTG) and MitoTracker 
Orange CM-H2TMRos (MTO) respectively. When co-localised these dyes fluoresce yellow 
and are reflective of the mitochondrial population consuming oxygen; and they change 
colour to red when mitochondrial activity is increased (Morici et al. 2007; Agnello et al. 
2008). Mouse oocytes stained with MTG and MTO showed relatively uniform cytoplasmic 
distribution and granular clusters of various sizes at the equatorial section of the oocyte 
which were visualised using confocal microscopy.  Interestingly, MTG fluorescence was 
most intense in the oocytes from HFD mice and reduced by BGP-15 treatment (Figure 3A). 
Following densitometry analysis, the relative intensity of MTG fluorescence was 
significantly increased in the HFD oocytes suggesting that there were more mitochondria 
distributed in those oocytes compared to the CD and HFD+BGP-15 oocytes (P ≤ 0.01; 
Figure 3B). 
 
The majority of the mitochondrial population was consuming oxygen as indicated by the 
MTO staining. No significant difference was detected between groups (Figure 3C). The ratio 
of MTO to MTG is thought to correspond to mitochondrial activity and by this measure 
mitochondrial activity in the HFD oocytes was significantly lower than that of the CD, and 
BGP-15 treatment restored the mitochondrial activity of HFD oocytes (P ≤ 0.01; Figure 3D). 
These data suggest that the mitochondrial population in the oocytes of CD and HFD+BGP-
15 mice were more active and had higher oxygen consumption compared to oocytes from 
HFD mice which had lots of inactive mitochondria.  
 
MtDNA copy number was also determined in oocytes of each of the treatment groups. No 
difference in mtDNA copy number was observed between the CD and HFD oocytes. 
However, mtDNA copy number was markedly increased in the HFD+BGP-15 oocytes when 
compared to those in CD and HFD oocytes, reaching an average maximum of 400,000 copies 
(P ≤ 0.0001; Figure 3E). 
  

























Figure 3 Effect of feeding control diet, high-fat diet (HFD) or HFD plus treatment with 
BGP-15 on mouse oocyte mitochondrial activity and mtDNA levels.  
Ovulated oocytes were stained with MitoTracker Green FM (MTG) followed by 
MitoTracker Orange CM-H2TMRos (MTO). (A) Representative photos of oocytes stained 
with the MitoTracker dyes. (B) Quantification of total green fluorescence, (C) red 
fluorescence and (D) the ratio. Data are presented as mean  SEM, n = 5-12 oocytes per 
group. (E) mtDNA copy number in individual oocytes. Data are presented as mean  SEM, 
n = 4-10 oocytes per group. ** P ≤ 0.01, **** P ≤ 0.0001, one-way ANOVA with Tukey’s 
post hoc test. CD- control diet. 
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3.3.4 Effects of HFD and BGP-15 on embryo development 
To determine whether or not the oocytes from HFD mice exhibited impairments later in 
development, embryos were collected from the mice 88 hours post-hCG treatment and their 
development assessed. Following superovulation and mating, the percentage of mice that 
yielded embryos was not statistically different between the HFD and CD groups (Figure 4A). 
There were fewer embryos retrieved from the uteri of HFD mice (Figure 4B) and a similar 
trend when the percentage of viable embryos was compared (Figure 4C) however there were 
no statistically significant differences between groups. Of the viable embryos, a high 
proportion were at the morula stage (Figure 4D).  
  




Figure 4 Effects of feeding control diet, high-fat diet (HFD) or HFD plus BGP-15 
treatment on embryo development.  
(A) Percentage of CD, HFD and HFD+BGP-15 mice that had embryos present in the uterus 
at 88 h post-hCG. (B) Number of embryos flushed from the uteri of each mouse. (C) 
Percentage of viable embryos assessed morphologically. (D) Developmental stage of 
embryos. Data are presented as mean  SEM, n = 14 (CD), n = 15 (HFD) and n = 14 
(HFD+BGP-15) mice. P > 0.05, one-way ANOVA with Tukey’s post hoc test. CD- control 
diet. 
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3.3.5 BGP-15 partially normalises lipid raft distribution in HFD embryos 
Since oocytes from mice fed a HFD exhibited a clear disruption in lipid raft abundance and 
a restoration following BGP-15 treatment, lipid rafts were also examined in the embryos to 
determine whether these modifications were maintained through development.  Embryos 
were flushed from uteri of mice from each of the treatment groups on day 4 (86-88 h post-
hCG) following mating. The morula stage embryos from CD showed lipid raft enrichment 
at the cell junctions at the apical edge of the blastomeres (Figure 5A). This pattern was not 
observed in the morulae from HFD fed mice. Interestingly, treatment with BGP-15 partially 
restored this organisation and punctate staining was clearly visible at the embryonic space 
(Figure 5A). Densitometry analysis showed a corresponding significant reduction of 
fluorescence intensity in the HFD morulae but not with the BGP-15 treatment (P ≤ 0.05; 
Figure 5B). 
  



























Figure 5 Effect of feeding control diet, high-fat diet (HFD) or HFD plus BGP-15 
treatment on lipid raft distribution in morula stage embryos.  
Embryos were flushed from the uteri, fixed and stained with CTB-AF488. (A) 
Representative photos of CTB-stained embryos. (B) Quantification of fluorescence intensity. 
Data are presented as mean  SEM, n = 18 (CD), n = 21 (HFD) and n = 12 (HFD+BGP-15) 
embryos from six mice per group. Different letters indicate significant differences by one-
way ANOVA with Tukey’s post hoc test (P ≤ 0.05). Scale bar = 100µm. 




Maternal obesity is well known to have negative impacts on fertility (Dag and Dilbaz 2015). 
In order to better understand the mechanistic basis for this negative impact, the present study 
determined whether maternal HFD disrupts membrane functional domains in the oocyte and 
embryos. The HFD used in this study largely mimics the ‘Western fast food diet’ and led to 
the onset of obesity, as well as dyslipidemia and mild hyperinsulinemia (Wu et al. 2010). 
Mice fed this diet had reduced numbers of ovulated oocytes and decreased MII rates. This 
disrupted physiologic environment was detrimental to oocytes, causing a disruption of 
membrane domains and mitochondrial activity in association with impaired embryo 
development and membrane raft formation. These results provide new insights into cellular 
alterations that might mechanistically contribute to obesity-associated impairments in oocyte 
developmental competence. Understanding the potential defects in membrane domains is 
important as alterations to the membrane structure in the oocytes of obese mice could impair 
or exacerbate downstream signaling pathways which may impact subsequent 
preimplantation processes. 
 
Surprisingly, in this study the mice fed HFD did not gain more weight compared to those 
fed a standard chow diet, as is typically reported by our lab and others. One explanation for 
this may be due to the fact that the two diets are not isocaloric, with almost 2 kcal/g more in 
the HFD. Moreover, the control diet was administered as pellets as purchased from Specialty 
Feeds (Glen Forest, Australia), however, the HFD was made in-house. Thus, differences in 
the consistency of the food could have introduced differences in food consumption when 
compared to the control diet group. Thus, whether the results of feeding a HFD are due to 
the absolute increase in the fat content of the diet, or due to increased intake of cholesterol 
or other specific lipids are yet to be determined. Alternatively, changes in relative proportion 
of carbohydrate and fat between the two diets may also account for the discrepancy. 
Importantly, even though body weight was not increased in mice fed HFD, dissection of fat 
pads post-mortem showed that by the end of 10 weeks of diet, there was a visible 
accumulation of mesenteric fat in the HFD mice; however, this was not measured as part of 
this study. 
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Even though mice fed HFD did not have increased body weight, the numbers of ovulated 
oocytes were significantly lower in the HFD mice. The reduced number of ovulated oocytes 
observed in the HFD mice is consistent with our previous findings in obese Blobby mice and 
HFD mice (Minge et al. 2008; Wu et al. 2010; Wu et al. 2015) and reports of others (Ge et 
al. 2014; Hou et al. 2016). Thus it seems likely that abdominal fat tissue contributed to the 
observed defects in ovulation, as increased fat mass has been found to be related to infertility 
(Zaadstra et al. 1993; Kuchenbecker et al. 2010).  
 
BGP-15 is an orally active compound and has been shown to have an excellent safety profile 
in multiple human clinical trials in healthy individuals (Literati-Nagy et al. 2010; Literati-
Nagy et al. 2012) and insulin-resistant non-diabetic patients (Literati-Nagy et al. 2009).  The 
initial rationale for assessing the therapeutic potential of BGP-15 in an animal model was 
related to its role to combat cellular stress by inducing chaperones (Literati-Nagy et al. 2010) 
and remodelling plasma membrane rafts (Gombos et al. 2011). It is important to note that a 
previous study from our laboratory showed that BGP-15 administration to obese Blobby or 
lean mice significantly increased the rate of ovulation but this was not observed in the current 
study. The most likely explanation is that these HFD mice were not severely obese, and 
hence the level of cellular stress was not sufficient to elicit detectable actions of BGP-15. In 
support of this there are other reports of BGP-15 having no effects in healthy cells and tissues 
(Chung et al. 2008; Nagy et al. 2010; Crul et al. 2013). 
 
Our demonstration that our HFD composition of 60 kcal% from fat impairs oocyte 
maturation is generally consistent with previous reports that showed decreased number of 
MII oocytes in mice with HFD-induced obesity (Ge et al. 2014; Sohrabi et al. 2015). In 
addition, Sohrabi et al. (2015) and Hou et al. (2016) collected murine germinal vesicle (GV) 
oocytes and continued to culture them in vitro. Following culture, they also observed a 
decreased proportion of HFD oocytes that matured to MII stage compared to those oocytes 
from control mice. 
 
An important finding of the current work is that following HFD, the oocytes exhibited 
disrupted raft distribution, however, this was restored by BGP-15 treatment. To our 
knowledge, this is the first study to demonstrate that HFD affects membrane rafts, and 
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further that BGP-15 is able to restore the defects. The mechanism behind the disruption of 
raft distribution however remains unknown. Cholesterol appears to be essential for the 
stability and functionality of lipid rafts. The obese Blobby mice have been found to have 
increased total lipid and cholesterol level in their blood (Wu et al. 2015) and this may lead 
to alterations in lipid composition within cells, including the oocytes. With obesity, 
intracellular accumulation of lipids in non-adipose tissues leads to high levels of free fatty 
acids, which leads to cellular stress response, specifically endoplasmic reticulum (ER) stress, 
mitochondrial dysfunction and ultimately apoptosis. ER is the organelle responsible for lipid 
membrane biosynthesis (English and Voeltz 2013) and so perhaps the alterations in lipid raft 
distribution are reflective of ER dysfunction. BGP-15 was previously shown to act on 
GRP78 (78 kDa glucose-regulated protein; a major ER chaperone) (Szabados et al. 2000) 
and here we showed that BGP-15 was able to restore lipid raft distribution in the HFD 
oocytes further supporting the relationship between lipid rafts and ER function. Since mouse 
prevoulatory oocytes synthesise little cholesterol and obtain cholesterol primarily from the 
surrounding cumulus cells (Su et al. 2008), it is also possible that in the presence of excess 
lipids, cholesterol biosynthesis by cumulus cells is altered by ER stress, thereby disturbing 
the ability of the oocyte to acquire sufficient cholesterol for raft formation.  It is more likely 
however that oocytes of obese mice have increased intracellular cholesterol consistent with 
the increased levels of oocyte neutral lipids detected by BODIPY stains (Wu et al. 2010; Wu 
et al. 2015) and that such increased levels would also affect plasma membrane structure. 
Interestingly, BGP-15 treatment was able to restore raft distribution in the oocytes. In 
Chinese hamster ovary cell plasma membrane, BGP-15 has been found to preserve raft 
integrity challenged by heat stress. It is likely that the BGP-15 induced raft remodelling via 
the Rac1 signaling cascade (Gombos et al. 2011). 
 
To examine mitochondrial function in oocytes in response to obesity, Igosheva et al. (2010) 
used a low toxicity potentiometric fluorescence dye TMRM to examine oocyte mitochondria 
in HFD-fed mice. They found that obesity led to a dramatic increase in inner mitochondrial 
membrane potential in oocytes. In contrast, our laboratory used the JC-1 potentiometric dye 
and found that oocyte mitochondrial membrane potential was lower in the oocytes from 
obese mice than those of mice on the control diet (Wu et al. 2010; Wu et al. 2015). This 
discrepancy may be explained by the use of different diet and strain of mice. In the current 
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study, we labeled mitochondria using the MitoTracker dyes which are suitable for multiple 
labeling. MitoTracker Green FM binds to all mitochondria irrespective of respiratory status 
whereas MitoTracker Orange is only taken up by actively respiring mitochondria thereby 
allowing us to measure the proportion of active mitochondria in relative to the total 
population of mitochondria present in the oocyte. This finding is supported by McPherson 
et al. (2015) who reported increased MitoTracker Green fluorescence in 2-cell embryos 
retrieved from HFD-induced obese mice. Interestingly, MitoTracker Green abundance 
becomes fluorescent only once it has accumulated in the lipid environment of the 
mitochondria, suggesting that oocytes generated from the HFD mice have increased lipid in 
their mitochondria. 
 
Here, we also discovered that the rafts and mitochondria may have some functional 
association, since the disruption of rafts in the oocytes of HFD mice was accompanied by a 
reduction in mitochondrial activity. This suggests that mitochondria may be closely apposed 
to membrane rafts. Although the functional significance of such co-localisation is not known, 
I speculated that rafts localise certain enzymes that produce reactive oxygen species (ROS) 
which may control mitochondrial function or protect the plasma membrane from the damage 
of mitochondria-derived oxidants. Moreover, I also speculate that the contact sites between 
ER and mitochondria, known as the mitochondrial associated membranes (MAMs) would 
play a crucial role in contributing to any such functional association. MAMs were identified 
as essential regions for phospholipid metabolisms, trafficking of lipid to mitochondria and 
the regulation of mitochondrial dynamics and homeostasis (Krols et al. 2016). Thus under 
circumstances such as obesity/HFD where there is an accumulation of lipids, it is suspected 
that these contact sites are damaged, limiting the transfer of substrates for normal 
mitochondrial metabolism. Future studies are necessary to confirm this theory. 
 
Similar to previous findings by our group (Wu et al. 2010) and others (Reynolds et al. 2015), 
our results indicate that HFD oocytes exhibit decreased mitochondrial activity. However, 
this is restored by BGP-15 treatment. In mice, oocytes with low mtDNA copy number are 
more likely to be compromised before and after fertilisation (Larsson et al. 1998; Santos et 
al. 2006). HFD mice had a small reduction in mtDNA copy number that was not statistically 
significant, in contrast to previous reports (Igosheva et al. 2010; Luzzo et al. 2012). This 
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could be due to the lack of severe obesity in mice in our experiments. However, as 
mitochondrial activity is decreased, we believe that this mitochondrial pool is compromised. 
It remains to be determined whether this depletion in activity is a consequence of changes to 
mtDNA or an initial event contributing to embryo arrest. mtDNA copy number increased 
markedly following BGP-15 treatment in the HFD oocytes suggesting that there may be 
increased stimulation of the mitochondria biogenic pathway by BGP-15 to compensate for 
impaired mitochondrial functions in the oocytes of HFD mice. Independent to HFD effects, 
a previous study by our lab showed that treatment of lean mice with BGP-15 had no effect 
on mtDNA levels in the oocytes, yet interestingly increased ovulation rate, in the absence of 
any effect on body weight (Wu et al. 2015). 
Preimplantation development of the embryo relies heavily on mitochondria for generation 
of ATP and energy consumption, with perturbations in this critical developmental time frame 
having consequences for growth and health trajectory of the embryo (McPherson et al. 2015). 
Although we did not see any difference between the treatment groups in terms of embryo 
development, the HFD-fed mice tended to have a lower percentage of mice that yield 
embryos and a lower number of embryos flushed. This is probably due to anovulation, 
similar to that observed in our previous studies which showed reduced blastocyst survival 
rates and abnormal embryonic cellular differentiation in obese female mice (Minge et al. 
2008). HFD mice also gave rise to a lower proportion of viable embryo compared to the 
control diet mice. Each of these parameters are moderately restored by BGP-15 treatment 
but not statistically significant, likely due to the relatively small number of animals used. In 
this study, we also observed a delayed on-time development to the blastocyst stage in the 
HFD mice as large proportions of morulae were flushed from the uteri after 88 hours post-
hCG. This indicates that obesity is associated with poor developmental outcome and 4 days 
of BGP-15 treatment prior to ovulation has slightly improved this phenomenon, 
demonstrating that changes in HFD oocytes are readily reversible. 
 
Our results indicate that lipid rafts are strategically located in embryonic space and time in 
a manner suggestive of a functional role for rafts in cleaving mammalian embryos. In 
morulae, we observed an enrichment of rafts that may indicate a role in the early stages of 
trophectoderm differentiation and in cavitation, both critical prerequisites for formation of 
the blastocysts (Watson 1992; Sheth et al. 1997). Further, embryos generated from the HFD 
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mice exhibited disrupted raft organisation which was partially restored by BGP-15. This 
compelling data suggests that alterations before conception, for instance as a result of an 
environmental insult, that change the phenotype of oocytes may be retained through the 
course of later development. 
  
Taken together, our functional data from embryo culture experiments in Chapter 3 support 
the concept of a critical role of lipid rafts in development, as oocyte cholesterol depletion 
slows the rate of cleavage in culture and reduces blastocyst development. In this chapter, we 
showed that lipid rafts are susceptible to a maternal HFD which has a significant impact on 
embryo quality and preimplantation development. Moreover, maternal HFD is also likely to 
have an effect on the uterine environment and potentially influenced the embryos recovered. 
Our data also verify that oocytes from HFD mothers are fundamentally deficient in 
mitochondrial activity and that this may be the basis for the reprogramming. Even more 
importantly, we have found that BGP-15 restores mitochondrial activity, in conjunction with 
normalising embryo development, providing important benchmarks for future pre-clinical 
and clinical evaluations of preconception pharmaceuticals. Our findings that a short 
treatment with BGP-15 is able to at least partially normalise membrane reorganisation in 
embryos from mice fed HFD demonstrate embryo membrane domains are acutely responsive 
to maternal nutrition and a membrane-stabilising pharmaceutical. However whether the 
effects of BGP-15 on membrane rafts are related to its effects on mitochondrial activity 
remains to be determined.  
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KINETICS OF MTDNA 
REPLICATION IN OOCYTES 
AND EMBRYOS AND 
INDUCTION BY BGP-15




Following the findings that BGP-15 was able to restore mitochondrial activity and increase 
mitochondrial DNA (mtDNA) levels in oocytes following a high-fat diet (HFD), my 
hypothesis was strengthened that mitochondria may be the underlying basis for their 
metabolic reprogramming.  
 
In addition, our laboratory also previously found that blastocysts generated following in vitro 
fertilisation (IVF) from the obese female mice have lower levels of mtDNA and gave rise to 
fetuses that had reduced liver and kidney mtDNA content per cell, indicating that maternal 
obesity before conception had altered the transmission of mitochondria to offspring (Wu et 
al. 2015). However, treatment with BGP-15 completely restored oocyte quality and the 
mtDNA content of fetal tissues to levels equivalent to those derived from lean mice. 
Therefore, I hypothesise that mitochondrial replication during oocyte maturation and 
embryogenesis is disrupted by exposure to excess lipid but induced by treatment with BGP-
15. Thus, this chapter, summarised in the schematic below, examined the kinetics of mtDNA 
replication during oocyte maturation and embryogenesis in mouse, cow, macaque and 
humans, the effects of high lipid during oocyte maturation on mtDNA replication and the 

















Altered mitochondria activity has been proposed as a mechanism for compromised oocyte 
quality and poor reproductive outcomes in obese females (Igosheva et al. 2010; Luzzo et al. 
2012; Grindler and Moley 2013; Wu et al. 2015). It is known that correct mitochondrial 
quality, quantity and distribution play a key role in the functional competence of oocytes, as 
mitochondria are maternally inherited, therefore any mitochondrial deficiencies could 
negatively affect the ability of the embryo to progress through preimplantation stages 
(Cummins 2004; Dumollard et al. 2007; Van Blerkom 2008; Van Blerkom 2011). Further, 
defects in mitochondria could have transgenerational impacts on the health of future 
generations. Indeed, the oocytes of obese mice have altered mitochondrial properties, uneven 
distribution of mitochondria throughout the cytoplasm and increased generation of reactive 
oxygen species. Van Blerkom et al. (2000) demonstrated that disproportionate inheritance 
of mitochondria in the cleavage stage of human embryos resulted in daughter cells with 
reduced adenosine triphosphate (ATP)-generating capacity and developmental competence.   
 
Mitochondrial DNA (mtDNA) is present inside the mitochondria and codes for proteins that 
are essential for cellular energy production (May-Panloup et al. 2007). Oocyte and 
embryonic mtDNA content are necessary for embryonic development. Reduced mtDNA 
content in ovulated oocytes from heterozygous Tfam (transcription factor A, mitochondrial) 
knockout mice has been found to affect fertilisation. It was reported that even if Tfam+/- 
oocytes were successfully fertilised and proceeded normally through preimplantation 
development, they eventually died during organogenesis (Wai et al. 2010).  
 
In most species, the oocyte has by far the largest number of mitochondria and mtDNA copies 
of any cell (approximately 2 × 105 copies) (May-Panloup et al. 2007). The enormous amount 
of mtDNA in oocytes and the fact that mtDNA is not replicated before implantation have 
led to the speculation that the number of mtDNA copies in oocytes could be used as a marker 
of viability (Reynier et al. 2001; May-Panloup et al. 2005a; Santos et al. 2006; May-Panloup 
et al. 2007). During oocyte development from the primordial to pre-ovulatory stage, 
processes of mitochondrial replication and expansion dramatically amplify the population 
of mitochondria, thereby supplying each gamete with a large copy number of both normal 
and potentially abnormal mtDNA. As such, the mitochondrial complement of the oocyte has 
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been suggested to have a correlation with developmental competence. Low mtDNA copy 
number has been linked to fertilisation failure and compromised development (Reynier et al. 
2001; May-Panloup et al. 2005a; El Shourbagy et al. 2006; Santos et al. 2006; Wai et al. 
2010; Ge et al. 2012) and absence of meiotic spindle in in vitro matured human oocytes 
(Zeng et al. 2007). These findings suggest that mtDNA copy number is associated with 
oocyte quality and subsequent fertility.  
 
Studies in mice (Piko and Taylor 1987; Ebert et al. 1988), rats (Kameyama et al. 2007), and 
pigs (El Shourbagy et al. 2006) have shown that mtDNA replication does not occur during 
the cleavage stages of embryogenesis, which would suggest that the mitochondrial content 
of the oocytes need to be amplified to sufficient levels prior to fertilisation in order to 
maintain development until implantation. Therefore, it has been proposed that the increase 
in mtDNA during oogenesis is a mechanism to ensure that sufficient numbers of organelles 
and genomes are present in cells of the developing embryo once mtDNA replication restarts 
(Shoubridge and Wai 2007) and that sufficient mitochondria are essential to provide energy 
for fertilisation and embryonic differentiation (St John 2014) .  
 
It was previously proposed that high mitochondrial content can increase the quality as well 
as the competence of mature mammalian oocytes (Santos et al. 2006), leading to the 
speculation that mtDNA copy number could be used as a marker of viability. A critical 
threshold of approximately 100,000 copies in the metaphase II (MII) oocytes has been 
proposed for mice (Piko and Taylor 1987), humans (Reynier et al. 2001) and pigs (El 
Shourbagy et al. 2006), whilst bovine oocytes possess a mean of 260, 000 copies (Michaels 
et al. 1982). However, the essential amount of oocyte mtDNA is controversial, as other 
studies in mice (Cree et al. 2008) and humans (Barritt et al. 2002) identified mtDNA copy 
number around 300,000 copies and 800,000 copies respectively. Equally, other studies show 
the threshold to be 50,000 (Chiaratti et al. 2010; Wai et al. 2010). In fact, studies have shown 
figures estimating oocyte mtDNA copy number to be hugely variable, even in oocytes 
collected from the same female (Barritt et al. 2002). 
 
Data from human studies indicated that mtDNA in cleavage stage embryos remain stable 
during the first three days of preimplantation development (Steuerwald et al. 2000; Reynier 
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et al. 2001; Barritt et al. 2002; Lin et al. 2004; Chan et al. 2005; May-Panloup et al. 2005a). 
This implicates that the mammalian embryo inherits mitochondria (and thus mtDNA) 
exclusively from the population found in the oocyte just prior to fertilisation. However, a 
study in the porcine also indicated that the amount of mtDNA during the cleavage stages of 
embryogenesis declined and began to increase only near the time of implantation when the 
embryo begins to grow in size (Spikings et al. 2007). Table 1 shows the regulation of 
mtDNA copy numbers throughout preimplantation embryo development in different species. 
 
mtDNA content of oocytes and embryos is sensitive to stressors, such as oxidative stress, 
obesity and aging (Wang et al. 2009; Wai et al. 2010; Chappel 2013; Wu et al. 2015; Sutton-
McDowall et al. 2016). Processes such as in vitro oocyte maturation, fertilisation and 
preimplantation embryo development, which are used in assisted reproductive technologies, 
are vulnerable to environmental stress and thus have great impact on fertility outcome 
(Fukuda et al. 2007; Ellenbogen et al. 2014). The mtDNA replication during oocyte 
maturation and embryo development is not fully understood. Similarly, the impacts of 
various environmental stressors during oocyte maturation on mtDNA content in the oocyte 
and embryo also remain unknown.  
 
High levels of palmitic acid (PA) treatment is a well-established model in our laboratory, 
where it caused identical effects as were seen in mice with obesity. Experiments using mouse 
cumulus-oocyte complexes (COCs) showed that high levels of PA induced endoplasmic 
reticulum (ER) stress in  the COCs, mitochondrial dysfunction in oocytes and caused poor 
embryo development (Wu et al. 2012). Similarly, non-esterified fatty acids (NEFA) is a 
standard model of bovine that mimics high lipid. NEFA are made of a mixture of palmitic, 
oleic and stearic acid and when present during in vitro maturation of bovine COCs also 
induced defects to oocytes and embryos similar to those induced by palmitic acid in the 
mouse model (Sutton-McDowall et al. 2016). Our group has previously reported that the ER 
stress inhibitor, salubrinal, can reverse the reduced mitochondrial activity (mitochondrial 
membrane potential) caused by high lipid stress in mouse cumulus-oocyte complexes (COCs) 
during in vitro maturation (IVM) (Wu et al. 2012). Similar findings have also been reported 
in bovine COCs (Sutton-McDowall et al. 2016). In addition, similar to salubrinal, BGP-15 
was also found to be able to restore mtDNA in blastocysts derived from oocytes of obese 
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mice. Interestingly, treatment of obese mice with salubrianl or BGP-15 before IVF also 
resulted in restored mtDNA levels in the tissues of the offspring derived from obese mothers 
to levels that are comparable to those from the non-obese control mice (Wu et al. 2015).  
 
Thus, in this chapter, I examined mtDNA replication by measuring copy number, using a 
qPCR method, on different time courses of in vivo versus in vitro mouse oocyte/embryo 
development; introduced stress to mice and bovine COCs with high lipid supplementation 
(PA or non-esterified fatty acids (NEFA)) in vitro in the presence or absence of BGP-15 to 
investigate how lipid stress will disturb mtDNA replication, and how this stress with or 
without treatment affects the blastocyst outcome and the mtDNA content in the resulting 
embryos. Based on the previous findings in this thesis, it is well-documented that BGP-15 
has some beneficial effects on mouse oocytes and embryos (partially restores membrane 
functional domains and normalises mtDNA copy numbers) in a high fatty acid environment. 
Furthermore, I sought to generate pre-clinical data on the efficacy of BGP-15 as an IVF 
additive by using the macaque animal model and human oocytes.  
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Table 1 Regulation of mitochondrial DNA (mtDNA) copy number throughout preimplantation embryo development in different 
species. 
Species Strain Findings Methods 
Mouse 
 
 (CD-1 females) 
(Mahrous et al. 2012) 
 There was a continuous increase in 
mtDNA copy number as oocytes grew in 
size, reaching a maximum of ~175 000 
copies. Thus, mtDNA steadily 
accumulates during oocyte growth.  
 No difference between immature and 
mature oocytes. Taken together, these 
results indicate that mtDNA accumulates 
during the growth phase of oocyte 
development but stops when oocytes 
reach full size. 
 In vivo: compared 18 day and 24 
day old mice oocytes 
 GV oocytes isolated from 20-22 
day old mice, incubated overnight 
to allow meiotic maturation 
Heterozygous floxed Tfam 
mice (Wai et al. 2010) 
 No significant differences in mtDNA 
copy number between fertilised and 
cleavage stage embryos in heteroplasmic 
floxed Tfam mice.  
 2-, 4-, and 8-cell embryos 
generated by natural matings 
Mouse (B6D2F1) 
(Thundathil et al. 2005) 
 Number of mtDNA molecules remained 
stable throughout preimplantation at 
256,000 on average but ranged from 
97,000 to 587,500. 
 No significant difference in the mean 
number of mtDNA molecules present in 
MII oocytes, 2-cell, 8-cell, morula and 
blastocyst. 
 4-6 week old females, males: FVB, 
embryos (2-, 8-cell, morula, 
blastocyst) flushed from uteri 
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Porcine Porcine (Spikings et al. 
2007) 
 Progressive decrease in mtDNA copy 
number form 2-cell to 4-cell and 8-cell 
embryo. Increase in mtDNA copy number 
in 16-cell embryos, morulae and then 
further increase in expanded blastocyst 
stage 
 COCs matured in vitro then 
cumulus cells removed for IVF 
Porcine (Mao et al. 2012)  Higher mtDNA copy number in MII 
oocytes than GV oocytes 
 COCs matured in vitro 




 No difference between mean mtDNA 
copy number in MII oocytes and 2-cell 
embryos 
 mtDNA content was higher in 2-cell 
embryos compared to 4/8-cell embryos. 
 No difference in mtDNA copy number 
between 4/8-cell stage, 8/16-cell stage and 
the morula 
 Considerable increase in mtDNA copy 
number at blastocyst stage 
 COCs matured in vitro then 
fertilised in vitro with frozen-
thawed semen 
Rat Rat (6-10 week old female 
Sprague-dawley) 
(Kameyama et al. 2007) 
 No difference in mtDNA between in vivo 
and in vitro derived zygotes, thus 
superovulation does not affect the 
mtDNA copy number 
 No difference at early 2-cell, late 2-cell 
and 8-cell stage, significant differences 
were observed at the morula and 
blastocyst stage between in vivo and in 
vitro embryos. 
 In vivo: naturally ovulated 
 Oocytes: Superovulation 
 Zygotes: naturally ovulated vs 
superovulated 
 Embryos: in vivo vs in vitro (in vivo 
from naturally mated females, in 
vitro from superovulated females- 
zygotes recovered were cultured in 
vitro) 
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 In vivo, mtDNA copy number was stable 
throughout early development (from 
zygote to blastocyst) 
 In vitro, mtDNA in 8-cell, morula and 
blastocyst embryos was significantly 




Human Human (Monnot et al. 
2013) 
 The average mtDNA amount decreased as 
maturation stage proceeded 
 mtDNA amount was reduced in MII 
oocytes when compared to the GV 
oocytes 
 No difference in mtDNA amount between 
oocytes and fertilised embryos 
 No difference in mtDNA amount between 
pre-blastocyst and blastocyst embryos 
 GV oocytes n = 2, MI oocytes n = 
7, MII oocytes n = 9 
 Pre-blastocyst n = 12, Blastocyst n 
= 5 
 Samples from 2 different patients 
 Ovarian stimulation 
Human  
(Santos et al. 2006) 
 Mean mtDNA copy number for fertilised 
oocytes was 250,454 whereas unfertilised 
group was 163,698 
 Significant difference between fertilised 
and unfertilised oocytes (P <0.002) 
 Fertilised oocytes = 35 zygotes 
from 21 patients, mean age = 32 
 Unfertilised oocytes = 65 from 36 
patients, mean age = 32 
 Ovarian stimulation 
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4.2 Materials and Methods 
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise 
indicated.  
 
4.2.1 Mouse Ovarian Stimulation and Oocyte Recovery 
All experimental procedures were approved by the University of Adelaide Animal Ethics 
Committee and were performed in accordance with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes. CBAF1 female mice were obtained from 
the University of Adelaide Laboratory Animal Services and housed in the Animal Facility 
under a 14:10 hour light:dark cycle at 24°C with ad libitum access to food and water.  
 
Female mice were induced to ‘superovulate’ by consecutive intraperitoneal (i.p.) injections 
of 5 IU (international units) per 12 g body weight of pregnant mare’s serum gonadotrophin 
(PMSG; National Hormone and Peptide Program, Torrance, CA, USA) and 5 IU human 
chorionic gonadotrophin (hCG; Merck, Sharp and Dohme) in 0.1 mL 0.9 % saline. 
 
For time course experiments, in vivo cumulus-oocyte complexes (COCs) were collected at 
different time points, 48 h after PMSG injection, and then 2 h, 4 h, 8 h and 16 h post-hCG 
injection. Three experimental replicates were performed, with 5 mice used per replicate. 
For in vitro maturation (IVM), immature COCs (isolated from mice treated with PMSG for 
48 h) were cultured in groups of 30 in bicarbonate-buffered α-MEM supplemented with 5% 
(vol/vol) fetal calf serum (FCS; Invitrogen), 50 mIU/mL recombinant human FSH, and 10 
ng/mL epidermal growth factor as control, or with the addition of indicated treatments, in 
drops of 100 μL overlaid with sterile paraffin oil (Merck, Darmstadt, Germany) and 
incubated at 37C in an atmosphere of 5% CO2 and 95% air for 2 h, 4 h, 8 h and 16 h. 
Treatments consisted of control media supplemented with 400 M palmitic acid and 400 
M palmitic acid with the presence of 10 M BGP-15 (kindly provided by N-Gene Research 
Laboratories, Budapest, Hungary). Palmitic acid was solubilised and prepared by the method 
of Downs et al. (2009). Four experimental replicates were performed, with 5 mice used per 
replicate. 
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4.2.2 In vivo embryo collection 
Female mice received ovarian hormonal stimulation as previously described and then were 
mated overnight with males which had previously been assessed for mating ability. Mating 
was confirmed the following morning with the presence of a vaginal plug. In vivo embryos 
were obtained by flushing the oviducts 44 h (2-cell), 60-62 h (8-cell), 72-78 h (morulae) and 
86-88 h (blastocysts) post-hCG with pre-warmed HEPES-buffered α-MEM supplemented 
with 1% (vol/vol) FCS. Seven experimental replicates were performed, with 3 mice used per 
replicates. 
 
4.2.3 Fertilisation and Embryo Culture 
Male mice, which had previously been assessed for mating ability (not less than 3 days prior), 
were used as sperm donors for in vitro fertilisation (IVF). Male mice were sacrificed by 
cervical dislocation and the epididymides and vasa deferentia were collected into 1 mL of 
warm (37C) Vitro Fertilisation medium (William A. Cook Australia Pty. Ltd., Queensland, 
Australia). Sperm were extracted into the medium and allowed to capacitate at 37C in an 
atmosphere of 5% CO2, 20% O2 and 95% air for 1 h. Ten L of capacitated sperm (35,000 
sperm/mL) was added to 90 L of fertilisation drop.  Following 16 h maturation, expanded 
COCs were washed twice in Research Vitro Wash (William A. Cook Australia Pty. Ltd., 
Queensland, Australia), and co-incubated with the sperm for 4 h at 37C in an atmosphere 
of 5% CO2, 20% O2 and 95% air (15-20 COCs per drop). All cumulus cell-free oocytes (10-
15 oocytes per 20 µL drop were then transferred to Research Vitro Cleave (William A. Cook 
Australia Pty. Ltd., Queensland, Australia) without the presence of BGP-15. Five 
experimental replicates were performed, with 4 mice per replicate. Embryo development 
was assessed on Day 2 as the percentage of embryos meeting the on-time development 
criteria from starting number of oocytes; while development on Day 5 as the percentage of 
embryos meeting the on-time development criteria from 2-cell embryos. For time course 
experiments, 2-cell, 8-cell, morulae and blastocysts were collected on Day 2, 3, 4 and 5 
accordingly. Three experimental replicates were performed, with 3 mice per replicate. 
 
4.2.4 Time-Lapse Embryo Culture 
In a separate series of experiments, time-lapse imaging was employed to more closely 
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analyse developmental kinetics in the embryos. Four hours post-insemination, presumptive 
zygotes were placed individually in 16-well dishes (Primovision, Vitrolife, Sweden) in 150 
L Cook Vitro Cleave in conditions described above, and monitored by Primo Vision time-
lapse embryo monitoring system (Primovision, Thermo Scientific HERAcell VIOS 160i 
CO2 incubator) with images of individual embryos generated every 15 min throughout 
culture. The timing of morphokinetics events, including first, second and third cleavage 
division and cavitation were recorded and intervals between each event determined and 
analysed using the Primo Vision Analyser Software (version 4.4.1.01.010). The diameters 
of the oocytes and embryos (measured to the outer circumference of the zona pellucida) were 
also automatically recorded throughout development. Three experimental replicates were 
performed, with 16 COCs per treatment group and replicate. 
 
4.2.5 Collection and Culture of Bovine COCs 
Materials and methods were derived from (Sutton-McDowall et al. 2016). 
NEFA aliquots were prepared as previously described (Downs et al. 2009). Briefly, 44.85 
mM stocks of oleic acid (C18:1), steric acid (C18:0), and palmitic acid (C16:0) were made 
with absolute ethanol. One mL of this stock was added to 0.5 g fatty acid-free (FAF) bovine 
serum albumin (BSA) (MP Biomedicals) in 30 mL Milli-Q water followed by 3 mL of 0.1 
M Sodium Hydroxide (NaOH) and was gently stirred until the solution was clear. Aliquots 
were frozen, freeze-dried, and reconstituted in IVM media prior to culture. 
 
In vitro oocyte maturation was performed using VitroMat (IVF Vet Solutions) + 6 mg/mL 
FAF bovine serum albumin (BSA; MP Biomedicals) + 0.1 IU/mL follicle stimulating 
hormone (FSH; Puregon, Organon). Cattle ovaries were transported from a local abattoir 
(Thomas Foods) in warm saline (30°C–35°C). Follicles were aspirated using an 18-gauge 
needle attached to a 10 mL syringe, and intact, unexpanded COCs surrounded by four or 
more cumulus cell layers and ungranulated ooplasms were selected in undiluted follicular 
fluid, quickly washed twice in IVM medium, and then transferred into pre-equilibrated IVM 
culture drops overlaid with paraffin oil (Merck, Darmstadt, Germany). Treatment groups 
were i) control (IVM medium), ii) control + 10 µM BGP-15, iii) NEFA (IVM medium + 
150 µM palmitic acid + 200 µM oleic acid + 75 µM steric acid) (Van Hoeck et al. 2011), 
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and iv) NEFA + 10 µM BGP-15. Groups of 10 COCs were cultured in 100 µL of media for 
23 h at 38.5°C with 6% CO2 in humidified air. 
 
4.2.6 Assessment of Cumulus Expansion Index (C.E.I.) 
Cumulus expansion was assessed after 23 h culture by an independent assessor, blinded to 
treatments, using a scale described previously (Vanderhyden et al. 1990), as follows: 0, no 
expansion of cumulus cells; +1, the outer most layers of cumulus cells expanded; +2, 
expansion of the entire outer half of cumulus cells; +3, all layers expanded except the corona 
radiatae; and +4, maximal expansion of all layers of cumulus cells. For each treatment group, 
a mean cumulus expansion index (CEI; over the range 0.0–4.0) was calculated.  
 
4.2.7 In Vitro Embryo Culture (Cattle) 
At the completion of IVM, COCs were washed once in wash medium- VitroWash (IVF Vet 
Solutions) + 4 mg/mL FAF BSA—transferred into 500 µL of IVF medium-VitroFert (IVF 
Vet Solutions) + 4 mg/mL FAF BSA + 10 IU/mL heparin + 25 µM penicillamine + 12.5 µM 
hypotaurine + 1.25 µM epinephrine and overlaid with paraffin oil. Two straws of bull sperm 
(Semex Australia Pty Ltd.) of proven fertility were thawed, prepared using a discontinuous 
Percoll gradient (45%:90%; GE Healthcare), and added to IVF wells at a final concentration 
of 1 × 106 sperm/mL. Following 23 h of coincubation with sperm (Day 1), presumptive 
zygotes were mechanically denuded by repeated pipetting, washed once in wash medium, 
and groups of five embryos were transferred into 20 µL of pre-equilibrated Vitro Cleave 
(IVF Vet Solutions) supplemented with 4 mg/ml FAF BSA overlaid with paraffin oil, and 
cultured at 38.5°C in 6% CO2, 7% O2, and 87% N2. On Day 5, five embryos were transferred 
into 20 µL of VitroBlast (IVF Vet Solutions) + 4 mg/mL FAF BSA and cultured at 38.5°C 
in 6% CO2, 7% O2, and 87% N2. Fertilisation rates and on-time embryo development were 
assessed on Day 8.  
 
Briefly, following 23 h IVM in the presence of NEFAs and BGP-15, COCs were 
mechanically denuded of their cumulus vestment by repeated pipetting. Denuded oocytes or 
Day 8 blastocysts were washed with 1 mg/mL polyvinylpyrrolidone (PVP) in phosphate-
buffered saline (PBS), collected individually into 1.5 mL siliconised low retention 
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microcentrifuge tubes (Fisher Scientific) with 5 µL of PBS/PVP, snap frozen in liquid 
nitrogen, and stored at -80°C until use. Four experimental replicates were performed, with 
30 COCs per treatment group. 
 
4.2.8 Macaque Ovarian Stimulation and Oocyte Recovery 
To examine the effects of BGP-15 on embryogenesis in a primate species, I collaborated 
with Prof. Jon Hennebold at the Oregon National Primate Research Center in Oregon and 
conducted experiments in their macaque model of IVF. The general care and housing of 
rhesus monkeys (Macaca mulatta) at the Oregon National Primate Research Center (ONPRC) 
was previously described (Wolf et al. 1990). The studies were conducted in accordance with 
the National Institutes of Health (NIH) guide for the Care and Use of Laboratory Animals 
and all protocols were approved by the ONPRC Animal Care and Use Committee. 
 
Ovarian stimulation and follicle aspiration were performed by surgical staffs at the ONPRC. 
Briefly, females were observed for signs of menstrual activity and were subjected to 
follicular stimulation through intramuscular injection of recombinant human follicle-
stimulating hormone (FSH; donated by Organon, 30 IU per day) over an 8-day period. On 
Day 8 of the stimulation protocol, the animal was injected with recombinant human 
chorionic gonadotropin (hCG; Ovidrel, 1100 IU). Ovarian morphology was recorded by 
ultrasonography two days before the last hormonal stimulation.  
 
COCs were collected from anesthetised animals by laparoscopic follicular aspiration 
(approximately 36 h post hCG injection) and placed in HEPES-buffered TALP (modified 
Tyrode solution with lactate and albumin) containing 0.3% bovine serum albumin (TH3) 
with 1% heparin (Fresenius Kabi USA, LLC) at 37C. Tubes containing follicular aspirates 
were placed in a portable incubator (Minitube, Verona) at 37C for transport back to the 
laboratory. Hyaluronidase (0.5 mg/mL) was added to the tubes containing aspirates and were 
gently agitated with a serological pipette to disaggregate cumulus and granulosa cells masses 
and then sifted through a cell strainer (Falcon, 70 m mesh size; Becton Dickinson). Oocytes 
were retained in the mesh, whereas cumulus and granulosa cells were washed through the 
filter. The strainer was then immediately backwashed with warmed TH3, and the medium 
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containing oocytes was collected. The oocytes were then sorted according to maturation 
(MII, MI, GV, atresia) and transferred into an appropriate well of TALP-complete medium 
covered with Ovoil (Vitrolife) equilibrated at 37C in 5% CO2. After 4 to 6 h of culture, the 
oocytes were again sorted according to maturation and MI and MII oocytes were split into 
3 groups (control, low dose 1 µM BGP-15, high dose 10 µM BGP-15) subjected to IVF.  
 
4.2.9 Macaque Semen Preparation and Embryo Culture 
Rhesus semen was collected by electro-ejaculation. Following liquefaction for 30 min at 
room temperature, the sample was washed three times in TALP-HEPES by centrifugation 
for 7 min at 1400 rpm. Sperm count and motility analyses were performed and the 
spermatozoa were resuspended in TALP-HEPES; then the sperm suspension was stored at 
room temperature. Approximately 1 h before insemination, spermatozoa were exposed to 1 
mM cyclic adenosine 3’, 5’-mono-phosphate (cAMP) and 1 mM caffeine for sperm 
activation. For IVF, ten oocytes were inseminated with 1.8  105 activated spermatozoa and 
cultured in 100 L drops of TALP-complete media with indicated treatments. Oocytes were 
examined 16 h post-insemination for the presence of two polar bodies (PB) and two 
pronucleic (2PN) to confirm fertilisation. Cleaved embryos (6-10 embryos) were then 
transferred to fresh drops (500 L) of global media (Life Global) supplemented with 10% 
of protein supplement (Life Global) with or without the presence of BGP-15 equilibrated at 
37C in 6% O2, 5% CO2 and 89% N2. Embryos were transferred to a fresh plate of global 
media every 2 days and cultured for a maximum of 10 days. Three experimental replicates 
were performed, with 15 oocytes per treatment group. 
 
4.2.10 Human Oocyte Collections 
All samples obtained from Fertility SA were donated to the Fertility SA BioResource and 
were approved by the St. Andrew’s Hospital Human Research and Ethics Committee (HREC; 
Project Number 93). Biochemical analysis of human samples were covered by St. Andrew’s 
Hospital HREC Project Number 80 and were approved by the Adelaide University HREC. 
 
Women undertaking intracytoplasmic sperm injection (ISCI) antagonist cycle were treated 
with 125-350 IU recombinant FSH (Gonal-F; Puregon, Merck Sharp & Dohme Australia 
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(MSD) Pty Limited, Macquarie Park, NSW, Australia) and ovulation was blocked with a 
gonadotrophin-releasing hormone (GnRH) antagonist (Cetrotide; Merck Serono Australia 
Pty Ltd, Frenchs Forest, NSW, Australia) or Orgalutran (MSD) or proceeding GnRH 
analogue (Synarel; Merck Serono) or Lucrin (MSD) as a long down-regulation protocol 
(Hohmann et al. 2003). There were no differences in stimulation protocols between patients 
according to BMI. When at least three follicles reached 16 mm in diameter, recombinant 
hCG (250 µg; Ovidrel, Merck Serono Australia Pty Ltd) was administered and transvaginal 
oocyte retrieval was performed 36 h later under anaesthesia. COCs were collected from 
women via transvaginal aspiration of follicles under anaesthetic. Oocytes were subjected to 
ICSI according to standard clinical practice.  
 
The mean (± SEM) age of the five women participating in the study was 32.4 ± 2.1 years. 
Immature oocytes (germinal vesicle to metaphase I) were discarded during routine 
assessment prior to ICSI and donated to research. Oocytes were then transferred into pre-
equilibrated 10 µL culture drops (G-1™ Plus,  Göteborg, Sweden) with or without 10 µM 
BGP-15 (one oocyte per drop) , overlaid with Ovoil (Vitrolife, Göteborg, Sweden) and 
cultured overnight in humidified MINC benchtop incubator (Cook Medical) for 16 h at 
37.5°C, 6% CO2 and 5% O2. Following 16 h culture, oocytes were washed three times in 
PBS/PVP and collected individually into 1.5 mL siliconised low retention microcentrifuge 
tubes (Fisher Scientific) with 5 µL of PBS/PVP, snap frozen in liquid nitrogen, and stored 
at -20°C until transported on ice to the University of Adelaide. 
 
4.2.11 Mitochondrial DNA (mtDNA) Copy Number Quantification 
The mtDNA copy number in individual oocytes or embryos was quantified as previously 
described (Kameyama et al. 2010; Wu et al. 2015). Briefly, denuded oocytes or embryos 
were washed with PBS/PVP (1 mg/mL of PVP in PBS), collected individually into 1.5 mL 
siliconised low retention microcentrifuge tubes (Fisher Scientific) with 5 L of PBS/PVP 
and stored at -80°C. Genomic DNA was isolated using the QIAamp DNA micro kit (Qiagen) 
according to manufacturer’s protocol with carrier RNA (1 g; Qiagen) added to each sample. 
Genomic DNA was eluted once with 50 L of water and diluted 10 times for quantitative 
PCR.  




To prepare the quantification standards, a 1186 bp fragment of the 12S ribosomal (r)RNA 
region of mtDNA was amplified from mouse liver by PCR using the primer pair 5′-
ACACCTTGCCTAGCCA-3′ and 5′-TTTGCCACATAGACGAGTT-3′ with the 
LongRange PCR kit (Qiagen), and then purified by using the QIAquick PCR purification kit 
(Qiagen) and cloned using the Qiagen PCR cloning kit (Qiagen). Plasmid DNA was purified 
from bacteria using Plasmid Maxi kit (Qiagen), and the concentration was determined by 
using a Nanodrop ND1000 Spectrophotometer (Biolab). Plasmid copy number was 
calculated as: mass of plasmid (g) = plasmid size (bp)×(1.096×10–21 g/bp); mass of plasmid 
required to generate 1×107 copy number standard stock = 1×107×mass of single plasmid. A 
standard curve was generated by using seven tenfold serial dilutions (10−1×107 copies), and 
standard curve correlation coefficients were consistently greater than 0.98. Real-time 
quantitative PCR using the primer pair 5′-CGTTAGGTCAAGGTGTAGCC-3′ and 5′-
CCAGACACACTTTCCAGTATG-3′ was performed in triplicate using SYBR Green PCR 
master mix (Applied Biosystems) and a Rotor-Gene 6000. Primer sequences for the 
quantification of mtDNA were derived from (Kameyama et al. 2007). Standard curves were 
created for each run and sample copy number was generated from the equation of Ct value 
against copy number for the corresponding standard curve. 
 
The PCR program employed an initial step of 95°C for 10 min followed by 40 cycles, 
denaturation at 95°C for 10s, annealing at 60°C for 30s and extension at 72°C for 20s. Every 
reaction was followed by melting curve analysis to ensure the specificity of the amplification. 
All reactions were performed in triplicate with total reaction volumes of 20 µL. Premix for 
quantitative PCR was prepared from Power SYBR Green PCR Master Mix (Applied 
Biosystems, CA, USA). The premix consisted of 10 μL of Power SYBR Green, 6 μL of PCR 
grade water, 2 μL of 50 µM primer pair; following which 2 μL of DNA template was added 
to 18 μL of premix for PCR reaction. 
 
4.2.12 Statistical Analyses 
All measures are reported as mean ± SEM. Statistical significance was determined as 
indicated, by using Student's t-test or one-way ANOVA with Tukey’s post hoc tests, as 
appropriate, using GraphPad Prism v008 for Windows. Time-lapse data were analysed by 
Chapter 4 mtDNA kinetics & BGP-15 in stress 
133 
 
using repeated measures with linear mixed-effects model in SPSS (IBM SPSS Statistics for 
Windows, Version 24.0. Armonk, NY: IBM Corp.). Normality of data was confirmed by 
analysing the spread of residuals. A P-value of less than 0.05 was considered statistically 
significant. 




4.3.1 Kinetics of mtDNA during oocyte maturation and embryogenesis in 
the mouse 
To examine the dynamics of mtDNA copy number throughout preimplantation embryo 
development, in vivo derived oocytes and embryos were collected from the mice following 
superovulation. During oocyte maturation, mtDNA copy number remained constant from 
GV oocyte to MII oocytes isolated at 16 h post-hCG. Similarly, mtDNA did not increase 
following fertilisation through the 18-32 cell stage but significantly increased at morula and 
blastocyst stage (P ≤ 0.01; Figure 1A). The average mtDNA copy number was 2.3 × 105 for 
GV oocytes and 4.1 × 105 for MII oocytes, increasing to an average value of 8.8 × 105 and 
1.3 × 106 for morula and blastocyst respectively.  Next, in order to determine whether there 
was biological variability in mtDNA content in the oocytes of the mice that were matured in 
vivo or in vitro, oocytes were collected at defined times after PMSG treatment. There was a 
continuous gradual increase in mtDNA copy number as oocytes progress to maturation, 
reaching a maximum of 5.0 × 105 copies in the IVM oocytes (Figure 1B). Identical kinetics 
were observed in both in vitro and in vivo matured oocytes. Thus, mtDNA slightly but 
steadily accumulates during oocyte growth.  
 
To further characterise the mtDNA replication during embryogenesis, developing 
preimplantation embryos (in vivo flushed and IVF-derived) were collected at different time 
points. Absolute mtDNA copy number was measured in 2-, 4-, 8-, 18-32 cell embryos, 
morula and blastocysts. mtDNA levels were gradually increased from a 2-cell embryo (5.7 
× 105 copies for in vivo and 6.8 × 105 copies for IVF embryos) to a blastocyst (1.3 × 106 
copies for in vivo and 1.2 × 106 copies for in vitro) (Figure 1C). An identical pattern was 
observed between in vivo and IVF-derived embryos clarifying that our methods of in vitro 
culture have no significant influence on mitochondrial biogenesis. 
  




Figure 1 Mitochondrial DNA (mtDNA) copy number during mouse preimplantation 
embryo development. 
(A) Quantification of mtDNA copy number in individual oocytes and embryos collected at 
different time points following ovulatory hCG administration and mating. Data are presented 
as mean  SEM, n = 10-12 oocytes and n = 9-23 embryos per group. (B) mtDNA copy 
number in in vivo and in vitro matured (IVM) oocytes. Data are presented as mean  SEM, 
n = 10-12 oocytes per group. (C) mtDNA copy number in in vivo flushed and in vitro 
fertilised (IVF) embryos, as determined by real time PCR. Data are presented as mean  
SEM, n = 9-23 embryos per group. Groups with different superscripts differ significantly by 
one-way ANOVA with Tukey’s post hoc test (P ≤ 0.01). 
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4.3.2 BGP-15 normalises mtDNA levels in high lipid-stressed oocytes  
To understand how mtDNA is impacted by exposure to high lipids, immature unexpanded 
COCs were cultured in the presence of high PA and/or BGP-15 throughout maturation. At 
2 h and 4 h of culture, PA-treated oocytes had increased mtDNA number (~5.3 105 copies), 
which was no longer higher than controls by 8 h and significantly decreased compared to 
controls by 16 h of maturation (1.85105 copies) (P ≤ 0.01; Figure 2). The presence of BGP-
15 with PA resulted in mtDNA levels comparable to those in the control oocytes at 2 h and 
4 h of IVM. However, oocyte mtDNA levels in PA+BGP-15 treated COCs were 
dramatically increased to a level much higher (7.7 105 copies) than the PA-treated oocytes 
by the end of maturation (P ≤ 0.01; Figure 2). No control IVM+BGP-15 group was 
undertaken because a previous study by our lab showed that lean mice treated with BGP-15 
had no change to mtDNA levels in the oocytes (Wu et al. 2015). 
 
4.3.3 Presence of high lipid during mouse IVM affects embryo 
development and mtDNA levels 
In a separate series of experiments, expanded COCs following 16 h of culture were subjected 
to IVF followed by morphometric assessment and time-lapse imaging to closely monitor 
developmental kinetics. The time range over which embryos reached every developmental 
event increased as embryo development progressed and there was no significant difference 
in these timings between each treatment group (Figure 3A). On Day 2, the cleavage rate was 
lower in the PA-treated oocytes when compared to the control (Control = 48 ± 6.66% vs. PA 
= 17.08 ± 4.96%; P ≤ 0.05) and it was partially normalised with BGP-15 treatment 
(PA+BGP-15 = 37.25 ± 6.17%) but that was not statistically significant (Figure 3B). Only 
zygotes that were successfully cleaved on Day 2 were further analysed. On Day 5, the 
blastocyst development rate in the PA-treated oocytes was reduced (8.26 ± 5.13%) when 
compared to the control (21.38 ± 3.64%) and partially restored with BGP-15 treatment 
(16.62 ± 2.78%), however, these rates of development were not significantly different 
between groups (Figure 3C). Subsequently, the duration of interval between each cell 
division also showed no significant difference between the groups except at 3-cell to 4-cell 
stage (Figure 3D). The time duration was significantly shorter in the PA+BGP-15 group 
when compared to the PA (Figure 3D).  




Blastocysts that were collected on Day 5 were quantified for mtDNA levels. There was a 
significant reduction in mtDNA copy numbers in the blastocysts that were derived from 
high-lipid treated oocytes (2.5 × 105 copies) when compared to the control blastocysts (5.0 
× 105 copies). BGP-15 supplementation during IVM did not significantly recover the 
mtDNA copies (3.8 × 105 copies) in the blastocysts. (Figure 4). Thus, the presence of high 
lipid during mouse IVM reduced mtDNA copy number in both the oocytes and the resulting 
blastocysts and BGP-15 in IVM media was able to at least normalise the mtDNA levels in 
the PA-treated oocytes and to a lesser extent in the blastocysts. 
  




Figure 2 Effect of palmitic acid (PA) and/or BGP-15 in in vitro maturation (IVM) media 
on mitochondrial DNA (mtDNA) levels in mouse oocytes. 
mtDNA copy number in oocytes that underwent IVM in the presence of 400 µM Palmitic 
acid (PA) with or without BGP-15.  Data are presented as mean  SEM, n = 10-12 oocytes 
from 4 mice per group. Groups with different superscripts differ significantly by one-way 
ANOVA with Tukey’s post hoc test (P ≤ 0.01).  
  




Figure 3 Mouse embryo developmental kinetics and developmental competence 
following in vitro maturation (IVM) in high palmitic acid (PA) and/or BGP-15. 
(A) Timing of developmental milestones in hours post-insemination in control, palmitic acid 
(PA) and PA+BGP-15 treated IVM groups. (B) Cleavage rate was assessed on Day 2 and 
(C) blastocyst rate on Day 5. Data are presented as mean  SEM, n = 3 experimental 
replicates. (D) Time intervals between each developmental stage. Data are presented as mean 
 SEM, n = 26-37 embryos from 4 mice per group. Groups with different superscripts differ 
significantly by one-way ANOVA with Tukey’s post hoc test and repeated measure by linear 
mixed-effects model; * P ≤ 0.05. 2C- 2-cell, 3C- 3-cell, 4C- 4-cell, ML- morula, BL- 
blastocyst. 





Figure 4 Effect of high palmitic acid (PA) and/or BGP-15 during in vitro maturation 
(IVM) on mitochondrial DNA (mtDNA) levels in mouse blastocysts. 
mtDNA copy number in individual embryos was quantified. Data are presented as mean ± 
SEM, n = 7-18 embryos from 3 experimental replicates. Groups with different superscripts 
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4.3.4 Effects of high lipid during bovine IVM on embryo development and 
mtDNA levels. 
To further examine the effects of high lipid and BGP-15 on oocyte maturation and whether 
the findings in mouse are common to other species, we further utilised a well-characterised 
in vitro bovine model of lipotoxicity during IVM. Here, we supplemented the maturation 
medium with NEFA as in (Sutton-McDowall et al. 2016) but in the presence or absence of 
BGP-15. After IVM, COCs were evaluated morphologically for cumulus expansion. No 
significant difference was observed between the groups, however, the COCs that were 
exposed to NEFA have poor expansion when compared to the control COCs (Figure 5A). 
Cumulus cells were then removed and the oocytes were quantitatively assessed for mtDNA 
copy number. The oocytes that were cultured in the presence of NEFA had lower mtDNA 
copy number (1.4 × 107 copies) when compared to the control (1.9 × 107 copies) but this was 
not statistically significant. Supplementation of the IVM culture media with BGP-15 
normalised the mtDNA copy number in the NEFA-exposed oocytes (2.2 × 107 copies) but 
this increase from the NEFA-only treated oocytes was not statistically significant (Figure 
5B). 
 
Maturation in the presence of NEFA had no significant effect on oocyte cleavage or 
blastocyst yield (Figure 6A). The blastocyst development rate was lower for the oocytes 
matured in the presence of NEFA (23.25 ± 7.49%) and tended to be normalised by BGP-15 
supplementation in the culture media (37.75 ± 9.63%) but there were no statistically 
significant differences between groups (Figure 6B). However, when blastocyst rate in the 
NEFA and NEFA+BGP-15 was analysed as independent experiments, it is clear that 
supplementation of BGP-15 in NEFA IVM culture media improves developmental rate 
(Figure 6C). Embryos generated from the IVF experiments were quantified for mtDNA copy 
number and no significant difference was observed between the groups. Nevertheless, the 
mtDNA copy number of blastocysts from the NEFA-treated group showed a slightly lower 
mtDNA copy number (6.1 × 108 copies) than the other groups (Control = 9.3 × 108 copies; 
Control+BGP-15 = 8.8 × 108 copies) and BGP-15 supplementation in the NEFA culture 
medium partially restored the mtDNA copy number in the embryos (9.2 × 108 copies) to 
levels identical to controls (Figure 6D).  
  




Figure 5 Effect of non-esterified fatty acid (NEFA) and/or BGP-15 supplementation on 
bovine cumulus oocyte complex maturation in vitro. 
(A) Cumulus expansion index (CEI) was assessed 23 h following culture. Data are presented 
as mean  SEM from 4 experimental replicates with approximately 40 COCs per 
experimental replicate per treatment group. (B) mtDNA copy number in individual oocytes 
collected from the indicated treatment groups. Data are presented as mean  SEM, n = 18-
19 oocytes per group. P > 0.05, one-way ANOVA with Tukey’s post hoc test. 
  






Figure 6 Effect of non-esterified fatty acid (NEFA) and/or BGP-15 supplementation 
during in vitro maturation (IVM) on bovine oocyte developmental competence. 
 (A) Cleavage and (B) Blastocyst development rate following IVF of oocytes from cumulus-
oocyte complexes (COCs) cultured in the presence of NEFA and BGP-15 as indicated. (C) 
Developmental rate in NEFA and NEFA+BGP-15 in the four independent experiments. (D) 
Quantification of mtDNA copy number in individual embryos collected following in vitro 
fertilisation (IVF). Data are presented as mean  SEM, n = 18-22 embryos per group. P > 
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4.3.5 Effect of BGP-15 in IVF media on macaque embryo mtDNA levels 
A total of 146 oocytes were retrieved from three ovarian stimulation of three different 
animals. Of these, 22.04 ± 5.073% were at MII stage, 49.77 ± 3.34% at the MI stage, and 
22.47 ± 3.181% at GV stage. 5.72% of oocytes were classified as degenerate/atretic or not 
fully grown and therefore were excluded (Figure 7A). Thus, a large proportion of the oocytes 
were at MI stage at the time of aspiration and this is typical for the controlled ovarian 
stimulation protocol in the macaque. Following culture, MI and MII oocytes were randomly 
allocated to different IVF culture media with or without BGP-15 for fertilisation and embryo 
culture. The treatment groups were: standard (control) media, media containing low dose 
BGP-15 (1 µM) or media containing high dose BGP-15 (10 µM). These doses were selected 
based on effects we observed in mouse and bovine which utilise 10 µM during IVM and 
IVF. 
 
Fertilisation was assessed visually at 12-15 h post-fertilisation by the presence of 2PN 
(Figure 7B). There was no significant difference in the 2PN rate between the groups (Figure 
7C). Embryos that were successfully cleaved were assessed daily. By Day 3 of culture, most 
embryos in the three groups were at the 6-8 cell stage and by Day 5 most were at the compact 
morula stage. The number of embryos that reached the morula stage were recorded on day 
5. By day 7, most embryos had developed to the blastocyst stage (Figure 8) and blastocyst 
development rate was determined. A lower cleavage rate was observed in the group treated 
with a low dose of BGP-15 when compared to the control and high-dose BGP-15 treatment, 
but was not statistically significant (Figure 9A). However, the group that was treated with a 
high dose BGP-15 had a lower percentage of embryos that reached the morula stage when 
compared to the control and low dose BGP-15 treatment, however, this was not statistically 
significant (Figure 9B). 
 
GV oocytes that were not matured were collected and quantified for mtDNA copy number. 
mtDNA levels did not increase between the oocyte and morula stage in the rhesus macaque 
(Figure 9C). There was a dramatic increase in mtDNA copy number as the embryos 
progressed to the blastocyst stage (Figure 9C). Morulae and blastocysts that were cultured 
from the low dose BGP-15 had a slightly higher level of mtDNA compared to the control 
and high dose BGP-15 treatment, but again, was not statistically significant (Figure 9C).  




Figure 7 Proportion of Rhesus macaque oocytes at different phases throughout 
maturation and presence of 2 pronuclei (2PN) after fertilisation. 
(A) The percentage of MII, MI, GV and atretic oocytes after aspiration. (B) Representative 
images of oocytes with 2PN on day 2 from each of the treatment groups. (C) The percentage 
of oocytes with 2PN. Data are presented as mean  SEM, n = 3 experimental replicates. P > 
0.05, one-way ANOVA with Tukey’s post hoc test. LD- low dose; HD- high dose 
Chapter 4 mtDNA kinetics & BGP-15 in stress 
146 
 
 Figure 8 Representative photos of Rhesus macaque embryos from day 2 to day 9 in 
vitro with the indicated treatments.  






Figure 9 Effect of BGP-15 on macaque embryo development and mitochondrial DNA 
(mtDNA) levels. 
(A) Cleavage rate was assessed on Day 2 and (B) morula rate was examined on Day 5. Data 
are mean  SEM, n = 3 experimental animals. (C) mtDNA copy number was assessed in 
individual oocytes and embryos using real-time PCR. Data are presented as mean  SEM, n 
= 1-11 oocyte/embryo. P > 0.05, one-way ANOVA with Tukey’s post hoc test. LD – low 
dose (1 µM) BGP-15, HD = high dose (10 µM) BGP-15. 
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4.3.6 Effect of BGP-15 on human immature oocytes 
Human immature oocytes (germinal vesicle to metaphase I) were cultured overnight (~16 h) 
in the presence or absence of BGP-15 (10 µM) and then collected for quantitative analysis 
of mtDNA. There was a great deal of variation between oocytes, even within individual 
patients. The average mtDNA in oocytes (with and without BGP-15) of patient 9176 was 
7.2  104 copies but there were marked differences between oocytes with 2 oocytes having 
much higher values than the other two. The average oocyte mtDNA level in patients 10680 
and 20153 increased with BGP-15 treatment, but this was not statistically significant. In 
patient 10680, average mtDNA copy number increased from 1.6  104 to 5.2  104 copies, 
and in patient 20153 from 3.7  104 to 7.4  104 copies. However, patient 8314 had lower 
mtDNA levels in the oocytes following BGP-15 treatment (from 2.5  104 to 9.9  103 copies) 
(Figure 10). There was no relationship between mtDNA copy number in oocytes and patient 






























Figure 10 Mitochondrial DNA (mtDNA) copy number in human germinal vesicle (GV) 
and metaphase I (MI) oocytes. 
The X-axis shows the patient number with 1-5 immature oocytes donated by each woman 
with half treated with BGP-15 as indicated. mtDNA level in individual oocytes was 
determined by real-time PCR.  P > 0.05, unpaired t-test.




The importance of mitochondria and its DNA genome in oocytes is well-established. 
Mitochondria supply the majority of adenosine triphosphate (ATP) in a cell and mtDNA has 
been proposed as a key marker of viability and might be a key determinant of 
preimplantation embryo development. However, little is known about its regulation during 
oocyte maturation and preimplantation development and how lipid stress and BGP-15 will 
disturb and/or restore its regulation. I investigated this in a number of models and contexts, 
particularly in the mouse, cattle, macaque and human during preimplantation development. 
 
Firstly I show that in mouse mtDNA copy number was relatively stable throughout oocyte 
maturation, but with higher mtDNA copy number in MII oocytes. The number of mtDNA 
molecules also remained remarkably stable throughout group and single cultured 
preimplantation development, beginning to increase only at the morula stage. To date, there 
is little information on mtDNA copy number during mouse oocyte maturation. It was found 
that the average mtDNA copy number in GV oocytes was 2.3 × 105 and in MII oocytes was 
4.1 × 105 which were higher than those reported previously at (Mahrous et al. 2012) (~1.75 
× 105 copies in GV and MII oocytes). The discrepancy might be due to different culture 
conditions and mouse strain used. Our results showing that mtDNA remained stable 
throughout oocyte maturation and reaches its maximum at MII agrees with the data reported 
by others (Mahrous et al. 2012; Mao et al. 2012). A similar lack of increase in mtDNA copy 
number from in vivo-derived GV and MII oocytes has also been shown in humans (Reynier 
et al. 2001; Barritt et al. 2002), suggesting that the majority of mtDNA replication had 
occurred by the completion of oocyte growth. It is well-established that there was an increase 
in ATP content in the oocyte in cattle (Stojkovic et al. 2001), pig (Brevini et al. 2005) and 
mouse (Yu et al. 2010) during the final oocyte maturation, suggesting our observation of an 
accumulation in mtDNA at the end of maturation is to coordinate with the ATP demands 
during oocyte growth and possibly to ensure successful fertilisation and survival to the later 
stages of preimplantation development.  
 
There is some variability among reports in relation to the mtDNA copy number during 
embryo development. Our results that mtDNA levels increased significantly at the blastocyst 
stage are consistent with findings in porcine (Spikings et al. 2007) and bovine (May-Panloup 
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et al. 2005d) but not with those in mice (Thundathil et al. 2005) and rats (Kameyama et al. 
2007) where there was no difference in mtDNA levels throughout preimplantation 
development. The discrepancies might be due to different species and different strain of mice 
used. The quantification standard used may also contribute to the variation observed. A study 
by (Thundathil et al. 2005) used a 189 bp fragment of the mt-Nd2 gene whereas the current 
study employed a 1186 bp fragment of the 12S ribosoman(r)RNA region of mtDNA as 
quantification standards. In different species, mtDNA varies greatly in size, structure and 
gene organisation therefore its kinetics of regulation may vary with species. Another 
explanation for this variation might be the different implantation patterns among species. 
Moreover, the method of DNA extraction used in the current study is robust, producing large 
amount of DNA from a single cell compared to previous methods reported in (Thundathil et 
al. 2005; Kameyama et al. 2007).  In addition, mtDNA copy number remained constant 
during early embryogenesis and began to increase only at the morula stage highlighting the 
general belief that mtDNA replication does not occur until after later stage of embryo 
development. A strength of my observation is that, a comparison in mtDNA copy number 
was also made between IVM and in vivo-derived oocytes and between IVF and in vivo-
derived embryos. No significant difference was observed between the groups indicating that 
IVM and IVF conditions in this experiment mimic in vivo development and had no impact 
on mtDNA replication progression during oocyte maturation and preimplantation 
development. Following fertilisation, mitochondria are thought to be randomly segregated 
between blastomeres, therefore it is expected that embryos will have a reduction in the 
numbers of mtDNA copies per cell. Thus, future studies will require measurement of a 
nuclear reference gene so that embryo cell number could be adjusted for and  mtDNA copy 
number per cell can be calculated. 
 
When exposed to high levels of PA lipid, oocyte mtDNA was significantly reduced by the 
end of maturation (16 hours). It is known that the cumulus cells which surround the oocyte 
nourish the developing oocyte through gap junctional cell-to-cell contacts and COCs are 
known to increase β-oxidation lipid metabolism for energy during maturation (Dunning et 
al. 2010). However, in the presence of excessive saturated fatty acids, COCs undergo 
lipotoxicity responses (Wu et al. 2012). Further, the cumulus cell layer is the first metabolic 
area that is affected by altered fatty acids in the culture media. Indeed, exposure to saturated 
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fatty acids in vitro induces apoptosis in cumulus cells but not in the oocyte (Mu et al. 2001; 
Leroy et al. 2005; Lolicato et al. 2015). Thus, future studies are necessary to determine this. 
In bovine, the cumulus cell layer also acts as a barrier, protecting oocytes from in vitro-
induced lipotoxicity (Lolicato et al. 2015). Thus, at the end of maturation, it is reasonable to 
speculate that the gap junctions between the oocytes and cumulus cells are disrupted, hence 
limiting the transfer of nutrients between the cells and ultimately altering mitochondrial 
dynamics. Furthermore, a previous study from our laboratory also found that exposure of 
COCs to high levels of PA resulted in ER stress and impaired mitochondrial activity (Wu et 
al. 2012), suggesting that the oocytes might be undergoing extensive unfolded protein 
response and protein folding to restore ER function and cellular homeostasis rather than 
mtDNA replication to maintain cell survival. It was interesting that mtDNA levels were 
initially increased by PA at 2 h and 4 h post-hCG and I speculate that this elevated mtDNA 
levels are a consequence of a compensatory mechanism, aimed at normalisation of ATP 
generation in the face of compromised organelles of reduced function. Importantly, BGP-15 
supplementation was able to normalise the decrease in mtDNA in oocytes exposed to PA to 
levels similar to the controls, indicating that BGP-15 might be enhancing mtDNA biogenesis 
under stress conditions or that it acts to prevent a lipid-induced degradation of mtDNA. 
Further investigation is required to biochemically dissect these two possibilities and to 
determine whether either involves a restoration of gap junction communication between 
oocytes and cumulus cells or modulation of apoptotic signals.   
 
We had previously showed that exposure to high levels of palmitic acids impaired cleavage 
and blastocyst formation rate (Wu et al. 2012). In the current study, the reduction in mtDNA 
levels in the oocytes is associated with lower cleavage rate following IVF. This finding is 
supported by a previous study in porcine (Mao et al. 2012) and human embryos (Reynier et 
al. 2001) where they showed that lower mtDNA levels may affect oocyte fertilisability and 
developmental competence. Conversely, other studies indicated that key checkpoints for 
cleavage are not strictly regulated by mtDNA copy number as very low mtDNA copy 
number (as few as 4000) did not inhibit embryo preimplantation development (Wai et al. 
2010). Importantly, the reduced mtDNA levels observed in the PA-treated oocytes were also 
reflected subsequently in the embryos; and BGP-15 treatment during IVM slightly improve 
the mtDNA levels in the embryos generated following exposure to high PA. This result 
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suggests that decreased and/or compromised mtDNA in the embryo is possibly reversible by 
the blastocyst stage, implicating that low levels of mtDNA in mature oocytes can be sensed 
and adjusted upward in the preimplantation embryos. 
 
The effect of BGP-15 in IVM medium was further tested in a bovine model. NEFA 
supplementation during oocyte maturation resulted in a decreased trend in mtDNA copy 
number in both mature oocytes and embryos. However, the effect was not statistically 
significant, most probably due to relatively low numbers of oocytes and embryos analysed 
within the groups and the high degree of variability in embryo development rates between 
experimental replicates. Nevertheless, the results were consistent with previous findings 
(Sutton-McDowall et al. 2016). In bovine, oocytes with higher mtDNA copy numbers also 
have better blastocyst development (Hua et al. 2007; May-Panloup et al. 2007). Similar to 
earlier findings in the mice, BGP-15 was able to normalise mtDNA levels in both the oocytes 
and embryos that were generated following exposure to high lipids, but this was not 
statistically different. The lack of statistical differences between groups in both embryo 
development and mtDNA levels is very likely due to variability across the experimental runs 
which is typically due to inconsistencies between the abattoir tissues. Overall however these 
results clearly implicate that mtDNA are vulnerable to external stressors and that mtDNA 
replication/biogenesis is altered in response to high lipids environment. Further, the findings 
that BGP-15 is able to at least partially normalise mtDNA in response to high lipids condition 
demonstrate that mtDNA levels can be enhanced by a drug currently in human clinical trials, 
which may lead to improved embryo development. 
 
From the mice and bovine studies, it is clear that addition of BGP-15 to IVM medium is able 
to slightly improve mtDNA levels and embryo development following exposure to high 
lipids. Therefore another goal of this study was to generate pre-clinical data on this 
compound’s effectiveness in Rhesus macaque assisted reproductive technology (ART). 
BGP-15 showed no significant impact on the macaque cleavage, blastocyst development and 
also mtDNA copy number in the blastocyst. Interestingly, there was a massive increase in 
mtDNA levels in the macaque blastocysts when compared to the GV oocytes and morula, 
further confirming that mtDNA replication does not take place prior to blastocyst stage in 
primates. This is the first study that looked at mtDNA levels in the macaque model and 
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importantly it shows that BGP-15 is not detrimental to development. Besides that, human 
oocytes that were not successfully fertilised were cultured overnight in the absence or 
presence of BGP-15. There were two out of five patients (10680 and 20153) whose oocytes 
had higher mtDNA following BGP-15 culture. The variable mtDNA copy number observed 
between patients and between samples is similar to the variability in mtDNA copy number 
previously reported in human oocytes (Steuerwald et al. 2000; Reynier et al. 2001; Barritt 
et al. 2002). It has been suggested that the biological variation in mtDNA in human oocytes 
is indicative of oocyte quality and attainment of a threshold of mitochondrial activity and/or 
ATP production necessary for fertilisation and embryogenesis (Reynier et al. 2001; Santos 
et al. 2006; Zeng et al. 2007). From the macaque and human studies, BGP-15’s effects 
remained inconclusive due to low experimental replicates and patient samples.  
 
Based on the findings in this chapter, although the results are promising, there are limitations 
in the current study. For instance, in the cattle studies, the use of abattoir material prevents 
the ability to identify whether oocytes were from obese or lean females, so variation would 
be expected in the ability of BGP-15 to modulate oocyte/embryo characteristics. 
Furthermore, differences in mtDNA replication across the different species may be due to 
difference in systemic lipid profiles and/or oocyte lipid content. Differences in lipid content 
between mouse, human, pig, sheep and cow have been previously reported (Dunning et al. 
2014). One additional confounding factor in the data presented in the current chapter is the 
use of different stimulation regimens in different species. For instance, gonadotropin 
stimulation is known to result in decreased oocyte mtDNA content in the cattle (Cree et al. 
2015). Moreover, unlike mice, humans, cows and macaques are not litter-bearing, so the 
mechanisms that regulate the generation of multiple follicles/oocytes in mice may also affect 
mtDNA copy number; with mice presumably having a higher number of oocytes with the 
‘required’ mtDNA copy number, rather than one or two dominant follicles/oocytes in the 
other species. It is also important to note that a different strain of mouse was used in this 
chapter compared to previous chapters which may also account for minor differences 
observed. Regardless, we have used the C57BL/6, the Blobby mouse (which is a C57BL/6J 
strain with an ENU-induced mutation) and the CBAF1 (C57 x CBA cross) (Wu et al. 2015). 
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In conclusion, the present study shows that there was an accumulation of mtDNA levels 
during oocyte maturation from GV to MII oocytes in the mice. There was also relatively 
abundant levels of mtDNA during embryo development in the mice, bovine and macaque. 
mtDNA replication/biogenesis is very sensitive to environmental stressors such as high 
lipids. This is demonstrated by my results in both mouse and bovine showing 
supplementation of IVM medium with high lipids suppressed mtDNA levels and this was 
partially prevented by BGP-15. Thus, supplementation of maturation medium with BGP-15 
may provide a means to increase mtDNA in both the oocytes and embryos, and thereby 
improve oocyte viability and developmental competence. 
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DEVELOPMENT DUE TO 
OXIDATIVE STRESS IS 
NORMALISED BY BGP-15 




In the previous chapter, I showed that presence of BGP-15 in in vitro maturation (IVM) 
culture media restored mitochondrial DNA (mtDNA) levels in embryos that were conceived 
from lipid-stressed oocytes. In this chapter, I sought to further understand BGP-15 
mechanism of action, particularly its beneficial effects on oocytes affected by high lipid 
levels or obesity by testing its efficacy in a general model of cellular stress, namely oxidative 
stress. 
 
Approximately 90% of cellular reactive oxygen species (ROS), a natural by-product of 
cellular respiration, are produced in the mitochondria (Balaban et al. 2005). Under 
homeostatic stress-free conditions, ROS are required for many physiological processes and 
in intracellular signal transduction regulation (Mittler et al. 2011). However, deficient 
management of ROS results in oxidative stress and prolonged oxidative stress is linked to 
pathological ailments such as cancer, arthritis, and neurological diseases (Hayes and 
McLellan 1999). Most of these diseases involve ROS and mitochondrial dysfunction, which 
can both be linked to glutathione (GSH) homeostasis imbalance (Schulz et al. 2000). 
Oxidative stress also has broad effects on the reproductive system and has been reported to 
impair function of ovarian steroidogenesis and ovulation (Agarwal et al. 2005), 
embryogenesis (Bedaiwy et al. 2004), and implantation and maintenance of pregnancy 
(Myatt and Cui 2004). In particular, oxidative stress plays a crucial role during ovulation by 
inducing apoptosis of luteal cells within the ovary, which perturbs the area inside and around 
ova and granulosa cells (Schallreuter et al. 1999) which could potentially decrease oocyte 
and embryo viability (Van Blerkom et al. 1997; Yang et al. 1998). Moreover, it was also 
previously reported that repeated exposure of oxidative stress in the ova and other cells 
during ovulation might trigger ovarian aging (Miyamoto et al. 2010). 
 
Several biomarkers of oxidative stress are increased in the blood of obese, non-pregnant 
women (Iyer et al. 2010), and oxidative stress has been implicated in obese pregnancies 
(Jarvie et al. 2010). In fact, women with obesity have high circulating levels of catalase and 
glutathione peroxidase enzyme activities, indicating systemic oxidative stress (Bausenwein 
et al. 2010).  Maternal diet-induced obesity has contributed to oxidative stress in the oocytes 
and zygotes (Igosheva et al. 2010) and also in other tissues such as the liver and adipose 
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tissues (Matsuzawa-Nagata et al. 2008). Thus, I hypothesise (see schematic below) that 
oxidative stress during oocyte maturation impairs oocyte mitochondria and subsequent 











To test this hypothesis, I utilised a brief treatment with hydrogen peroxide (H2O2) to induce 
oxidative stress in oocytes and then determined whether the changes in ROS, mitochondrial 
activity, mtDNA and embryo quality are reversible by supplementing the in vitro fertilisation 
(IVF) media with BGP-15. 
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A hallmark of mitochondrial dysfunction is oxidative stress. Oxidative stress is considered 
an enhanced state of oxidants or a lack of antioxidants in cells, a situation in which the 
concentration of reactive oxygen species (ROS) increases above its biological values 
(Gonzalez-Flecha et al. 1993; Sikka 2001). Some amount of ROS is needed in the ovarian 
follicle (Attaran et al. 2000) as well as for normal sperm-oocyte interaction and sperm 
capacitation (de Lamirande et al. 1997). However, raised levels of ROS have a deleterious 
effect on cell membranes, cellular DNA, and mitochondria and ultimately accelerate cell 
death by apoptosis or necrosis (Alvarez 2003). Mitochondria are a major source of ROS and 
ROS production can be triggered by dysfunctional mitochondrial oxidative phosphorylation; 
as well as increases or decreases in ROS-related enzymes (Kamogashira et al. 2015). 
Oxidative stress can also result from impaired cellular antioxidant defense mechanisms 
(Rahal et al. 2014). Mitochondria are themselves also sensitive targets for the damaging 
effects of oxygen radicals. In fact, mitochondrial DNA (mtDNA) is highly susceptible to 
damage because it is not protected by histones and is directly exposed to ROS generated by 
the respiratory chain (Alexeyev 2009).  
 
In multiple contexts of physiological stress, particularly aging and obesity, oxidative stress 
is a common feature in the gametes as in other cells. In mice it has been shown that oocytes 
from females with diet-induced obesity exhibit oxidative stress, with increased ROS levels 
(Igosheva et al. 2010; Zhang et al. 2015; Hou et al. 2016).  Furthermore, similar to obese 
females, high-fat diet-induced obesity in males resulted in increased oxidative stress in 
sperm (Bakos et al. 2011; Palmer et al. 2011; Fullston et al. 2012). Moreover, the role of 
oxidative stress in maternal aging has also been suggested (Tarin et al. 1996; Takahashi et 
al. 2003; Bartmann et al. 2004; Thouas et al. 2005; Lord et al. 2013). Aged oocytes 
generated either in vitro or in vivo have been reported to have increased levels of ROS, an 
indicative of oxidative stress, as determined by fluorescence staining (Mitchell et al. 2009; 
Yamada-Fukunaga et al. 2013).  
 
In human and animal oocytes, oxidative stress has been correlated with abnormal 
chromosome segregation and reduction of pole-to-pole distance of the metaphase II (MII) 
spindle and spindle alignment during meiotic division, and with increased fragmentation and 
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aberrant morphology in embryos originating from aging oocytes (Tarin 1996; Hall et al. 
2007; Miao et al. 2009; Selesniemi et al. 2011). Oocytes exposed to high ROS exhibit 
subsequent defective embryo development, apoptosis and embryonic arrest (Goto et al. 1993; 
Yang et al. 1998; Hashimoto et al. 2000; Guerin et al. 2001). For instance, bovine oocytes 
that were exposed to high oxygen tension had increased ROS contents and resulted in poor 
developmental competence (Hashimoto et al. 2000). In addition, a direct relationship was 
also observed between increased ROS concentration and apoptosis in human fragmented 
embryos, suggesting that ROS may induce apoptosis in embryos (Yang et al. 1998). Apart 
from that, it has been noted that bovine embryos cultured in 20% oxygen conditions sustain 
a 10-fold increase in intracellular ROS levels and a 2-fold increase in the frequency of 
permanent embryo arrest at the 2-to 4-cell stage, compared with embryos cultured in 5% 
oxygen tensions (Favetta et al. 2007). 
 
Oxidative stress is detrimental to cells because ROS and their metabolites can damage DNA, 
lipids, and proteins; alter enzymatic systems; produce irreparable alterations; and cause cell 
death (Agarwal et al. 2014). For instance, a classic inducer of oxidative stress is hydrogen 
peroxide (H2O2) which has been well-characterised in a number of in vitro systems and 
documented to affect cell membrane lipids, affect DNA content, accelerate apoptosis, and 
cause mitochondrial dysfunction (Tatsumi and Kako 1993; Ballinger et al. 2000; Li et al. 
2003; Zhu et al. 2005). There are several reports detailing the detrimental effects of H2O2 
treatment on oocytes and embryos. H2O2 treatment of MII oocytes in vitro has been shown 
to cause a decline in levels of the anti-apoptotic molecule Bcl-2 (Takahashi et al. 2009), 
induce expression of pro-apoptotic Bax and caspase-3, and precipitate both DNA 
fragmentation (Chaube et al. 2005) and cytochrome c release (Liu et al. 2000). Moreover, 
exposure to H2O2 also attenuates spindle abnormalities and chromosome misalignment in 
oocytes (Choi et al. 2007; Shaeib et al. 2013) and increases cumulus cell death (Shaeib et al. 
2016). However, the exact mechanisms by which increased ROS in oocytes impacts 
subsequent embryo development and health is not entirely clear.  
 
Cumulatively, studies examining the phenotypes of oocytes from obese females and oocytes 
subjected to oxidative stress demonstrate that they have a lot of similarities in terms of 
cellular abnormality; specifically in terms of their mitochondrial dysfunction which can be 
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indicative of high levels of ROS (Zhang et al. 2006a; Igosheva et al. 2010; Lord and Aitken 
2013; Zhang et al. 2015). Mitochondria are also vulnerable targets of ROS. Free oxygen 
radicals can damage the mtDNA of quiescent oocytes and lead to the loss of their intrinsic 
mitochondrial function (Brenner et al. 1998; Barritt et al. 1999; Hsieh et al. 2004), such as 
accumulation of mtDNA mutations, decreased mtDNA copy number and mRNA expression 
of mitochondrial genes. Mitochondrial damage induced in oocytes by oxidative stress would 
have detrimental consequences for oocyte viability and developmental competence because 
mitochondrial function plays a major role in fertility. In particular the activity of 
mitochondria in both oocytes and preimplantation embryos is correlated with embryo 
development (Van Blerkom et al. 1995; Wilding et al. 2001). For instance, lower 
mitochondrial membrane potential (MMP) in disordered mitochondria leads to 
abnormalities of oocyte meiotic apparatus, resulting in chaotic mosaicism (where 
chromosomes segregate randomly) of embryos (Wilding et al. 2003). In addition, the 
interactions of mtDNA, proteins or lipids with ROS cause a decline of glutathione 
(GSH)/glutathione disulphide ratio (Tarin 1996), which may affect the stability of oocyte 
spindles. Furthermore, oxidative phosphorylation within mitochondria provides a major 
source of adenosine triphosphate (ATP) needed for mature MII oocytes that consume high 
levels of ATP (Dumollard et al. 2004). Mitochondrial over-production of ROS, however, 
does not generate ATP but rather consumes it, resulting in a decrease in ATP levels within 
oocytes and further exacerbating mitochondrial dysfunction. 
 
Importantly, we (Wu et al. 2015) have found that BGP-15, a nicotinic acid derivative is able 
to normalise the mitochondrial defects that occur in oocytes from obese mice. Others (Chung 
et al. 2008; Literati-Nagy et al. 2009; Literati-Nagy et al. 2010; Henstridge et al. 2014a; 
Henstridge et al. 2014d) have also been conducting experiments with BGP-15 and reporting 
that it is able to restore mitochondrial functions in stressed cells. More specifically, we found 
that treatment of obese mice with BGP-15 improved oocyte developmental competence by 
restoring mitochondrial activity and inducing mtDNA in oocytes; an effect that led to 
restored mtDNA levels in the blastocysts and fetal offspring tissues (Wu et al. 2015). Further, 
in the previous chapter, I showed that the presence of BGP-15 in mouse and cattle in vitro 
maturation (IVM) media was able to restore or maintain the mtDNA copy number in oocytes 
exposed to high lipid conditions. Others have also found that BGP-15 has beneficial effects 
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on mitochondria (Szabados et al. 2000; Halmosi et al. 2001; Sarszegi et al. 2012). It 
improves insulin sensitivity and inflammation in a genetic mouse model of insulin resistance 
(Chung et al. 2008), likely via increasing mitochondrial volume, and improves metabolic 
homeostasis in a rat model of type II diabetes (Henstridge et al. 2014a). Thus numerous 
reports indicate that BGP-15 is likely to confer protection against disturbed metabolic 
homeostasis via multiple modes of action including, but not limited to improving cellular 
function via its action on mitochondria. 
 
Although the mechanisms of BGP-15 action are not entirely understood and are likely to be 
cell-type specific, BGP-15 may be acting via reducing oxidative stress (Szabados et al. 2000; 
Halmosi et al. 2001). It was previously shown to have antioxidant properties in the kidney 
during cisplatin-induced nephrotoxicity (Racz et al. 2002). Previous reports have also 
attributed the beneficial effects of BGP-15 (nicotinic amidoxime derivatives) in pathological 
conditions with severe oxidative stress to their poly(ADP-ribose) polymerase (PARP)-
inhibitory and heat shock protein 72 (Hsp72) chaperone inducing effects (Vigh et al. 1997; 
Halmosi et al. 2001; Ray et al. 2001; Chung et al. 2008; Song et al. 2008).  
 
Thus I sought to determine the efficacy of BGP-15 in reversing oxidative stress in oocytes, 
and thereby further understand its mechanisms of action, particularly its beneficial effects in 
oocytes affected by high lipid conditions or obesity. Therefore, the experiments both 
investigated the direct effect of oxidative stress and increased oocyte intracellular ROS on 
oocyte developmental competence and differentiation; and examined the ability of BGP-15 
to alleviate any cellular defects, particularly mitochondrial defects. 
 
To mimic oxidative stress conditions, in vivo matured (ovulated) cumulus-oocyte complexes 
(COCs) were incubated with hydrogen peroxide (50 M, H2O2) for 30 min. The COCs were 
then fertilised in vitro using standard in vitro fertilisation (IVF) culture medium or medium 
containing BGP-15; to determine its ability to alleviate any cellular defects caused by 
oxidative stress. The results demonstrated the efficacy of BGP-15 in reversing oxidative 
stress-induced alterations in oocytes, and thereby allowed us to further understand its 
mechanisms of action in oocytes, particularly its beneficial effects in oocytes affected by 
high lipid conditions or obesity.  
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5.2 Materials and Methods 




All experimental procedures were approved by the University of Adelaide Animal Ethics 
Committee and were performed in accordance with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes. C57BL/6 mice were obtained from the 
University of Adelaide Laboratory Animal Services and housed in the Animal Facility under 
a 14:10 hour light:dark cycle with ad libitum access to food and water.  
Female mice (6 weeks of age) were hormonally induced to ovulate by intraperitoneal (i.p.) 
injection of 5 IU (international units) per 12 g body weight of pregnant mare's serum 
gonadotrophin (PMSG; National Hormone and Peptide Program, Torrance, CA, USA) 
followed 48 h later by 5 IU per 12 g body weight human chorionic gonadotrophin (hCG; 
Merck, Sharp and Dohme), each in 0.1 mL 0.9 % saline. Mice were humanely killed by 
cervical dislocation 13 h to 16 h post-hCG and COCs obtained from oviducts and collected 
in HEPES-buffered -minimum essential medium (MEM) handling media (Life 
Technologies, Invitrogen, Carlsbad, CA, USA) supplemented with 1% fetal calf serum (FCS) 
(Life Technologies, Invitrogen, Carlsbad, CA, USA) and pre-warmed to 37C prior to use. 
Male mice (8 weeks of age) of proven fertility were humanely killed by cervical dislocation 
and vas deferens/epididymis dissected for isolation of sperm for IVF. 
 
5.2.2 Short-term Hydrogen Peroxide (H2O2) Exposure 
For all experiments, immediately before fertilisation, COCs were incubated in 500 µL of 50 
µM of H2O2 for 30 min. Meanwhile, for the control group, ovulated COCs were kept in α-
MEM handling media without H2O2. COCs were then washed in α-MEM handling media 
and denuded with hyaluronidase by the addition of 10 µL of pre-warmed 1000 IU/mL 
hyaluronidase to the handling media, for live cell staining (JC-1 staining, detection of 
reactive oxygen species and autophagy assay). For IVF, COCs were first washed in α-MEM 
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handling media and then transferred to Cook wash media (William A. Cook Australia Pty. 
Ltd., Queensland, Australia) before fertilisation with sperm.  
 
5.2.3 In vitro Fertilisation (IVF) and Embryo Culture  
Fertilisation, wash and embryo culture media were Research Vitro Fertilisation, Research 
Vitro Wash and Research Vitro Cleave respectively from Cook Medical (William A. Cook 
Australia Pty. Ltd., Queensland, Australia). Stock concentration (1 mM) of BGP-15 (kindly 
provided by N-Gene Research Laboratories) was prepared in MilliQ water prior to use. 
Ovulated COCs cultured with or without H2O2 were used for (IVF). Epididymides and vasa 
deferentia from male mice were collected into 1 mL of warm (37C) fertilisation medium. 
Sperm were extracted into the medium and allowed to capacitate at 37C in an atmosphere 
of 6% CO2, 20% O2, nitrogen balance for 1 h. Ten L of capacitated sperm (35,000 
sperm/mL) was added to 90 L of fertilisation drop in the presence or absence of BGP-15 
(10 M), which contained the washed COCs (15-20 COCs per drop), followed by co-
incubation 4 h at 37C in an atmosphere of 6% CO2, 20% O2, nitrogen balance.  BGP-15 
treatment was applied on Day 1 of IVF in the fertilisation medium through to Day 5 (cleave 
medium also contained 10 M of BGP-15). 
 
On Day 2, fertilisation was assessed and 2-cell embryos were transferred into a fresh 20 L 
drop of Cook cleave medium (10-15 embryos per drop) and cultured at 37°C in an 
atmosphere of 5% CO2, 20% O2 and 95% air. . Embryo morphology was classified as 
appropriately developed (‘on-time’) using the following criteria; on Day 2, embryos at the 
2-cell stage and on Day 5, blastocysts or hatching blastocysts. Development rate was 
assessed on Day 2 as the percentage of embryos meeting the on-time development criteria 
from starting number of oocytes; while development on Day 5 as the percentage of embryos 
meeting the on-time development criteria from 2-cell embryos. 
 
In a separate series of experiments, time-lapse imaging was employed to more closely 
analyse developmental kinetics and cell size of oocytes. A Control + BGP-15 group was not 
included in the time-lapse experiments as no effect of BGP-15 was observed when compared 
to the untreated control group in the initial experiments. Oocytes were fertilised as 
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previously described and presumptive zygotes placed in 16-well dishes (Primovision, 
Vitrolife, Sweden), in culture medium and conditions as described above, and monitored by 
Primo Vision time-lapse embryo monitoring system (Primovision, Thermo Scientific 
HERAcell VIOS 160i CO2 incubator) with images of individual embryos generated every 
15 min throughout culture. The timing of morphokinetics events, including first, second and 
third cleavage division and cavitation were recorded and intervals between each event 
determined and analysed using the Primo Vision Analyser Software (version 4.4.1.01.010).  
 
5.2.4 Detection of Intracellular Reactive Oxygen Species (ROS) 
Stock concentration of CM-H2DCFDA (1 mM) was prepared in dimethyl sulfoxide (DMSO) 
prior to staining. Denuded oocytes or embryos (10-15 oocytes/embryos in 500 µL drop) were 
incubated with 10 M CM-H2DCFDA for 30 min at 37C in the dark. Oocytes or embryos 
were washed once with α-MEM handling medium and images were captured using the 
Olympus Fluoview FV10i confocal microscope using the green filter (excitation = 488 nm, 
emission = 519 nm). A single optical scan was acquired through the centre of the oocyte. 
Images were captured at 10x magnification and laser, sensitivity, and imaging parameters 
were kept constant between replicates and across experiments. Intensity of fluorescence was 
determined using Image J version 1.47r software by placing a circle across the oocyte image 
and measuring pixel intensity. The mean, area and integrated density (the sum of the pixel 
values in the circle) were reported and the corrected total cell fluorescence was calculated 
using the formula stated below. The data were then represented graphically as intensity of 
fluorescence over pixel widths. Three experimental replicates were performed, with 15 
oocytes per treatment group. 
Total fluorescence = Integrated Density- (Area of selected cell  Mean fluorescence of 
background readings) 
 
5.2.5 Autophagy Assay 
Autophagic vacuoles in live denuded oocytes were visualised using the Cyto-ID Autophagy 
Detection Kit (Enzo Life Sciences, Farmingdale, NY, USA) according to the manufacturer’s 
instructions. Briefly, oocytes were washed twice in 1x assay buffer followed by incubation 
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with dual-detection solution at 37°C in the dark for 30 min. Then oocytes were washed once 
with 1x assay buffer and imaged immediately in the green filter (excitation = 488 nm, 
emission = 519 nm) using the Olympus Fluoview FV10i confocal microscope. A single 
optical scan was acquired through the centre of the oocyte. Images were captured at 40x 
magnification and laser, sensitivity, and imaging parameters were kept constant between 
replicates.  Intensity of fluorescence was determined as described above for ROS staining. 
Two experimental replicates were performed, with 10 oocytes per treatment group. 
 
5.2.6 Mitochondrial Membrane Potential (MMP) Assay 
MMP was examined using the mitochondrial probe JC-1 (5,5’, 6,6’-tetrachloro-1,1’, 3,3’, 
tetraethylbenzimida-zolylcarbocyanine iodide (Invitrogen, CA, USA). Denuded oocytes or 
embryos were incubated with 1.5 mM JC-1 in handling media (oocytes)/Cook Vitro Wash 
(embryos) for 15 min at 37C in the dark. Oocytes or embryos were washed once in 1x 
phosphate buffered saline (PBS) with 1 mg/mL polyvinylpyrrolidone (PBS/PVP) and then 
imaged immediately using the Olympus Fluoview FV10i confocal microscope. Images were 
captured at 40x magnification and laser, sensitivity, and imaging parameters were kept 
constant between replicates. Intensity of fluorescence was determined as described above 
for ROS staining. 
 
5.2.7 Tetramethyl rhodamine methyl ester (TMRM) Staining 
Mitochondrial staining was performed using a modified method as previously described 
(Igosheva et al. 2010). To determine the distribution of active mitochondria in the oocytes 
were incubated with TMRM (Molecular Probes, Eugene, OR, USA). Mitochondrial 
distribution pattern is categorised as in (Ou et al. 2012b; Hou et al. 2016). TMRM is a 
fluorescent lipophilic cation sequestered by active mitochondria commonly used as a 
fluorescence indicator of MMP (Zhang et al. 2006b; Esteves et al. 2012). A stock 
concentration of 12.5 µM was prepared in DMSO and stored in the dark at -20C. Working 
concentration (25 nM) was obtained by diluting stock in pre-warmed-MEM handling 
media. Ovulated oocytes from hyaluronidase-treated COCs were incubated at 37˚C for 30 
min in the dark. Oocytes were then washed once in PBS/PVP and mounted under a coverslip 
in 5 µL PBS/PVP and then imaged using the Olympus Fluoview FV10i confocal microscope. 
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Images were captured at 40x magnification and laser, sensitivity, and imaging parameters 
were kept constant between replicates. Intensity of fluorescence was determined as described 
above for ROS staining. 
 
5.2.8 Mitochondrial DNA (mtDNA) Copy Number Quantification 
The mtDNA copy number in individual oocytes or embryos was quantified as previously 
described (Kameyama et al. 2010; Wu et al. 2015). Briefly, denuded oocytes or embryos 
were washed with PBS/PVP (1 mg/mL of PVP in PBS), collected individually into 1.5 mL 
siliconised low retention microcentrifuge tubes (Fisher Scientific) with 5 L of PBS/PVP 
and stored at -80°C. Genomic DNA was isolated using the QIAamp DNA micro kit (Qiagen) 
according to manufacturer’s protocol with carrier RNA (1 g; Qiagen) added to each sample. 
Genomic DNA was eluted with 50 L of water and diluted 10 times for quantitative PCR.  
 
To prepare the quantification standards, a 1186 bp fragment of the 12S ribosomal (r)RNA 
region of mtDNA was amplified from mouse liver by PCR using the primer pair 5′-
ACACCTTGCCTAGCCA-3′ and 5′-TTTGCCACATAGACGAGTT-3′ with the 
LongRange PCR kit (Qiagen), and then purified by using the QIAquick PCR purification kit 
(Qiagen) and cloned using the Qiagen PCR cloning kit (Qiagen). Plasmid DNA was purified 
from bacteria using Plasmid Maxi kit (Qiagen), and the concentration was determined by 
using a Nanodrop ND1000 Spectrophotometer (Biolab). Plasmid copy number was 
calculated as: mass of plasmid (g) = plasmid size (bp)×(1.096×10–21 g/bp); mass of plasmid 
required to generate 1×107 copy number standard stock = 1×107×mass of single plasmid. A 
standard curve was generated by using seven ten-fold serial dilutions (10−1×107 copies), and 
standard curve correlation coefficients were consistently greater than 0.98. Real-time 
quantitative PCR using the primer pair 5′-CGTTAGGTCAAGGTGTAGCC-3′ and 5′-
CCAGACACACTTTCCAGTATG-3′ was performed in triplicate using SYBR Green PCR 
master mix (Applied Biosystems) and a Rotor-Gene 6000. Primer sequences for the 
quantification of mtDNA were derived from (Kameyama et al. 2007). Standard curves were 
created for each run and sample copy number was generated from the equation of Ct value 
against copy number for the corresponding standard curve. 
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The PCR program employed an initial step of 95°C for 10 min followed by 40 cycles, 
denaturation at 95°C for 10s, annealing at 60°C for 30s and extension at 72°C for 20s. Every 
reaction was followed by melting curve analysis to ensure the specificity of the amplification. 
All reactions were performed in triplicate with total reaction volumes of 20 µL. Premix for 
quantitative PCR was prepared from Power SYBR Green PCR Master Mix (Applied 
Biosystems, CA, USA). The premix consisted of 10 μL of Power SYBR Green, 6 μL of PCR 
grade water, 2 μL of 50 µM primer pair, with 2 μL of DNA template added to 18 μL of 
premix for PCR reaction. 
 
5.2.9 Inner Cell Mass (ICM) and Trophectoderm (TE) Assessments 
Allocation of cells to TE and ICM lineages was assessed in blastocyst-stage embryos using 
a modified method of Handyside and Hunter (1984). Briefly, blastocysts were incubated 
with 0.5% pronase (Sigma-Aldrich, St. Louis, MO, USA) at 37C to remove the zona 
pellucida, followed by 10 min incubation at 4C in 10 mM TNBS (2,4,6-trinibrobenzene 
sulfonic acid) in the dark. Blastocysts were then washed and incubated with 0.1 mg/mL anti-
DNP for 10 min at 37°C. Following, blastocysts were washed again and incubated for 5-10 
min in 10 g/mL of propidium iodide (PI) in 10% guinea pig serum. Blastocysts were then 
transferred to 6 g/mL bisbenzimide in ethanol overnight and washed in 100% ethanol the 
following day. Blastocysts were then mounted on microscopic slides in glycerol underneath 
a cover slip and visualised using an epifluorescence microscope (Nikon, TE 2000-E) at 200× 
equipped with an ultraviolet filter (excitation, 340–380 nm; emission, 440–480 nm). ICM 
nuclei labeled with bisbenzimide appear blue whereas TE nuclei labeled with a combination 
of bisbenzimide and PI appear pink or red. Total and TE cell numbers were counted 
individually and ICM cell numbers were calculated by subtracting TE from the total cell 
number.  
 
5.2.10 Oct4/Cdx2 Staining of Blastocysts  
Expanded blastocysts were fixed in 4% paraformaldehyde (in PBS/PVP) overnight at 4C 
and then kept in PBS/PVP until needed. After fixation, blastocysts were incubated for 5 min 
in 0.1 M glycine (in PBS/PVP) at room temperature and permeabilised in 0.5% triton X-100 
(in PBS/PVP) for 30 min. Then blastocysts were incubated in blocking solution (10% 
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donkey serum in PBS/PVP) for 1 h, followed by incubation in primary antibodies (Oct3/4 
goat polyclonal IgG, Santa Cruz Biotechnology Sc-8628; Cdx2 rabbit monoclonal, Abcam 
ab76541) at a concentration of 1:500 in PBS/PVP overnight at 4°C. On the following day, 
blastocysts were transferred through several washes of PBS/PVP and placed in secondary 
antibodies diluted in PBS/PVP at 1:1000 concentration (Donkey anti-goat Alexa Fluor 488, 
Invitrogen A11055; Donkey anti-rabbit Alexa Fluor 594, Abcam ab150076) for 1 h at room 
temperature. Hoechst 33342 in 1:250 concentration (Life Technologies H1399) was added 
during the last 10 min of incubation. Blastocysts were transferred onto glass slides with a 
small amount (~5 µL) of glycerol under a coverslip for imaging. ICM nucleic labeled with 
Oct3/4 appear green, whereas TE nucleic labeled with Cdx2 appear red. Similar to 
differential staining, total and TE cell numbers were counted individually and ICM cell 
numbers were calculated by subtracting TE from the total cell number.  
 
5.2.11 Statistical Analyses 
All data were tested for normality of distribution prior to analyses. All measures are reported 
as mean ± SEM. Statistical significance was determined as indicated, by using Student's t-
test or one-way ANOVA with Tukey’s post hoc tests, as appropriate, using GraphPad Prism 
v008 (GraphPad Software, La Jolla, CA, USA) for Windows. Time-lapse data were analysed 
by using repeated measures with linear mixed-effects model in SPSS (IBM SPSS Statistics 
for Windows, Version 24.0. Armonk, NY: IBM Corp.). Normality of data was confirmed by 









5.3.1 H2O2 increases intracellular ROS in the oocytes 
To verify the effect of H2O2 on oocytes, ROS level was measured using 5-(and-6)-
chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA). Oocytes of 
COCs exposed to ROS clearly exhibited increased ROS levels compared to untreated 
oocytes (Figure 1A). Quantification verified that there was a significant increase in 
intracellular ROS in the H2O2-treated oocytes (P ≤ 0.01; Figure 1B). 
 
Active autophagy in live oocytes was measured using the Cyto-ID Autophagy Detection Kit. 
Confocal imaging revealed that both the control and H2O2-treated oocytes showed multiple 
green puncta throughout the oocyte cytoplasm (Figure 1C). Quantification showed no 
significant difference in fluorescence levels between the two groups (Figure 1D). 
  




Figure 1 Effect of short exposure of mouse oocytes to hydrogen peroxide (H2O2) on 
intracellular reactive oxygen species (ROS) and autophagy levels in the oocytes 
(A) Representative photos of oocytes stained with CM-H2DCFDA for detection of ROS. (B) 
Fluorescence intensity analysis of CM-H2DCFDA-stained oocytes. Data are presented as 
mean  SEM, n = 25-40 oocytes from four mice per group. (C) Live oocytes were assessed 
for autophagic vacuoles, visualised as green fluorescence. (D) Autophagy levels were 
quantified as the sum of total green fluorescence within each oocyte. Data are presented as 
mean  SEM, n = 10-17 oocytes from three mice per group. ** P  0.01, unpaired t-test. OS-
oxidative stress. Scale bar = 50 µm. 
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5.3.2 H2O2 alters oocyte mitochondrial activity and distribution 
The effects of oxidative stress (OS) imposed by H2O2 exposure resulting in excessive 
intracellular ROS levels on oocyte mitochondria were examined next. Firstly it was 
determined whether the MMP was altered. The oocytes exhibited red punctate fluorescence 
around the pericortical region, indicating a high membrane potential, whereas green 
fluorescence, an indication of low membrane potential, was confined to the cytoplasm of the 
oocytes (Figure 2A). In oocytes treated with H2O2, the red punctate fluorescence was visibly 
higher compared to that of oocytes from the control group. Analysis of the red to green 
fluorescence ratio, an index of mitochondrial activity, showed that the H2O2-treated oocytes 
have significantly increased mitochondrial activity compared to the control oocytes (P ≤ 
0.001; Figure 2B). The mtDNA copy number was also assessed in individual oocytes with 
no difference between the control and H2O2-treated oocytes was observed (Figure 2C). 
 
To further examine the distribution of active mitochondria, oocytes were stained with 
TMRM. Quantitative analysis of TMRM fluorescence intensity revealed that the H2O2-
treated oocytes exhibited significantly higher signal, an indicator of higher MMP (P ≤ 0.05; 
Figure 2E).  
 
The distribution of mitochondria in the oocytes was also examined. Based on a previous 
report (Ou et al. 2012a), MII oocytes were categorised into three groups based on their 
mitochondrial distributions: i) Homogeneous distribution (normal); ii) Surrounding 
chromosome (normal); and iii) clustered in the cytoplasm (abnormal) (Figure 2D). The 
majority of the control oocytes (77%) displayed homogeneous mitochondrial distribution 
pattern, while 13% showed clump mitochondrial distribution (Figure 5.2F). However, in the 
H2O2 treated group, the homogeneous mitochondrial distribution was less prevalent (29%) 
which was a significant reduction compared to the control group (77% versus 29%, P < 0.05) 
(Figure 2F). Interestingly, the distribution of heterogeneous mitochondria in large clumps 
was increased in the H2O2-treated oocytes compared with the control oocytes (53% versus 
13% in controls) (Figure 2F).  
  
















Figure 2 Mitochondrial activity and distribution in hydrogen peroxide (H2O2)-treated 
mouse oocytes.  
(A) Representative images of live mouse oocytes stained with JC-1, where red fluorescence 
indicates high mitochondrial membrane potential (MMP), and green indicates low MMP. (B) 
Ratio of red to green fluorescence, an indicator of mitochondrial activity. Data are presented 
as mean  SEM, n = 17-19 oocytes from three mice per group. (C) mtDNA copy number in 
individual oocytes collected from the indicated group. Data are presented as mean  SEM, 
n = 15 oocytes from three mice per group. (D) Representative images of live mouse oocytes 
stained with TMRM, where red fluorescence indicates the distribution of active 
mitochondria. (E) Quantitative analysis of TMRM fluorescence intensity. Data are presented 
as mean  SEM, n = 23 oocytes from four mice per group. (F) Proportion of MII oocytes 
with each distribution pattern. * P  0.05, *** P ≤ 0.001, unpaired t-test. OS- oxidative stress, 
TMRM- tetramethyl rhodamine methyl ester. Scale bar = 50 µm. 
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5.3.3 BGP-15 restores developmental competence of oocytes exposed to 
oxidative stress 
Ovulated COCs that had been exposed to H2O2 were fertilised in vitro, and oocyte 
developmental competence was compared to those of control untreated COCs. In addition a 
separate cohort of COCs exposed to H2O2 were subsequently treated with BGP-15 during 
IVF and embryo culture. Time-lapse imaging was carried out to closely monitor 
developmental kinetics of the ovulated COCs. Embryos cleaved at 14 h post-insemination 
and reached the 3-cell stage, 4-cell stage, morula and blastocyst at 40 h, 42 h, 68 h and 86 h 
respectively (Figure 3A). Interestingly, the timing of morphokinetic events revealed that the 
time to reach 4-cell was shorter in the OS+BGP-15 group when compared to the control (P 
≤ 0.05; Figure 3A). Similarly, the time duration for OS and OS+BGP-15 groups to reach 
blastocyst stage was shorter when compared to the controls (P ≤ 0.05; Figure 3A). On Day 
2 after fertilisation, the percentage of putative zygotes that cleaved was significantly lower 
in the H2O2-treated oocytes. When BGP-15 was added, no difference between the controls 
and OS group was observed (Figure 3B). Exposure of COCs to H2O2 did not impair 
subsequent blastocyst formation on Day 5. However, BGP-15 treatment improved blastocyst 
development, particularly in those where oocytes had been exposed to H2O2 (Figure 3C). 
The zygotes that were successfully cleaved on Day 2 were further analysed. The time to 
cleavage showed no significant difference between the groups. Interestingly, the transition 
time from 2-cell to 3-cell embryos was shorter in the H2O2 treated group compared to the 
control. However, embryos that were treated with BGP-15 took a shorter time to cleave from 
3-cell to 4-cell compared to the H2O2 treated group. Furthermore, BGP-15 treated embryos 
also took less time to develop from morula to blastocyst when compared to both the control 
and H2O2-treated group (Figure 3D).  
 
  
























Figure 3 Developmental kinetics and developmental competence in oxidative stress (OS) 
mouse oocytes. 
(A) Timing of developmental milestones in hours post-insemination (PI) in control, OS and 
OS+BGP-15 groups. Data are presented as mean  SEM, n = 24-30 embryos from four mice 
per group. (B) Cleavage rate was assessed in Day 2 and (C) blastocyst rate on Day 5. Data 
are presented as mean   SEM, n = 11 experimental replicates. (D) Time intervals between 
each developmental stage. Data are presented as mean  SEM, n = 24-30 embryos from four 
mice per group. Groups with different superscripts differ significantly by one-way ANOVA 
with Tukey’s post hoc test (P ≤ 0.01). * P ≤ 0.05, ** P ≤ 0.01, one-way ANOVA with 
Tukey’s post hoc test. 2C- 2-cell, 3C- 3-cell, 4C- 4-cell, ML- morula, BL- blastocyst. 
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5.3.4 Embryo mitochondrial activity and mtDNA biogenesis is impaired 
by oxidative stress but restored by BGP-15 
To examine the health of the resulting embryos, they were examined for mitochondrial 
activity, mtDNA replication and ROS levels. MMP in the embryos was assessed by JC-1 
staining. A significant reduction in the red:green fluorescence intensity of the JC-1 probe 
was observed in embryos derived from the OS group compared to control (P ≤ 0.05 ; Figure 
4A). This difference indicates a reduced mitochondrial activity in the embryos generated 
from the H2O2-treated COCs. However, this was not normalised with the BGP-15 treatment. 
Interestingly, BGP-15 supplementation caused a dramatic increase in the MMP in the control 
embryos (P ≤ 0.0001; Figure 4A). 
 
We next determined whether the intracellular ROS level in these embryos was altered by 
staining with the fluorescent probe CM-H2DCFDA. There was no increase in intracellular 
ROS in the OS embryos compared to control embryos. BGP-15 supplementation in IVF 
media resulted in a decrease in embryo ROS level in only the H2O2 treated embryos, but not 
the control embryos (P ≤ 0.05; Figure 4B). 
 
As another measure of mitochondrial capacity, mtDNA copy number was quantitatively 
assessed in individual embryos. The mtDNA copy number was reduced in the blastocysts 
from COCs that were treated with H2O2 compared with control blastocyst (P ≤ 0.01; Figure 
4C). Blastocyst mtDNA copy number was normalised by BGP-15 supplementation in the 
IVF medium (P ≤ 0.05; Figure 4C). In the control group, mtDNA levels were significantly 
up-regulated in the blastocyst-stage embryos. There was a 78% increase in mtDNA levels in 
the blastocysts when compared to the oocytes (P ≤ 0.01; Figure 4D). This phenomenon did 
not occur in the H2O2 group (Figure 4D). 
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Figure 4 Effect of oxidative stress (OS) and BGP-15 on mitochondrial activity, reactive 
oxygen species (ROS) and mitochondrial DNA (mtDNA) levels in mouse embryos.  
(A) Ratio of red to green fluorescence, an indicator of mitochondrial activity, in live embryos. 
Data are presented as mean  SEM, n = 10-17 embryos from four mice per group. (B) 
Fluorescence intensity analysis of CM-H2DCFDA-stained embryos. Data are presented as 
mean  SEM, n = 11-28 embryos from four mice per group. (C) mtDNA copy number in 
individual embryos collected from the indicated groups. Data are presented as mean  SEM, 
n = 17-28 embryos from four mice per group. Groups with different superscripts differ 
significantly by one-way ANOVA with Tukey’s post hoc test (P ≤ 0.01). (D) The mtDNA 
copy numbers in mouse oocytes and blastocysts, as determined by real-time PCR. Data are 
presented as mean  SEM, n = 15-28 embryos. ** P ≤ 0.01, unpaired t-test.  
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5.3.5 Embryo cell lineage allocation is affected by oxidative stress but 
restored by BGP-15 
To examine cell number embryos were stained for ICM and TE using two different methods; 
differential staining using propidium iodide (PI) and bisbenzimide stains and Oct4 and Cdx2 
immunohistochemistry. Following differential staining for ICM and TE, a significant 
difference in total cell number was seen between control and OS blastocysts (control= 
47.915 ± 0.888 vs OS= 40.34 ± 1.138, P < 0.0001, Figure 5A). This was attributable to 
blastocysts derived from OS oocytes having a significantly smaller ICM compared with 
control blastocysts (Figure 5C). However, there was no significant difference in the 
allocation of cells to the TE between the groups (Figure 5B) and, no difference was observed 
in the ICM:TE ratio between the control and OS groups (Figure 5D). Interestingly, BGP-15 
intervention in the IVF medium was able to restore the total cell number and ICM cell 
numbers in the OS embryos to a level that was comparable to the controls (Figure 5A and 
5C). In addition to that, BGP-15 supplementation also increased the ICM:TE ratio in the OS 
embryos (Figure 5D). 
 
Immunofluorescence for Oct4 and Cdx2 proteins was also performed to examine embryo 
cell number and lineage differentiation in the ICM and TE (Figure 6A). Based on previous 
reports, Oct4 distribution is restricted to the ICM by the mature blastocyst stage (Okamoto 
et al. 1990; Rosner et al. 1990; Scholer et al. 1990) whereas Cdx2 is found only in the TE 
(Beck et al. 1995; Niwa et al. 2005). Similar to previous findings (Szczepanska et al. 2011; 
Madeja et al. 2013), a strong signal of Oct4 staining was present in the nuclei of ICM but 
was much less intense in the nuclei of TE cells and the presence of Cdx2 protein was 
restricted to the nuclei of TE cells only (Fig 6A). Consistent with differential staining, total 
cell numbers in the embryos were much lower in the OS embryos when compared to those 
in the controls (Figure 6B). Similarly, no difference in TE cell number was observed (Figure 
6C) but there was a reduction in ICM cell numbers in the OS embryos (Figure 6D). 
Importantly, there was also an increase in the ICM:TE cell ratio in the OS embryos following 
BGP-15 supplementation (Figure 6E). BGP-15 supplementation also normalised the ICM 
numbers in the OS embryos but not their total cell numbers (Figure 6B and 6D). These results 
indicate that BGP-15 has some beneficial effect on cell proliferation and/or differentiation 
in the embryos. 
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Figure 5 Effect of oxidative stress in mouse oocytes and presence of BGP-15 in in vitro 
fertilisation (IVF) media on embryo lineage allocation. 
(A) Total cell number in embryos that reached blastocyst stage. (B) Trophectoderm (TE) 
cell numbers in the embryos. (C) Inner cell mass (ICM) cell numbers in the embryos. (D) 
Proportion of ICM to TE in the embryos. Data are presented as mean  SEM, n = 37-40 
embryos per group. Groups with different superscripts differ significantly by one-way 
ANOVA with Tukey’s post hoc test (P ≤ 0.01). 
  



















Figure 6 Immunofluorescence of Oct4 and Cdx2 in expanded mouse blastocysts.  
(A) Representative blastocysts stained for Oct4 ICM marker (green), Cdx2 TE marker (red) 
and Hoechst 33342 DNA marker (blue). (B) Total cell numbers detected by Hoechst 333342. 
(C) Trophectoderm (TE) cell numbers determined by Cdx2+ staining. (D) Inner cell mass 
(ICM) cell numbers determined by Oct4+ staining. (E) Proportion of ICM to TE in the 
embryos. Data are presented as mean  SEM, n = 20-21 embryos per group. Groups with 
different superscripts differ significantly by one-way ANOVA with Tukey’s post hoc test (P 
≤ 0.01). Scale bar = 100 µm. 




The data in this chapter show that acute exposure of COCs to H2O2 increases ROS levels in 
the oocytes and alters mitochondrial localisation and activity and causes an impaired 
cleavage rate. BGP-15 treatment improved blastocyst development only in embryos from 
H2O2-treated COCs. Embryo differentiation was altered as shown by a reduction in 
blastocyst cell numbers, particularly ICM cells, in the embryos generated from the H2O2-
treated COCs; and this was normalised with BGP-15 treatment. ROS levels in embryos from 
H2O2-exposed oocytes were not different compared to control embryos, but were reduced 
by BGP-15 treatment. Both MMP and mtDNA copy number in the embryos generated from 
the H2O2-treated COCs were decreased compared to the control. BGP-15 did not alter MMP 
in embryos from H2O2-treated oocytes, but was able to restore mtDNA copy number in these 
embryos. 
 
It is currently unclear what mechanisms underlie such differences in mitochondrial activity 
between control and oxidative-stressed oocytes. It is possible that as ROS production is 
increased, rapid mitochondrial respiration took place in order to maintain redox homeostasis 
within the oocytes and it is possible that the distributional change of mitochondria that we 
observed may contribute to this process. Whether oocytes that show increased MMP also 
have abnormally higher ATP content remains to be determined. 
 
Cleavage rate, but not blastocyst development, was impaired following exposure to H2O2. 
This finding may be due to the fact that the first cleavage corresponds to the critical phase 
in which genomic activation occurs, transitioning from maternal to embryonic control of 
development. Analysis of the embryos that were generated with H2O2-treated COCs showed 
that embryo development time was shorter as they progressed from 2-cell to 3-cell stage and 
that BGP-15 treatment resulted in embryos reaching blastocyst stage at a faster rate when 
compared to the controls and embryos generated from H2O2-treated COCs. It is important to 
highlight that it is unclear if early cleavage between developmental stages is an independent 
predictor of pregnancy or if it is correlated with other variables such as embryo morphology 
and cell number. Furthermore, preimplantation genetic screening (PGS) has revealed that 
embryos with abnormal cleavage can develop to blastocysts with chromosomal 
abnormalities yet appear morphologically indistinguishable from normal embryos 
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(Sandalinas et al. 2001; Somfai et al. 2010; Chavez et al. 2012; Dal Canto et al. 2012; 
Campbell et al. 2013a; Campbell et al. 2013b).  
 
BGP-15 in the IVF medium improved embryo development in the H2O2-treated COCs. In 
our previous obese mouse model, we also observed significant improved blastocyst 
development in obesity-stressed oocytes when treated with BGP-15 in vivo. Although the 
precise molecular mode of action of BGP-15 is not yet completely clear, our results clearly 
implicate its effectiveness in the presence of cellular stress, similar to previous reports 
(Chung et al. 2008; Nagy et al. 2010; Crul et al. 2013). In the present study, BGP-15 reduced 
ROS levels in the embryos generated from H2O2-treated COCs indicating its antioxidant 
effect. However, it was previously reported to induce mitochondrial replication factors Tfam 
(transcription factor A, mitochondrial) and Drp1 (dynamin related protein 1) in oocytes in 
vivo (Wu et al. 2015) and increase mitochondrial numbers in the muscle (Henstridge et al. 
2014a). Thus, it is likely that BGP-15 improves embryo development by enhancing 
mitochondrial biogenesis. 
 
Although a source of ROS, mitochondria are also a target of ROS and their responses to 
oxidative stress have been investigated in various fields. A reduced MMP was observed in 
the embryos generated from the H2O2-treated COCs but was not normalised with BGP-15 
treatment. Our present results demonstrate that dysfunction of embryo mitochondrial activity, 
which is directly caused by accumulation of ROS in the oocytes, may further impair 
mitochondrial biogenesis and normal cell proliferation in the embryos. Measurement of 
mtDNA is often used as a proxy for mitochondrial number, however there is often little 
correlation between mtDNA copy number and the number of mitochondria or mitochondrial 
function. For instance, expression of human transcription factor A in mouse embryos 
significantly increases mtDNA copy number, but with no detectable effect on mitochondrial 
number, measured by mitochondrial mass or maximal respiratory capacity (Ekstrand et al. 
2004).  Similarly in the present study, even though there was a restoration in mtDNA copy 
number in the presence of BGP-15 in the stressed embryos, this was not accompanied by an 
increased MMP.  In human embryos, as well as in mice, lower mtDNA copy number in 
embryos correlates with reduced viability (Stojkovic et al. 2001; Santos et al. 2006; Ge et 
al. 2012), suggesting some benefit to increased copy number in the presence of BGP-15 in 
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the IVF culture media. The increase in mtDNA copy number in response to BGP-15 may be 
indicative of increased mitochondrial biogenesis. Importantly the current results cannot 
discern whether mtDNA copy number (or number of mitochondria) is differentially affected 
in cells of the ICM versus TE. 
 
Because the exposure of COCs to H2O2 caused a reduction in ICM cell numbers, oxidative 
stress in oocytes is likely to influence cell lineage and numbers required for normal growth 
and thereby have long-term effects for the embryos into adulthood.  Analysis of blastocyst 
differentiation revealed a reduction in total and inner cell mass (ICM) cells in the embryos 
generated from the H2O2-treated COCs compared to the control embryos. The ICM cells are 
relatively quiescent compared with the TE cells, so the reduction in ICM cells may indicate 
that cells giving rise to the ICM are more susceptible to oxidative stress. Also, ICM cells 
were not themselves directly counted therefore the ICM numbers derived could be due to 
errors in counting the TE or total cell numbers accurately. Interestingly, when sperm were 
exposed to H2O2, the resulting embryos also had reduced blastocyst total and ICM cells, 
similar to the phenotype observed in this study (Lane et al. 2014). In the current study, it is 
unknown whether BGP-15 had any impact on the sperm, which then manifested in improved 
embryo development. An effect on sperm is unlikely however,  in light of the findings in 
Chapter 3 and in (Wu et al. 2015), where BGP-15 was shown to work more effectively in in 
vivo environment and in addition has no discernible effects in the absence of cellular stress 
(Chung et al. 2008; Nagy et al. 2010; Crul et al. 2013). Studies have shown that decreased 
ICM cell number may be a causative factor for fetal growth retardation (Lea et al. 1996; 
Kwong et al. 2000). A reduction in the number of ICM cells in the blastocyst is also 
reflective of reduced embryo viability post-transfer (Lane and Gardner 1997; Lane et al. 
2014). Additionally, in rodents, blastocyst cell numbers as well as the proportion of cells 
within the late blastocysts have also been shown to positively correlate with implantation 
and pregnancy rates (Lane and Gardner 1997). This suggests that the presence of BGP-15 in 
IVF medium could potentially improve implantation and live birth rates, by restoring cell 
allocation in the blastocyst. It is also important to note that there was an apparent difference 
of approximately 20 cells in the blastocyst total cell count between Figure 5 (differential 
staining) and Figure 6 (Oct4/ Cdx2 immunohistochemistry). This was due to different culture 
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condition (single drop versus group culture) and also different stages of development of the 
embryos (blastocyst (Fig 5) versus expanded blastocyst (Fig 6)). 
 
In conclusion, the present study shows that the presence of oxidative stress increases ROS, 
alters mitochondrial activity and disturbs normal mtDNA replication processes. In support 
of this, mtDNA content does not change markedly in embryos from oxidative-stressed 
oocytes during embryogenesis; remaining static at an average of 6.5×105 copies in oocytes 
to 6.3×105 copies in blastocysts. By contrast, embryos from the control oocytes increased 
mtDNA from 6.3×105 copies to 12.0×105 copies, as is known to occur in preparation for 
implantation and consistent with the results in Chapter 4 Fig. 1A.  Our results also 
demonstrate that COCs are acutely responsive to oxidative stress which impairs cleavage 
rates as well as embryo differentiation potentially via effects on mitochondria. Importantly, 
BGP-15, a drug currently in human clinical trials, is able to alleviate the effects of oxidative 
stress in oocytes and improve embryo development. These provide us with a better 
understanding of oocyte and embryo capability to counteract stress with BGP-15 and also 
demonstrate the possibility that BGP-15 (or a similar) supplement in media may result in 
improved embryo development. 
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6.1 Summary and Future Directions 
It is now well-established that environmental and metabolic insults occurring early in 
development can have long-term health implications (Perera and Herbstman 2011). In 
particular, maternal obesity during the peri-conceptual period negatively affects oocyte 
developmental competence (Robker 2008; Lane et al. 2015). The need to further study this 
effect is driven by the increasing prevalence of metabolic conditions such as obesity and 
diabetes. Nevertheless, although there are some known consequences of maternal obesity on 
oocytes such as altered mitochondrial activity and compromised embryo development 
(Igosheva et al. 2010; Wu et al. 2011; Luzzo et al. 2012; Wu et al. 2015; Hou et al. 2016), 
the mechanisms remain largely unknown. However, before we can hope to reverse any 
adverse outcomes arising from peri-conception maternal obesity, we must quantify the 
sensitivity of oocytes to different environmental and metabolic insults and understand the 
causal mechanisms involved. 
 
The research in this thesis was aimed at explaining how a perturbed metabolic environment 
acts during the periconception period to causes long term developmental outcomes. 
Cumulatively, these studies show that 1) cholesterol in mouse oocytes is required for 
embryogenesis and formation of membrane functional domains in blastocysts, 2) maternal 
high-fat diet alters oocyte lipid raft distribution and 3) high lipid conditions or oxidative 
stress in oocytes impacts mitochondrial DNA (mtDNA) copy numbers in embryos. I also 
provide evidence in multiple species and physiological contexts that BGP-15 counteracts 
stress via its effect on mitochondria.  
 
It is well-established that the cumulus-oocyte complex (COC) relies on follicular fluid for 
nutrients, cytokine/growth factors and other peptide hormones, steroids and energy 
substrates (Dumesic et al. 2015). The composition of follicular fluid is generally reflective 
of venous blood (Revelli et al. 2009); hence, poor maternal health, resulting in abnormal 
metabolic profiles systemically, is reflected within the follicular environment. One major 
metabolite in the follicular fluid is cholesterol, as well as triglycerides and free fatty acids. 
These are known to be altered in obesity creating an ‘obesogenic environment’ for the oocyte 
that can be mimicked and studied in vitro using high palmitic acid lipid or a blend of high 




markers are also increased in follicular fluid in numerous contexts, for instance it has been 
localised in the follicular fluid in the patients undergoing in vitro fertilisation (IVF) and 
intracytoplasmic sperm injection (ICSI) (Oyawoye et al. 2003; Pasqualotto et al. 2004) and 
in this thesis this ‘maternal environment’ was emulated using simple hydrogen peroxide. 
These approaches enabled me to explore the effects of a variety of environmental conditions 
which the oocyte might experience, on its subsequent development and differentiation.  
 
One remarkable insight from this thesis has been the importance of cholesterol in membrane 
raft formation that confers developmental competence. The compromised embryo 
development outcome and changes in cell lineage numbers that result from altering oocyte 
cholesterol levels support the concept that disrupted rafts may also be one of the underlying 
issues with obesity-mediated effects on conception rates. Although much is known about the 
role of cholesterol in cardiovascular disease, its relationship with the female reproductive 
system is only beginning to be understood. My observations have confirmed the need to 
better understand the roles of cholesterol metabolism within follicular fluid on oocyte quality 
and developmental competence. Future studies to elucidate the mechanisms that regulate 
intrafollicular cholesterol transport during folliculogenesis and the role of cholesterol in 
membrane trafficking and signaling in oocytes are needed. Based on the findings of raft 
distribution patterns reported in this study, it will be worth identifying the proteins that are 
located in the embryonic lipid rafts and to understand their role in membrane organisation 
and cell signaling events in the context of their location within lipid raft structures. Given 
that BGP-15 treatment resulted in only partial restoration of lipid rafts in the blastocysts 
from female mice fed a high-fat diet (HFD), this suggests that there remains some residual 
impact of the HFD or increased maternal adiposity. I would predict that full restoration could 
be achieved from a longer duration of BGP-15 interventions, i.e. through to the blastocyst 
stage rather than preconception only, but this remains to be determined. 
 
I propose that mitochondrial dysfunction and oxidative stress may act as the initiators for a 
cascade of events that create the HFD oocyte phenotype. Operational mitochondria are 
crucial to normal oocyte function, with these organelles representing the primary source of 
adenosine triphosphate (ATP) production within both oocytes and early embryos (Babayev 




oxidative stress exposure has been demonstrated by a loss of mitochondrial activity, 
followed by a reduction in mtDNA in embryos. Therefore, it is likely that loss of 
mitochondrial integrity results in aberrant protein synthesis, particularly of the respiratory 
chain complexes, and inactivation or loss of mtDNA. 
 
I also hypothesise that oxidative stress may act as the ‘trigger’ for a cascade of other factors 
that orchestrate mitochondrial dysfunction, as well as directly affecting multiple aspects of 
oocyte biochemistry and functionality. Oxidative stress has the potential to directly affect 
mitochondrial function and I have shown that oxidative stress is linked with changes in 
mitochondrial activity and mtDNA levels. The DNA, proteins and lipids within the 
mitochondria are particularly susceptible to oxidative attack, not only because of their close 
proximity to the source of ROS production, but in the case of mtDNA, because of the absence 
of protective histones and repair mechanisms (reviewed by (Alexeyev 2009)). In mammals, 
mtDNA is maternally inherited and transmitted for many generations (Sato and Sato 2013). 
Therefore, changes in mtDNA copy number and/or mutation load are carried into the next 
generation and in some circumstances may influence offspring metabolism, fertility and/or 
aging. However, not all mutations are carried through, and there are commonly thresholds 
above which mutation load must exist for a phenotypic effect. 
 
The findings that environmental insults (maternal HFD, high lipid conditions and oxidative 
stress) negatively impacts mitochondrial activity and mtDNA provides mechanistic insight 
into how perturbed oocyte biology could contribute to long-term health of the embryos. In 
Chapter 4, I showed that mtDNA levels varied between species and acted differently in 
response to BGP-15. Differences in mtDNA replication observed may be due to difference 
in oocyte lipid profiles in the different species. Intriguingly, in invertebrate species lipid 
droplets seem to regulate the function of proteins related to embryo genome activation. Thus, 
lipid stores in oocytes may function not only as a source of energy reserve, but also as a 
potential reservoir for signaling factors that play a role in cellular fate for mammalian early 
embryo development (Kim et al. 2012).  Importantly, I document a relationship between 
mtDNA quantity and improved embryo development and embryo health. This was shown in 
the mouse and bovine studies in Chapter 4 and oxidative stress model in Chapter 5. Notably, 




associated with the embryos; for instance impairments in the transcription of essential 
mitochondrial genes. Taken together, the studies in Chapters 3, 4 and 5 provide evidence 
that the perturbations in oocytes, embryo development and embryo health are not entirely 
permanent and can be at least in part reversed by BGP-15 intervention. Although the precise 
molecular mode of action of BGP-15 is not yet completely clear, our results implicate its 
effectiveness in the presence of cellular stress, consistent with previous reports (Chung et al. 
2008; Nagy et al. 2010; Crul et al. 2013). Based on the findings in this thesis, it is clear that 
BGP-15 acts on the mitochondria irrespective of species. Recent studies also reported that 
BGP-15 has a protective role by preserving mitochondrial integrity and reducing 
mitochondrial ROS production (Sumegi et al. 2017) and improved mitochondrial function 
by increasing mitochondrial content (Salah et al. 2016). So, future studies are needed to fully 
delineate the molecular mechanisms by which BGP-15, directly and/or indirectly, acts on 
oocyte/embryo mitochondria. 
 
Supplementation of BGP-15 in in vitro maturation (IVM) and in vitro fertilisation (IVF) 
provides a means to increase mtDNA in both the oocytes and embryos under stress 
environments. The increase in mtDNA following BGP-15 treatment suggests that there may 
be an increased stimulation of mitochondria biogenic pathways or mtDNA replication to 
compensate for impaired mitochondrial functions. However, it is yet unclear whether this 
increase in mtDNA is the result of a general increase in transcription of nuclear genes, or 
whether mitochondria have a specific role to play in this process such as a shift in 
mitochondrial metabolism; therefore these possibilities need to be further evaluated. Future 
studies could be directed towards elucidating these by using knockout mouse models for 
nuclear-encoded mitochondrial genes and examining whether mtDNA levels are still 
regulated by BGP-15. Regardless of whether mtDNA replication occurs when the embryonic 
genome is activated, mtDNA copy number was not increased until at least the blastocyst 
stage in the mouse and macaque. Future studies such as embryo transfer studies are also 
required to investigate the relationship of increased/decreased mtDNA in implantation, 






Although promising, there are some limitations associated with the present studies. One of 
the constraints is that the experiments were in vitro and such experimental design may 
increase the risk of artefactual response as in vitro environments do not entirely mimic in 
vivo conditions and therefore may cause a decline in the developmental competence of IVM 
oocytes. An in vitro maturation environment would impair not only spindle assembly and 
cytoplasm maturation but also DNA epigenetic modifications and subsequent RNA 
transcription and protein expression (Anckaert et al. 2013; El Hajj and Haaf 2013). Another 
confounder is variations among species. The use of abattoir material prevents the ability to 
identify whether oocytes were from obese or lean females, so variation would be expected 
in the ability of BGP-15 to modulate oocyte or embryo characteristics. Equally, the high 
lipids added in the studies are tailored for each species, therefore the current findings may 
be due to these biological differences in lipid profiles in these species.  
 
In conclusion, my research extends our understanding of the mechanisms by which the 
preimplantation period is a critical stage in which the environment impinges on development. 
The data generated in this thesis provide information on the interplay between membrane 
rafts, mitochondrial activity, mtDNA copy number and cell response upon alteration of 
environmental cues. These provide new insights into fundamental mechanisms that may 
determine human oocyte quality and subsequent healthy development, which may lead to 
new measurements or therapies of human fertility. In particular, this study highlights the 
importance of mitochondria as a determinant of developmental competence, indicating that 
it will be of value to increase our understanding of the biochemical processes by which 
mitochondria impinge on continued developmental progression and embryo metabolism. 
The direct mechanism by which BGP-15 exerts its effect on mtDNA levels and alleviates 
stress responses on subsequent embryo health is clearly multifactorial. Importantly, BGP-15 
provides a means to increase mtDNA levels and improve embryo development, providing 
new leads for future therapeutics aimed at combatting the impact of metabolic syndrome on 
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Table 1 High-fat diet (HFD) ingredients (made in-house using the same recipe as 
D12492; Research Diets, Brunswick, NJ) 





Potassium Citrate 21.318 
Dicalcium Phosphate 16.796 
Mineral Mix 12.92 
Vitamin Mix 12.92 
Calcium Carbonate 7.106 
L-Cystine 3.876 
Choline Bitartrate 2.589 





Table 2 Nutrient compositions present in the high-fat diet (HFD) 
 Standard chow (SF-105) HFD (D12492) 
Nutrient kcal% g% kcal% g% 
Protein 16 19.6 20 26.2 
Carbohydrate 64 48.3 20 26.3 
Fat 20 10 60 34.9 






Table 3 Summary of Lineage-Specific Protein Detection in Preimplantation Embryos 
Transcription 
factor 





(Oct4 / Pou5f1) 
In all cells of the early embryo 
from 8- to 32-cell stage. By the 
mature blastocyst stage, its 
distribution is restricted to the 
ICM 
 Essential for establishing and 
maintaining pluripotency of the ICM 
 Essential to prevent ICM from 
diverting towards the TE lineage 
 Oct4 null embryos die around the time 
of implantation and fail to outgrow in 
culture 
(Nichols et al. 1998; Avilion et al. 
2003; Niwa et al. 2005; Strumpf et al. 
2005; Ralston and Rossant 2008; Guo 




Levels of Sox2 decrease in the 
embryo until it reaches its 
lowest levels at 8-cell 
stage/morula. By the mature 
blastocyst stage, its expression 
is restricted to the ICM 
 Pluripotency in blastomere 
 May act to maintain or preserve 
developmental potential 
 Its down-regulation correlate with a 
commitment to differentiate, such that 
it is no longer expressed in cell types 
with restricted developmental potential 
(Avilion et al. 2003; Niwa et al. 2005; 





In all cells of the early embryo 
from 8- to 32-cell stage. By 
64-cell stage, it is exclusively 
expressed within the ICM. By 
the mature blastocyst stage, its 
distribution is restricted to the 
ICM 
 Maintenance of pluripotency in ICM 
 Oct4 and Sox2 together promotes the 
expression of Nanog 
(Avilion et al. 2003; Niwa et al. 2005; 








Ubiquitous before 32-cell 
stage. Found only in the TE 
 Key role in trophectoderm 
specification 
 Expression regulated by the 
transcriptional regulator Tead4 
 Important for down-regulating the 
expression of Oct4 and Nanog 
 Influences cell polarity by up-
regulating polarity genes such as 
aPKC 
 In the absence of Cdx2, TE cell 
identity cannot be maintained in the 
blastocyst stage 
(Strumpf et al. 2005; Dietrich and 
Hiiragi 2007; Jedrusik et al. 2008; 





Ubiquitously expressed from 
the 2-cell stage onwards 
without an apparent 
localisation to ICM or TE 
 Act upstream of Cdx2 to regulate TE 
formation 
 Crucial for the initiation of TE 
formation 
 Tead4-null embryo exhibits defects 
specifically in TE 
(Yagi et al. 2007; Nishioka et al. 2008; 





similar to Yap) 
mRNA and nuclear protein 
detectable from 4-cell stage 
onwards 
 Dominant-negative Yap expression 
leads to reduced Cdx2 expression 
 Overexpression in inner cell mass of 
blastocyst induces Cdx2 expression 
 
(Stephenson et al. 2012) 
Eomesodermin 
(Eomes) 
Protein undetectable until 
blastocyst stage, TE-restricted 
 Encodes a T-box transcription factor (Ciruna and Rossant 1999; Russ et al. 




  expression by the blastocyst 
stage 
 Knockout of Eomes leads to failure to 
TE proliferation downstream from 
Cdx2 
 Control the establishment of 






Detected at late 8-cell stage, 
TE restricted expression by the 
blastocyst stage 
 Involved in the transcription factor 
networks that drive trophoblast cell 
lineage development 
 Expression dependent on Tead4, 
suggesting that Gata3 and Cdx2 act in 
parallel pathways downstream of 
Tead4 and function to activate target 
genes within the TE lineage 
(Home et al. 2009; Ralston et al. 2010) 
Kruppel-Like 
Factor 5 (Klf5) 
Ubiquitously early, strong in 
TE, weak in ICM of blastocyst 
 Required for the formation of the TE 
and ICM, and for repressing primitive 
endoderm development 





Table 4 Techniques used to identify membrane lipid rafts. Adapted from (Simons and Toomre 2000) 
Approach Purpose Live cells Comments 
Flotation of detergent-resistant 
membranes (DRMs) 
Identifies putative raft association 
Identifies possible raft proteins 
No  Easy to do 
 Most common approach for identifying 
putative proteins involved in signaling 
 Weak associations with rafts are difficult 
to detect 
Antibody patching and 
immunofluorescence 
microscopy 
Identifies putative raft association No  Easy to do 
 Common approach 
 Better than floatation for detecting weak 
raft associations 
 Cell-cell variability makes 
quantification difficult 
Immunoelectron microscopy Determines location of raft 
components 
No  Promising results 
 Requires technical expertise 
Chemical crosslinking Identifies native raft protein 
complexes 
Yes  Straightforward  
 Choice of appropriate conditions and 
reagents is semi-empirical 
Single fluorophore tracking 
microscopy 
Monitors the diffusion and dynamics 
of individual raft proteins or lipids 
Yes  Requires highly specialised equipment 
and expertise 
Photonic force microscopy Determined the diffusion constant, 
size and dynamics or individual rafts 
Yes  Very informative technique 
 Requires highly specialised equipment 




 Time-consuming acquisition and 
analysis 
Fluorescence resonance energy 
transfer (FRET) 
Detects whether two raft components 
are spatially close (for example, 
<10nm) 
Yes  Powerful approach 
 Choice of appropriate donor and 
acceptor probes is important 







Figure 1 Arcsine Transformation on embryo developmental rates. 
To validate the statistical analysis on embryo development, data was arcsine transformed. 
Arcsine transformed data showed no difference to the original data in the thesis. (A) 
Developmental data from Chapter 2 (Figure 3A). (B) Mouse developmental data from 
Chapter 4 (Figure 3B and 3C). (C-D) Cattle developmental data from Chapter 4 (Figure 6A 
and 6B). (E-F) Mouse developmental data from Chapter 5 (Figure 3B and 3C). Groups with 
different superscripts differ significantly by one-way ANOVA with Tukey’s post hoc test. * 
P ≤ 0.05, **** P ≤ 0.001. MβCD- methyl-beta cyclodextrin, PA- palmitic acid, NEFA- non-
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